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Cerebral small vessel disease and cognitive performance 
Cerebral small vessel disease (SVD) encompasses all the pathological processes that affect 
the small vessels of the brain, including small perforating end-arteries and arterioles 
supplying the white matter, deep grey matter nuclei and brainstem As these small vessels 
cannot be visualized in vivo yet, the parenchymal lesions that are thought to be caused by 
changes in these vessels have been adopted as an imaging marker of SVD On magnetic 
resonance imaging (MRI), cerebral SVD is characterized by small focal areas of infarction 
(lacunar infarcts), more diffuse areas of incomplete ischemia (white matter lesions (WML)), 
and perivascular collections of hemosiderin deposits (microbleeds) (Box 1) 
Cerebral SVD is common m elderly people, it increases with age and is associated with 
vascular risk factors, in particular hypertension 1 2 The prevalence of SVD varies considerably 
across studies depending on the population studied and the imaging technique used In 
the general population, WML occur in 90%, lacunar infarcts m 20% and MB in 5% of the 
individuals over 60 years of age 3 5 In addition, there is accumulating evidence of SVD related 
parenchymal involvement, in the 'normal appearing white matter (NAWM)', that is not 
visible on conventional MRI 
In this thesis we use the term SVD to describe the cerebral lesions related to arterio(lo) 
sclerosis and vascular risk factors, which is by far the most prevalent form of SVD Other 
forms of SVD, as hereditary SVD (e g hereditary cerebral amyloid angiopathies and Cerebral 
Autosomal Dominant Artenopathy with Subcortical Infarcts and Leukoencephalopathy) 
and inflammatory or infectious SVD (ι e small vessel vasculitis) will not be discussed m this 
thesis 
Clinical manifestations of cerebral SVD consist of both acute symptomatology, such as 
transient ischemic attacks and lacunar syndromes, and of subacute symptoms, such 
as cognitive, motor (gait) and mood disturbances, and urinary symptoms such as urge 
incontinence 6 The clinical spectrum is heterogeneous ranging from mild symptoms to full 
blown dementia Brain changes often exist long before subacute symptoms become evident 
Therefore, it has been suggested that m clinical studies the selection of individuals should be 
based on the more consistent brain imaging features (ι e based on the presence of SVD)7 
Both hospital and population-based studies have shown a relation between WML, lacunar 
infarcts and MB and cognitive impairment8 " In addition WML and (silent) lacunar infarcts 
have shown to be predictors of cognitive decline and dementia 1 2 1 5 
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Box 1. Conventional magnetic resonance imaging 
In cerebral SVD, a number of abnormalities 
can be observed with conventional MRI 
sequences, encompassing ischaemic and 
haemorrhagic manifestations. 
WMLs are defined as white matter 
hyperintensities on T2 weighted sequences, 
such as fluid-attenuated inversion recovery 
(FLAIR) scans, which are not, or only faintly, 
hypo-intense on T l weighted images. They 
range from small focal lesions to more or 
less confluent areas that are bilaterally 
and symmetrically sited in the hemispheric 
white matter.16 
White matter lesions 
Lacunar infarcts are defined as foci with 
low signal intensity on T l and 12 weighted 
images, ruling out enlarged perivascular 
spaces and infraputaminal pseudo-
lacunes.16 There is no full consensus on 
the size of lacunar infarcts; the maximum 
accepted diameter is 15 mm, because 
this is the size derived from the original 
pathological studies.1718 A consensus on 
the minimum diameter is more difficult to 
establish; we used a cut-off size of 2 mm. 
Lacunar infarcts 
Cerebral microbleeds are round or ovoid 
lesions, seen on gradient echo T2* weighted 
imaging as black lesions with a blooming 
effect, representing hemosiderin deposits.19 
They are mostly located in the basal ganglia 
or cortical-subcortical areas. They must be 
distinguished from other potential mimics 
such as iron or calcium deposits, bone or 
flow voids. Various size cut-off points have 
been used to classify microbleeds, with a 
maximum diameter of 5-10 mm.20 
Microbleeds 
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In patients with SVD, cognitive impairment is usually of a characteristic 'subcortical' pattern 
and include psychomotor slowing due to impaired executive function, déficits of attention, 
planning and set-shifting 6 Symptoms are thought to be caused by white matter tract 
disruption and a subsequent 'disconnection-syndrome', due to disruption of cortical-cortical 
and cortical-subcortical connections 21 
Individuals with virtually identical SVD burden on conventional MRI present with a wide 
variance of cognitive performance, independent of other factors, such as AD pathology, 
depressive symptoms and previous cognitive level, that also are known to influence cognitive 
function The majority of individuals with SVD have no complaints at all, others present with 
subjective cognitive complaints or objective cognitive impairment, whereas only a relatively 
small proportion presents with dementia There might be other SVD related changes, apart 
from those visible on conventional that determine whether identical appearing SVD on 
conventional MRI leads to cognitive decline in one person, while leaving others more or less 
unaffected 
One of these factors could be the presence cerebral microbleeds(MB), not visible on routine 
T l and 12 weighted sequences 
Another factor could be the heterogeneity of white matter lesions itself, as identical 
appearing WML on conventional MRI are heterogeneous at pathological examination 2223 
It could be that only the WML with the highest loss of microstructural integrity are related 
to cognitive impairment and decline Furthermore, it is also important to realize that only 
a small proportion of the white matter (usually less than a few percent) is affected by SVD, 
even among individuals with severe SVD ^  As conventional MRI is not sensitive to early loss 
of microstructural integrity in the NAWM, changes m this largest part of the white matter 
cannot be assessed Damage m this part of the white matter could therefore contribute to 
cognitive impairment and decline 
In the past decades, magnetic resonance imaging has shown to be a powerful non-
invasive imaging modality to assess brain changes and recently there has been substantial 
progress in the development of relatively new MRI techniques to assess these macro-
and microstructural abnormalities Diffusion tensor imaging (DTI) allows us to assess the 
microstructural integrity of the WML and NAWM as it measures the magnitude and direction 
of water diffusion in the whole white matter25 (Box 2) 
Box 2. Diffusion tensor imaging 
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Diffusion tensor imaging is an MRI sequence 
that measures the magnitude and direction 
of the diffusion of water molecules. In 
this way, it provides valuable information 
on the microstructural integrity of the 
whole-brain white matter. Diffusion is the 
random thermal motion of molecules and 
is an intrinsic physical process that is 
totally independent of the MR effect of the 
magnetic field. It is a three-dimensional 
process (Fig A), limited by anatomical 
boundaries. Hence, molecular mobility in 
tissues may not be the same in all directions. 
In and around intact axons for example (Fig 
D), the diffusion of a water molecule (black 
line) will be mainly in one direction (i.e. 
anisotropic). Water diffusion at each voxel 
is modeled by a tensor, characterized by 
its three principal eigenvectors and their 
associated eigenvalues (λ., λ2, λ3) (Fig Β). 
The first is referred to as axial diffusivity, 
and represents the magnitude of diffusivity 
parallel to the white matter tracts. The 
average of λ2 and λ3 is termed radial 
diffusivity, and reflects the magnitude of 
diffusivity perpendicular to these tracts. 
FA map MD map 
Two different, but complementary, 
common DTI metrics can be derived from 
these eigenvalues: the mean diffusivity 
(MD), which is the average of the three 
eigenvalues and represents the overall 
magnitude of water diffusion, and the 
fractional anisotropy (FA), a normalized 
ratio of diffusion directìonality.2S 
intact axons axonal 
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The FA ranges between 0 and 1 FA reflects axons, diffusion is restricted (Fig D) and the 
the shape of the tensor, with more isotropic MD will therefore be low In axonal loss, 
(spherical) tensors having a lower FA value water molecules have more space to diffuse 
and more anisotropic tensors a higher FA (Fig E), and the MD will be high In tissues 
(Fig C) Tissues with intact axons (Fig D) will such as the cerebrospinal fluid, diffusion is 
have a high FA, while tissues with axonal not restricted to boundaries and the MD 
loss or the cerebrospinal fluid for example will even be higher Loss of microstructural 
will have a lower FA integrity is therefore typically reflected by a 
The MD reflects the magnitude of water reduction in FA and increase in MD 26 
diffusion and is expressed in mmVs In intact 
The increased use of MRI will identify more people with SVD on neuroimagmg More 
knowledge on the role of SVD in cognitive performance and decline is important, firstly 
from a pathophysiological point of view Neuroimagmg markers of SVD could both serve 
as an explanation for cognitive decline and as surrogate markers for cognitive function In 
addition, it could help us better predict the prognosis of patients presenting with cognitive 
disturbances attributable to vascular changes found on MRI Furthermore, SVD markers on 
neuroimagmg might be of great interest as they may offer more sensitive outcome measures 
m therapeutic trials on disease-modifying drugs and might reduce the number of patients 
needed to demonstrate a treatment effect27 
Aim and outline of the thesis 
The aim of this thesis was to investigate the relation between conventional and 'new' MRI 
parameters of cerebral SVD and cognitive performance, in subjects with cerebral SVD 
The studies presented in this thesis are based on the Radboud University Nijmegen Diffusion 
tensor and Magnetic resonance imaging Cohort (RUN DMC) study, a prospective cohort 
study among 503 independently living, non-demented elderly, aged between 50 and 85 
years, with cerebral SVD The RUN DMC study was designed to investigate the risk factors 
and cognitive, motor and mood consequences of functional and structural brain changes , 
as assessed by MRI 
In part I of the thesis we describe the rationale and design of the prospective part of the 
RUN DMC study (chapters) 
Part II of the thesis describes the relation between brain changes, assessed with conventional 
MRI, and cognitive performance in individuals with SVD In chapter 4 we describe the relation 
between presence, number and location of MB and cognitive performance, independent of 
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other manifestations of SVD Subjective cognitive complaints, have shown to be predictive 
of dementia2829 and have been related to WML3031 In chapter 5 we describe the relation 
between presence, number and location of MB and subjective cognitive complaints, 
independent of coexisting SVD and hippocampal volume In addition, subjective cognitive 
complaints have been related to hippocampal volume but without taking the degree of 
WML into account In chapter 6 we report on the relation between hippocampal volume 
and subjective cognitive complaints, independent of WML volume 
In part III of the thesis the relation between brain changes, assessed by DTI, and cognitive 
function is described In chapter 7 we report on the association between the microstructural 
integrity of both the WML and the NAWM and cognitive performance, this relation was 
investigated in strata of WML seventy In addition, the microstructural integrity of specific 
locations m the brain might be important in relation to cognitive performance In chapter 
8 and 9, the relation between the microstructural integrity of both the hippocampus and 
the cmgulum bundle and memory performance is described In chapter 10 we used Tract-
Based-Spatial-Statistics (TBSS) to investigate the relation between white matter integrity 
and cognitive performance 
In part IV, chapter 11, we report on the possible (additional) clinical value of DTI over 
conventional MRI sequences with respect to cognitive performance 
16 (Chapter 1 
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Abstract 
Alzheimer's disease (AD) is the most common type of dementia Both its incidence and 
prevalence are expected to increase exponentially as populations' age worldwide Despite 
impressive efforts of research worldwide, neither cure nor effective preventive strategy is 
available for this devastating disease Currently there are several hypotheses on what causes 
AD, with the amyloid hypothesis being the most investigated and accepted hypothesis over 
the past 20 years However the exact role of amyloid-ß in the onset and progression of AD is 
not yet fully understood, and even the validity of the amyloid hypothesis itself is still being 
discussed This debate is fuelled by the vascular hypothesis, as increasing epidemiological, 
neuroimaging, pathological, pharmacotherapeutic and clinical studies suggest that vascular 
pathology plays a key role in the onset and progression of AD We here will discuss arguments 
in favor and limitations of both hypotheses within the framework of available literature, but 
also provide arguments for convergence of both hypotheses 
Finally we propose approaches that may aid in unraveling the etiology and treatment of AD 
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Introduction 
Alzheimer's disease (AD) causes an immense economic burden and an unparalleled social 
challenge with over 15 million persons affected worldwide together with a decreasing 
number of potential caregivers in the coming decades 1 Before Alzheimer's publication 
on the disease in 1907, dementia had been recognized for centuries and was ever since 
attributed to vascular factors as for example illustrated by Lobstem who coined the term 
"dementia artenosclerotica", already as early as m 1833 And even before, the history of 
vascular dementia dates back to cases of dementia after apoplexia described by Thomas 
Willis m 1672 
In 1906, it was Alzheimer, or actually his teacher Kraepelm, who started confusion with the 
description of the case of 51-years old Auguste D that resembled "ordinary dementia" cases 
but who was considerably younger and had neuropsychiatrie symptoms2 On post mortem 
neuropathological examination her brain contained senile plaques and neurofibrillary 
tangles 
This presenile disorder affecting patients m their forties and fifties with early symptoms of a 
severe progressive dementia with focal signs such as amnesia, aphasia, apraxia and agnosia 
was then named AD In his later work, Alzheimer reported the degeneration of the smaller 
cerebral blood vessels at a cellular level m a 56 year-old patient, a process also referred to 
as Alzheimer's sclerosis Alzheimer questioned whether the co-occurrence of plaques and 
tangles and vascular pathology being typical or atypical for AD, an ever actual issue 
After the identification of the plaque's mam compound amyloid m the 1960's, much research 
was devoted on its physiology and pathophysiology, followed by a reappraisal of vascular 
factors based on the abundance of vascular changes m the brain of patients with cognitive 
decline and dementia when large scale neuroimagmg became available 3 7 
Currently there are several hypotheses on what causes AD, with the amyloid hypothesis 
being the most investigated and accepted hypothesis over the past 20 years However the 
exact role of amyloid-ß m the onset and progression of AD is not yet fully understood, and 
even the validity of the amyloid hypothesis itself is still being discussed This debate is fuelled 
by the vascular hypothesis, as increasing epidemiological, neuroimagmg, pathological, 
pharmacotherapeutic and clinical studies suggest that vascular pathology plays a key role 
m the onset and progression of AD We will give a critical appraisal with respect to their 
causality m AD and provide a framework that enables a convergence of the two hypotheses 
towards one explanatory model for AD and that will provide clues for future research 
22 [Chapter 2 
The amyloid hypothesis 
Observational 
The first description of the amyloid composition of the neuritic plaques, that Alzheimer 
observed decades before, appeared in 1966 by Roth, Tomlmson and Blessed This British 
research group quantified the relation between clinical symptoms and pathological changes 
(plaques and tangles) in the brain 8 9 In 1984 the ammo-acid sequence of the amyloid-beta 
peptide was elucidated, that initiated the discussion on its origin 10 The presence of the 
amyloid -β protein was first sequenced from (especially leptomenmgeal) blood vessels of AD 
patients and patients with Down syndrome " A year later the same peptide was recognized 
as the primary component of the senile (neuritic) plaques of AD patient brain tissue 12 These 
findings resulted in the hypothesis that the blood borne accumulation of amyloid resulted in 
plaques The subsequent cloning of the gene encoding for amyloid-ß precursor protein (APP) 
and its localization on chromosome 21 and that of presemlm 1 and 2 that are now known to 
be involved in splicing the APP suggested that amyloid-ß accumulation is the primary event 
m AD Mutations m the APP gene were identified causing hereditary cerebral hemorrhage 
with amyloidosis (Dutch type), this showed that APP mutations could cause amyloid-ß 
deposition, outside the brain parenchyma " " The amyloid-ß protein is cleaved from APP 
by the sequential action of ß-secretase and y-secretase respectively, the resulting amyloid 
protein fragment can be either 40 (Αβ1ι]0) or 42 (Aß142) ammo acids m length Mutations 
in the presemlms result m relative high levels of extracellular Aß42 15 Many mutations in 
these genes have now been described, each with an early onset AD as clinical picture, but it 
should be noted that these mutations represent less than 0 1 % of all AD cases 16 
Apohporotem E (apoE) is the most consistently associated risk gene for AD, it is involved 
m the amyloid-ß clearance and associated with increased amyloid burden and cholinergic 
dysfunction Individuals with two apoE ε4 alleles have a more than seven times increased 
risk of developing AD 17 
In the late 1980's and begin 90's it was recognized that amyloid-ß protein was not only 
a pathological constituent but could also be part of physiological cellular mechanisms 
throughout life of healthy humans 18 20 Based on these observations the later called "amyloid 
hypothesis" of AD was formulated (left panel, figure I)2122 In short, this theory implies 
that AD is initiated by abnormal cleavage of the APP resulting in a chronically enhanced 
production and/or decreased clearance of soluble, diffusible amyloid-ß This could lead 
to a gradual precipitation of aggregated non-diffusible amyloid- β m the form of spherical 
plaques and vascular deposits m AD Factors which cause this aggregated amyloid-ß include 
genetic causes like dominant mutations of the genes encoding APP and presemlm 1 and 
In addition, tau, a microtubule-associated protein, is the major constituent of neurofibrillary 
tangles The "amyloid hypothesis" proposes that an imbalance between amyloid-ß 
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production and amyloid-ß clearance resulting in toxic concentrations of amyloid-ß which 
triggers changes in tau and consequent neurofibrillary tangle formation25, although the 
pathways linking amyloid-ß and tau are not fully understood Braak and Braak published 
the pathological stages of distribution of neurofibrillary tangles that followed a predictable 
pattern, with initial changes in the entorhmal cortex, than spread into the entorhmal region 
of the temporal cortex, followed by involvement of the neocortical associated areas26 
There is still conflicting evidence between the amyloid burden and the attendant cognitive 
performance In favor for a role of amyloid pathology in cognitive impairment was the 
observation that neurotoxic amyloid -β soluble oligomers could impair cognitive function 
in rats 2 7 2 8 These highly organized, low molecular weight ohgomeric assemblies precede the 
formation of amyloid fibrils and they have been identified in the brains of patients suffering 
from AD as well 2 9 
From the viewpoint that amyloid-ß is a crucial factor in the etiology of AD it is evident that 
much effort has been put m its detection during life, ideally within the living brain or, second 
best, in the cerebrospinal fluid (CSF) Indeed, recent research suggests that a fairly reliable 
distinction between AD and non-demented can be made on the basis of CSF findings 30 
However, the results seem less promising when other dementias, as in clinical practice, have 
to be distinguished, necessitating further research on the role of amyloid-ß in the etiology, 
but also on its use as a diagnostic tool Evidence from a longitudinal study suggests that 
CSF biomarkers, amyloid-ß(l-42), tau and ptau-181, are not sensitive markers for disease 
progression in Alzheimer's patients [17] Although others do not agree with this finding31 
and recent reports show a CSF AD profile in subjects with subjective and mild cognitive 
impairment32 and a relation between increased levels of t-tau and intensity of disease and 
disease progression 33 
ln-vivo detection of amyloid-ß became possible with the development of the Pittsburg 
Imaging Compound Β (PIB) and recently also other amyloid-probes that enable visualization 
of amyoid burden using Positron Emission Tomography (PET) scanning 34 Positive cortical PiB 
binding has been associated with low cerebrospinal fluid Αβ42 concentrations in AD 35 This 
development offers possibilities for early diagnosis and possibly also tracking progression of 
disease, although the latter could not be found m a recent small study, m which it appears 
that anti-amyloid therapies will need to induce a significant decrease m amyloid-ß load 
in order to detect a drug effect with PIB PET36 As PiB is not ideal for commercialization, 
because of its 20-minute half life, several 18F-labeled tracers have been developed 37 At this 
time, these tracers are undergoing extensive phase II and III trials Recently, it has been 
demonstrated that florbetapir-PET imaging was correlated with the presence and density 
of amyloid-ß 38 Next to investigate the effect of novel amyloid-ß modifying drugs on a clinical 
level, these amyloid binding agents may also have the potential to investigate the effects on 
the presence of amyloid-ß m both the parenchyma as vessel wall 
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Figure 1 Interaction between the amyloid hypothesis and the vascular hypothesis in the 
etiology of Alzheimer's Disease 
Experimental 
The ultimate proof for a role of amyloid-ß peptide in AD would be to reduce the brain's 
amyloid-ß burden, using disease modifying therapies and to investigate its effect on 
cognitive decline. As such the amyloid-ß has become a major therapeutic target. Therapeutic 
strategies include lowering the production of the peptide by 1) prevention of APP 
transcription 2) inhibiting the enzymes responsible for amyloid-ß generation (APP splicing 
by β- and y-secretase), 3) preventing aggregation of solid amyloid-ß, and 4) increasing the 
rate of amyloid-ß clearance from the brain. Amyloid-ß immunotherapy uses anti amyloid-ß 
antibodies, generated following vaccination or introduced passively. Preclinical studies 
in animal models showed that amyloid-ß immunization lowered the plaque burden39 and 
reversed behavioral deficits.40 First phase human clinical trials in AD in which patients 
were immunized wi th aggregated human amyloid-ß 1-42 to stimulate clearance of amyloid 
plaques were associated wi th serious adverse events (meningoencephalitis), the trial had 
to be terminated prematurely.41 Later analysis of this interrupted trial showed that some 
patients ("the antibody responders") had an increased loss of brain volume and no better 
cognitive performance compared to the placebo group, except for some composite z-score 
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of the neuropsychological test battery.4142 On the basis of these studies numerous amyloid-ß 
immunotherapy's are currently in human clinical trials 
Another approach to decrease levels of amyloid-ß is passive immunization with antibodies 
targeting portions of the amyloid-ß molecule. Bapmeuzumab is a humanized monoclonal 
antibody investigated in two trials In the first trial the amyloid-ß burden was decreased, 
however m the other trial no difference was found in cognitive function between the 
treatment group and the controls4344 A safety concern was the occurrence of reversible 
vasogenic edema. 
Another area of drug development involves the targeting of y secretase, one of the enzymes 
required for production of amyloid-ß from APP As y-secretase has many functions m the 
body, treatment with y-secretase inhibitors may lead to toxicity Nevertheless a number 
of inhibitors have been tested. Recently, a large, multicentre, randomized, double blind, 
placebo-controlled, phase III trial on Tarenflurbil showed no beneficial effect m the 
treatment group compared to placebo 45 
In addition, although several observational studies have concluded that the use of 
nonselective nonsteroidal anti-imflammatory drugs (NSAIDs) is associated with a reduces 
risk of AD,46 clinical trials of nonselective or COX2-selective NSAIDs in patients with 
dementia or with mild cognitive impairment have not demonstrated any effect on cognitive 
performance 4749 
Possible explanations for these negative trials may be because of their use in patients with 
advanced stages of disease, the pathological processes may start years before the onset 
of clinical symptoms, this suggests that treatment administration would need to occur 
much earlier m patients deemed to be at high risk In addition, it might be because of study 
design, sample size or choice of treatment dosage However, it may also be that the negative 
findings reflect the still incomplete understanding of the pathogenesis of AD, and the role 
other (neurodegenerative and vascular) factors 
Discrepancies 
Notwithstanding the overwhelming observational data on amyloid and AD, some important 
issues need to be addressed. 
A first discrepancy are the negative results of the trials in which the effect of amyloid-ß 
lowering drugs on disease was studied In addition, pathological studies on the relation 
between senile plaques and neurofibrillary tangles (AD pathology) and cognitive performance 
and clinical AD show various discrepancies There are numerous reports showing a lack 
between the degree of amyloid pathology and cognitive function during life,50 whereas 
other studies correlated soluble and fibrillar forms of amyloid-ß with cognitive scores.5152 
Many cogmtively intact, healthy elderly have abundant senile plaques, some even with the 
same density of senile plaques as patients with AD m their brains without clinical signs 
of AD.5354 Plaques and tangles are found m cognitive intact individuals after the age of 
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forty without neuronal loss " This is in line with findings from a large pathology study that 
found that there is much mixed pathology (cerebrovascular and AD pathology) in healthy 
individuals from the general population who did not meet the clinical diagnostic criterium 
of dementia 56 There are reports on several lines of transgenic mice overexpressmg APP m 
which there is a correlation between the extent of learning and memory déficits and the 
amount of deposited amyloid-ß found m the central nervous system,57 however there are 
also reports on transgenic animal models with high levels of brain amyloid deposits that 
show no significant neurodegeneration 58 A recent report shows that neuropathological 
processes related to AD in persons without dementia were correlated with subtle cognitive 
dysfunction and that by the age of 80-85 years many non-demented elderly have substantial 
AD pathology59 Furthermore, recent studies m humans showed that clearance of amyloid 
depositions resulted neither in cognitive improvement nor m a decreased rate of mental 
deterioration These observations suggests that senile plaques may not be the mam cause 
of neurodegeneration and cognitive decline in AD, accordingly other theories have been 
established over the past years 
A first theory is based on soluble amyloid-ß, which proposes that toxic amyloid-ß-42 or 
its oligomers interfere with synaptic plasticity in vitro of with membrane dysfunction and 
promote cell death 6061 However these findings are based on experimental animals models, 
overexpressmg exogenous APP, and may not be applicable to AD Soluble amyloid-ß 
peptides however are normal components of human serum and cerebrospinal fluid and it 
is not clear under what conditions these peptides become toxic, especially as no significant 
disease-associated abnormalities have been detected with their production " 
A second theory is the presenilin hypothesis which suggests that loss of function of 
presenilin may be the primary event triggering neurodegeneration m AD Amyloid-ß-42 
may act primarily to antagonize presenilin dependent functions, possibly by operating as 
active site-directed inhibitor of y-secretase, mimicking the effect of presenilin mutations 
Loss of presenilin activity results m synaptic dysfunction and ultimately leads to progressive 
neurodegeneration characterized by loss of synapses, dendrites, and neurons, astrogliosis 
and tau hyperphosphorylation " 
Finally, others suggest that tau protein plays a central role m the chain of events leading 
from amyloid neurotoxicity to tau hyperphosphorylation, microtubular destabihzation, 
disturbed axonal transport and synaptic failure to neurodegeneration In this hypothesis 
the pathological conversion of normal tau into functionally impaired phosphorylated tau, 
which forms neurofibrillary tangles and dystrophic tau neuritis and thereby depleting levels 
of of functional microtubules binding and stabilization tau below a critical point that results 
m depolymenzation of microtubules and a disruption of axonal transport These events are 
thought to culminate m neuronal dysfunction and degeneration, leading to AD 6'' 
Other mechanisms may also play a role, for example the cognitive reserve theory65 The 
cognitive reserve theory provides at least two explanations of not finding a relation between 
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the degree of amyloid pathology and cognition The first is that individuals functioning at 
a previously high level possibly have a greater cognitive capacity and/or more efficiency 
and m that way may be less susceptible to disruption compared to the average elderly 
Consequently, they may experience a longer subclinical cognitive deterioration, despite 
the possible presence of amyloid plaques Another explanation could be the presence of 
compensatory networks that may compensate for amyloid-based disruption of pre-existing 
networks 26 This may obscure the relation between amyloid burden and the cognitive 
decline during the course of AD 
Vascular hypothesis 
Observational 
The history of vascular dementia can be traced back to cases of dementia postapoplexia 
described by Thomas Willis m 1672 In 1833 Lobstem introduced the term "dementia 
atherosclerotica" In 1894 Bmswanger described the subcortical arteriosclerotic 
encephalopathy, now known as Bmswanger disease Before the CT and MRI era this disease 
was thought to be very rare 
With the advent of non-invasive imaging of the brain with CT in the 1970's and 1980's 
and MRI m the 90's it became evident that small vessel disease was not rare at all and a 
common finding in the general population and m AD patients The term "leuko-araiosis" was 
introduced only 25 years ago as a neutral term for deep white matter changes on the basis of 
vascular disease that were considered to be associated with cognitive impairment66 It was 
demonstrated that "healthy" elderly with leuko-araiosis performed less on certain cognitive 
tasks than those without leuko-araiosis and that, in patients with AD, leuko-araiosis was 
associated with a greater degree of cognitive impairment67 68 Large longitudinal population 
based cohort studies were then initiated and consistently showed a relation between 
several vascular risk factors and white matter lesions (WML)69 71 These vascular risk factors, 
hypertension, diabetes, atherosclerosis, homocysteine, smoking and atrial fibrillation 
have found to be related to AD 7276 Presumably these relations underlie the emergence of 
vascular (white matter) lesions, as it was demonstrated that individuals with silent brain 
infracts, periventricular and subcortical WML have an increased risk of AD " Furthermore, 
pathology studies have revealed the presence of ischemic lesions in patients with AD and 
it was shown that among non-demented people those with coronary heart disease had 
greater plaque burden m the brain those without heart disease 77 This resulted m large 
population based autopsy studies to unravel the vascular risk factors for cognitive decline m 
elderly In a prospective population based cohort study, 209 subjects consented to donate 
their brain for post-mortem evaluation Before, they all underwent neuropsychological 
screening with incident dementia at 2 and 6 years as the primary outcome measure 56 The 
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median age of death was 85 years, at that time 48% of the subjects were demented of 
which 64% fulfilled the criteria for probable or definite AD Over one third of the clinically 
diagnosed AD patients did not have any plaques at all whereas in one third of the clinically 
non-demented elderly moderate to severe plaques were found Around 80% of the subjects 
had vascular abnormalities of the brain, which were significantly more severe in the 
demented population The vascular hypothesis emanated from these findings (fig 1, right 
panel) Vascular risk factors induce neurovascular dysfunction and cause endothelial damage 
by oxidative stress and inflammation which lead to local hypoperfusion and ischemia which 
are radiologically represented by WML and silent and/or lacunar brain infarctions 7e As 
discussed earlier, these radiological changes are related to cognitive decline and dementia 4 
Experimental 
Proof of concept for a role of vascular factors in the etiology of dementia could come 
from intervention trials In the Syst-Eur trial showed that treatment of isolated systolic 
hypertension with calcium antagonists among elderly over the age of 60 was associated 
with a decrease of incident dementia The absolute risk reduction was 3% 79 A 2-year 
open label extension of this study revealed the same results, long-term antihypertensive 
therapy reduced the risk of dementia by 55% compared with placebo (p < 0 001)80 In the 
Leiden 85-plus study it was also reported that the use of a calcium antagonists prevents 
the development of dementia, they did not find this for other antihypertensive drugs They 
suggested that the protective effect found in the Syst-Eur trial and m their own study was 
due to the effect of the calcium channel inhibition rather than its blood pressure lowering 
properties a i The PROGRESS study was a randomized, double blind, placebo controlled trial 
involving 6105 patients with previous stroke or ischemic attack Participants were assigned 
to active treatment (permdopnl for all participants and mdapamme for those with neither an 
indication for nor a contraindication to a diuretic) or matching placebo(s) After a follow-up 
of 3 9 years the risk of dementia was reduced from 7 1% to 6 3% (nonsignificant) however 
the risk of cognitive decline was significantly reduced from 11% to 9 1% Although, it could 
be that this benefit was due to the prevention of recurrent stroke 82 Preliminary results of 
the observational OSCAR study support these findings 83 
Discrepancies 
The previously described intervention studies could not be replicated m several other 
studies In the SHEP (systolic hypertension in elderly program) study over 2000 patients 
were enrolled for treatment with chlortahdone or placebo Neither the decline in cognitive 
function nor the incidence of dementia were significantly different between both groups 
after the treatment period ^ In the PROSPER study 6000 individuals with pre-existing 
vascular disease or raised risk of such disease were randomized to either pravastatin or 
placebo and followed for a mean of 3 2 years, one of the secondary outcomes was cognitive 
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decline There were no significant differences for both groups and several cognitive rating 
scalesS5 
A Cochrane review with a meta-analysis of four randomized controlled trials (Syst-Eur 
trial. Scope trial, SHEP trial and the HYVET trial)79848687 on the effects of blood pressure 
lowering m late-life on the development of cognitive decline and dementia on patients with 
hypertension without apparent prior cerebrovascular disease This Cochrane concluded that 
blood pressure lowering in late-life is not indicated with the aim of prevention of cognitive 
decline or dementia alone, as only the Syst-Eur trial reported a benefit from treatment but 
neither the SCOPE, SHEP nor HYVET showed a benefit, and when the trials were entered in 
a meta-analysis, no statistically significant effect was seen 88 As suggested by the authors, 
primary outcome measures of all trials was cardiovascular disease, cognitive function and 
dementia were secondary end-points Trials were terminated once the primary end-points 
were shown, m that way possible beneficial effects on cognition later m the follow-up can 
be missed 
One of the possible explanations for this unequivocal role of (treatment of) hypertension 
could be that the deleterious effects of vascular risk factors in general and hypertension 
specific already occurs decades before either cardiovascular or cognitive symptoms occur 
By the time the risk factors result into disease, the damage is not remediable anymore 
Convergence of the amyloid hypothesis toward the vascular 
hypothesis 
The diagnosis AD is based on the DSM-IV-TR89 and the NINCDS-ADRDA criteria90 In these 
criteria, the presence of other systemic or brain diseases that may account for the progressive 
memory loss and other cognitive déficits, is an exclusion criterion The criteria for vascular 
dementia (NINDS-AIREN) include decline from a previously higher level of functioning and 
manifested by impairment of memory and of two or more other cognitive domains, which 
also exclude patients systemic or brain disorders (such as AD) that m themselves could 
account for deficits in memory and cognition 91 According to these criteria the presence of 
cerebrovascular disease in a demented individual rules out AD and vice versa 
However, the pathological changes characteristic of AD are observed together with vascular 
pathology in more than 40% of elderly demented individuals 92 Several studies show a 
variety of underlying neuropathology among clinically diagnosed "probable" AD patients 
This pathology includes both Braak and Braaks' criteria fulfilling amyloid plaques and tau 
tangles but also vascular lesions such as lacunar infarctions and WML A study among 102 
women between 76-100 years showed that dementia prevalence was highest among those 
who met the neuropathological criteria for AD and had coexisting vascular pathology93 In 
the presence of vascular pathology in the basal ganglia, thalamus and deep white matter 
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fewer neuropathologic lesions were needed to result in a clinical diagnosis of AD than in 
those without coexisting vascular pathology, indicating the possible interaction between 
these factors In contrast, among those who did not meet the neuropathological criteria 
for AD, vascular lesions were only weakly associated with poor cognitive function and 
dementia The Honolulu Asia Aging Study, a community based study in very old men, of 
which 29% were demented ante mortem, suggested that the burden of AD and vascular 
lesions independently contribute to a clinical AD diagnosis, which is compatible with the 
view of the additive effect that these two types of lesions on cognitive impairment may 
have 94 The combination/interaction of cerebrovascular damage with damage to the brain 
caused by amyloid-ß may result m a lower cognitive threshold of dementia than the two 
separately93 The simultaneous double hit by amyloid-ß and vascular damage might affect 
cognitive function more than the sum of parts, their effects may even be synergistic 9596 
These findings are more or less confirmed by the MRC CFAS study that showed an extensive 
overlap of intermediate Alzheimer type pathology among demented and non-demented 
older people despite equivalent degrees of vascular pathology56 
In addition, hypoxia and ischemia resulting from vascular insufficiency may interact with 
amyloid-ß on a more basic pathofysiological level They increase the transcription of APP 
and its cleavage by ß-secretase resulting m more amyloid-ß production9798 Furthermore 
vascular damage may promote amyloid-ß accumulation m the CSF by reducing the 
vascular clearance of this peptide 99100 And vascular amyloid-ß is a potent vasocontnctor 
and impairs fundamental mechanisms regulating cerebral circulation and m that way 
may induce ischemia 101102 In that way the interaction between the amyloid and vascular 
pathway enhances their pathogenic effects and favour the formation of amyloid plaques 
and cerebral amyloid angiopathy (CAA)103 Others Imaging of in vivo parenchymal and 
vascular amyloid-ß, with PET-radiopharmaceuticals could help m studying this potential self 
strengthening mechanisms 10', Next to investigate the effect of novel amyloid-ß modifying 
drugs on a clinical level, PIB-PET may also have the potential to investigate these effects on 
the presence of amyloid-ß 
Neuroimagmg studies lend further support for an interaction between amyloid-ß features 
with vascular factors and vice versa The key radiological hallmark of typical AD is the medial 
temporal lobe atrophy (MTA) The degree of atrophy was reported to be related to the disease 
stage defined by Braak and Braak105106 but a relation between vascular (risk) factors and the 
severity of MTA has also been observed 107108 Non-demented patients with diabetes have 
more MTA on MRI than those without diabetes 109 At the population level there is a positive 
association between blood pressure and medial temporal lobe atrophy meaning that increase 
in blood pressure was related to more severe MTA 110 Among patients with AD a linear relation 
between systolic blood pressure and the severity of MTA has been observed WML could be 
a possible intermediate m this relation as both population based studies and studies among 
AD patients showed a relation between WML and MTA 107108 A small prospective study 
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showed that baseline WML were associated with progression of MTA among 35 clinically 
defined "probable" AD patients. Stratification on WML indeed revealed that the relation 
between blood pressure and MTA only existed in AD patients with WML.111 in stroke patients 
it was shown that patients with post-stroke reduced episodic memory function had reduced 
medial temporal lobe functionality as demonstrated by fMRI.112 Other cardiovascular risk 
factors than hypertension have been related to AD. Diabetes mellitus doubles the risk of AD 
corresponding with an increase in microinfarcts and without a corresponding increase in 
plaques and tangles.113 Higher total cholesterol, LDL concentrations and a history of diabetes 
is associated with faster cognitive decline in AD.114 Additionally, in studies on AD patients the 
presence of atherosclerosis was related to an increased frequency of neuritic plaques and 
neurofibrillary tangles.115116 Furthermore, treatment of vascular risk factors in patients with 
AD is associated with slower cognitive decline.117 Conversely, there is increasing evidence for 
a role of the amyloid metabolism on presumed cerebral vascular lesions and its effects on 
cerebral blood vessels. Cerebral microbleeds might be a missing link between the amyloid 
and vascular hypothesis. Cerebral microbleeds in the cortico-subcortical regions might be 
a marker of CAA.118 CAA is characterized by of deposition of amyloid- β peptide within the 
walls of the small and medium sized cerebral arteries,119 and is associated with AD.12C ApoE 
plays a crucial role in lipid metabolism and neuronal repair.121 The apoE e4 allele is not only 
associated with cognitive impairment and dementia, but also with vascular risk factors 
for WML.122 ε4 Homozygotes exhibit more extensive WML than other genotypes.123 It was 
hypothesized that the ε4 allele was related to cognitive impairment because of the presence 
of WML. Large population based studies showed interactions between hypertension and 
apoE ε4 allele with regard to subcortical WML, and relations between plasma amyloid- β 
levels and WML and lacunar infarcts in people who carry a apoE ε4 allele.12"125 However, 
studies in demented populations and other population based studies could not find these 
relations.126·127 The ε4 allele modulates the severity of amyloid-ß deposits in animal models128 
and in humans129, especially in patients with WML.130 In a sample of autopsy proven AD 
patients apoE ε4 was associated with small vessel arteriosclerosis, microinfarcts, neuritic 
senile plaque density and CAA.131 On the other hand cerebral microbleeds in the deep grey 
matter and infratentorial regions are related to hypertensive vasculopathy and might be a 
result of microangiopathy, such as arteriosclerosis or ischemia.132 
In addition, experimental findings suggest cytotoxic effects of amyloid-ß on the vascular 
smooth muscle cells, resulting in prolonged and intensified endothelium dependent 
vasoconstriction that could possibly result in hypoperfusion.101 In a study, based within the 
same Rotterdam Study, in-vivo support for these observations has been obtained. High 
plasma levels of amyloid-ß assessed 6.5 years before transcranial Doppler investigations were 
related to impaired C02 enhanced transcranial Doppler assessed vasomotor reactivity.133 
Next to this classical approach, novel developments, including those from other areas, may 
help in elucidating the cause of AD. One of these could be the systems approach to the 
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networks of aging as proposed by West.134 This approach emphasizes the multiplicative effect 
that damage in network systems such as the vascular tree may have on organ functions in 
general In this way the cerebrovascular damage, probably highly related to amyloid plaque 
depositions in the vascular wall, may act m a synergistic way with the amyloid plaques, 
leading a further compromised neuronal function In addition this theory makes use of the 
fundamental physiological properties of different species as they age with molecular and 
cellular changes, analyzing a system from both a top-down (a system decomposing into 
parts), but also from a bottom-up approach. 
Future perspectives 
Most likely there is no single one-risk factor based explanatory model for AD as more and 
more evidence suggests that it is not a single cause disease entity, but a variety of causes, 
including neurodegenerative (amyloid-ß), vascular and probably more 
None of these risk factors alone are proven to be necessary risk factors (which means that 
the disease (AD) must always be preceded by this risk factor) nor sufficient risk factors 
(ι e the risk factor always leads to the disease). Most likely the factors described here are 
contributory risk factors (the risk factor is sometimes succeeded by AD and the other way 
around) In addition to this interaction between several of these factors may also play a role 
in the final development of the clinical syndrome of AD as we call it today. (Fig. 1) 
Dementia is very complex disease in the elderly with a large heterogeneity m phenotype 
and genotype, with a heterogeneous life-time exposure to a lot of different frequently 
interacting vascular, amyloid and/or other damaging risk factors 
In future research more distinctive and reliable biomarkers might play an important role, 
yet they are part of the revised research criteria for AD, proposed to allow earlier and more 
specific AD diagnosis 135 
Although some discrepancies as discussed earlier, CSF markers may be a potentially promising 
approach for pathology m vivo, as they can distinguish between AD and non-demented 
patients and it was shown that subjects with subjective and mild cognitive impairment have 
a AD CSF profile, and this profile was predictive of AD-type dementia 3032 are related to. 
If amyloid deposition plays an important role in the etiology of AD, development of anti-
amyloid-ß therapies, including amyloid-ß immunotherapy, that reduce the plaque burden 
or even prevent the development of amyloid plaques is one of many future approaches to 
reduce the ever-growing incidence of AD 
Imaging can be used as another biomarker With the advance of imaging techniques that are 
now available, repeated imaging with thinner slices m combination with a valid automated 
lesion detection tool could quantify the total lesion volume more precisely Furthermore, 
as identical appearing WML on conventional MRI are actually histopathologically 
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heterogeneous,136 it could be that only WML with the highest loss of structural integrity 
are related to cognitive impairment It is also important that only a small portion of the 
white matter (usually less than a few percent) is affected by WML As conventional MRI 
is not sensitive to early loss of microstructural integrity m the normal appearing white 
matter, possible changes in this largest part of the white matter cannot be assessed The 
integrity of the normal appearing white matter might be an important factor for a better 
understanding of the relation between white matter integrity and cognitive function and 
decline These limitations of conventional MRI can potentially be overcome with the use of 
novel imaging techniques as Diffusion Tensor Imaging (DTI) which allows the assessment 
of the microstructural integrity of the whole white matter137 DTI may particularly be suited 
to detect subtle white matters' structural abnormalities at even earlier moments m time 
(at least before detection with conventional FLAIR imaging) And as such these early signs 
of microstructural loss can be found before actual disabling cognitive consequences may 
have occurred and as such may aid in the selection of patients who may be at risk for future 
development of "leuko-araiosis" and the possible attendant cognitive decline Even more 
stringent treatment of vascular risk factors may, although unproven until now, possibly 
postpone future cognitive deterioration In future it could be possible to use these new 
imaging techniques to visualize neural compensation networks Therapeutic strategies may 
then be developed that aim at stimulating the formation of such networks 
Analogous to the amyloid theory much needs to be done to establish a causal role for 
vascular factors m the etiology of dementia, as most of the data are cross-sectional or 
of non-replicated intervention studies In future research on the etiology of AD and the 
possible role vascular factors in this etiology, the phenotype of the study population should 
critically defined This phenotype should be defined by the clinical presentation, exposure 
to risk factors and age of the study population In etnologie research, the phenotype should 
not be based on the absence or presence of biomarkers as these are the etnologie factors 
you want to investigate and when part of the diagnosis, obviously there will be a relation 
between the biomarker and disease It should be a very large study sample m order to be 
able to define subgroups to investigate interactions between these groups In prognostic 
or intervention trials biomarkers can be used in the definition of disease, although there 
should be consensus on the definition of these biomarkers For example, the presence 
of WML, there can rated semi-quantitatnvely, by location, by volume estimation or by 
automated or manually segmented total volume, and with or without taking silent brain 
infarcts or lacunar infarcts into consideration or by using new imaging techniques which 
assess the microstructural integrity of the whole white matter Dementia should be among 
the endpomts in any cardiovascular intervention trial, with an extended, open-label follow 
up to be able to detect incident dementia occurrence after the primary vascular outcome 
events 
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Conclusion 
In 1907, Alois Alzheimer described a clinical syndrome, now known as AD, characterized 
by progressive behavioral abnormalities with prominent focal symptoms and an impaired 
memory m a relatively young woman 
Nowadays, patients that are being diagnosed with AD are usually much older than Auguste 
D and the clinical symptoms differ Alzheimer most likely described a presenile dementia 
based on amyloid-ß pathology without, or with only few concomitant (vascular) risk 
factors Although some clinical similarities between Auguste D's dementia and the senile 
dementia exist, the latter is probably being caused by accumulated cerebral damage caused 
by life-time exposure to vascular, amyloid and/or damaging factors that probably differs m 
terms of pathophysiology from Auguste D Vascular factors as a contributing cause to the 
development of AD have come into play again, next to affecting the large arteries at the 
skull's base as one thought m the 19'h century, the small vessels (arterioles) deep within the 
brain parenchyma also play a role The presence of small vessel cerebrovascular disease m 
AD is very common, cerebrovascular disease and AD share the same risk factors, coexisting 
cerebrovascular disease and AD results in more severe cognitive impairment , either by 
direct damage of the neural pathway or indirect by worsening the impact of AD pathology 
As hypothesized by others, this suggests that cerebrovascular disease may be in the causal 
pathway for development of AD or interacts synergistically with AD pathology103138 
Future studies on the etiology of AD should preferably start with proper diagnostic research 
criteria m order to exactly define the disease investigated instead of etiologic research 
on merely a complex of symptoms rather than a single disease entity A well described 
phenotype and large numbers of patients are important factors to enable unraveling the 
complex interacting pathologies, best in etiological studies m vivo using MRI, CSF markers 
and PET135 Once that has been accomplished studies on etiology should be large, prospective 
and presumably already start during mid-life or even before Treatment of risk factors found 
by this approach should then be further evaluated m intervention studies with dementia 
as a primary end point We should also keep an open eye towards innovative approaches 
including those derived from systems biology, a field which focuses on complex interactions 
of biological systems,134 that may possibly speed up the quest for the etiology of AD 
Imaging and biomarkers have improved dramatically over the last ten years Identifying the 
individuals at risk before clinical onset of symptoms, might help us the treat these individuals 
and to reduce the ever growing incidence of AD 
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Abstract 
Background Cerebral small vessel disease (SVD) is a frequent finding on CT and MRI scans 
of elderly people and is related to vascular risk factors and cognitive and motor impairment, 
ultimately leading to dementia or parkinsonism in some In general, the relations are 
weak, and not all subjects with SVD become demented or get parkinsonism This might 
be explained by the diversity of underlying pathology of both white matter lesions (WML) 
and the normal appearing white matter (NAWM) Both cannot be properly appreciated 
with conventional MRI Diffusion tensor imaging (DTI) provides alternative information on 
microstructural white matter integrity The association between SVD, its microstructural 
integrity, and incident dementia and parkinsonism has never been investigated 
Methods The RUN DMC study is a prospective cohort study on the risk factors and cognitive 
and motor consequences of brain changes among 503 non-demented elderly, aged between 
50-85 years, with cerebral SVD First follow up is being prepared for July 2011 Participants 
alive will be included and invited to the research centre to undergo a structured questionnaire 
on demographics and vascular risk factors, and a cognitive, and motor assessment, followed 
by an MRI protocol including conventional MRI, DTI and resting state fMRI 
Discussion The follow up of the RUN DMC study has the potential to further unravel the 
causes and possibly better predict the consequences of changes in white matter integrity in 
elderly with SVD by using relatively new imaging techniques When proven, these changes 
might function as a surrogate endpomt for cognitive and motor function in future therapeutic 
trials Our data could furthermore provide a better understanding of the pathophysiology 
of cognitive and motor disturbances in elderly with SVD The execution and completion of 
the follow up of our study might ultimately unravel the role of SVD on the microstructural 
integrity of the white matter m the transition from "normal" aging to cognitive and motor 
decline and impairment and eventually to incident dementia and parkinsonism 
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Background 
Cerebral small vessel disease (SVD) includes white matter lesions (WML) and lacunar infarcts 
and is a frequent finding on computer tomography (CT) and magnetic resonance imaging 
(MRI) scans of elderly people.1 It is associated with vascular risk factors, such as hypertension, 
atherosclerosis, diabetes mellitus and atrial fibrillation.24 In cerebral SVD symptoms are 
due to either complete (lacunar syndromes) or incomplete infarction (WML) of subcortical 
structures leading to accompanying complaints including the lacunar syndromes, cognitive, 
motor (gait) and/or mood disturbances.5 The prevalence of WML and lacunar infarcts 
varies considerably across studies from 5-95% and 8-28% respectively, depending on the 
population studied and the imaging technique used.16 There is evidence of an increased 
risk of cognitive decline, dementia, gait and balance disturbances and parkinsonism among 
individuals with SVD, although prospective studies are scarce.710 
However, individuals with a virtually identical WML burden on conventional FLuid Attenuated 
Inversion Recovery (FLAIR) imaging present with a wide variance in cognitive and motor 
performance ranging from no complaints at all to subjective cognitive complaints and mild 
parkinsonian signs to dementia and parkinsonism. Apparently there are other factors that 
determine whether identical appearing WML on FLAIR lead to for example cognitive or 
motor decline in one person, while leaving others unaffected. 
One of the other factors could be the presence the coexisting manifestations of cerebral 
SVD on conventional MRI such as lacunar infarcts and cerebral microbleeds which might 
influence the cognitive and motor performance.11 
As identical appearing WML on conventional MRI are actually histopathologically 
heterogeneous12, it could be that only the WML with a high loss of microstructural integrity 
are related to cognitive and motor impairment. It is also important to realize that only a 
small proportion of the white matter (usually less than a few percent) is affected by SVD, 
even among individuals with severe SVD.13 As conventional MRI is not sensitive to early 
loss of microstructural integrity in the normal appearing white matter (NAWM), possible 
changes in this largest part of the white matter cannot be assessed.1415 These limitations 
of conventional MRI can potentially be overcome with the use of Diffusion Tensor Imaging 
(DTI) which allows us to assess the microstructural integrity of the whole white matter.16 
DTI, amongst others, provides two parameters; mean diffusivity (MD), a measure of the 
magnitude of diffusion of water in the white matter, and fractional anisotropy (FA), which 
provides information about the directionality of water diffusion. Damage to the white 
matter is supposedly accompanied roughly by an increase in MD and a decrease in FA.17 
Another explanation for the clinical diversity due to WML could be the efficiency of 
compensation mechanisms that prevent further cognitive and motor (gait) deterioration. 
Support for the existence of compensatory mechanisms comes from a study among young 
carriers of a pre-senilin mutation (at risk for genetically determined Alzheimer's' disease 
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(AD), but still without cognitive impairment) who showed altered functional connectivity 
(assessed with fMRI) compared with controls.18 With innovative resting state fMRI techniques 
the strength of functional connectivity between brain regions can be investigated.19 In that 
way it might be that these compensation mechanisms also play a role in the variety of 
clinical presentation of individuals with SVD. 
In the RUN DMC (Radboud University Nijmegen Diffusion tensor and Magnetic resonance 
imaging Cohort) study we prospectively investigate the effect of SVD on the transition from 
non-demented, independently living elderly people with cerebral SVD between 50 and 85 
years towards cognitive and motor (gait) decline, and ultimately dementia and parkinsonism 
in a population with cerebral SVD. The primary objective of the RUN DMC study is to 
prospectively investigate the risk factors for and cognitive and motor (gait) consequences of 
longitudinal functional and structural changes in the integrity of the cerebral white matter 
as assessed by DTI, resting state fMRI and conventional structural MRI. To the best of our 
knowledge there are no other prospective cohort studies investigating the development 
of incident dementia and parkinsonism using these novel imaging techniques. Here we 
describe the study design and protocol of the RUN DMC study. 
Patients and Methods 
Study population 
Cerebral SVD is characterized on neuroimaging by either WML or lacunar infarcts. Symptoms 
of SVD include acute symptoms, such as transient ischemic attack (TIA) or lacunar syndromes, 
but also subacute manifestations such as cognitive and motor (gait) disturbances.5 As the 
onset of cerebral SVD is often insidious, clinically heterogeneous, and typically with mild 
symptoms, it has been suggested that the selection of subjects with cerebral SVD in clinical 
studies should be based on the more consistent brain imaging features.20 
Accordingly, in 2006, consecutive individuals referred to the Department of Neurology 
between October 2002 and November 2006, were selected for possible participation. 
Inclusion criteria were: (a) age between 50 and 85 years; (b) cerebral SVD on neuroimaging 
(WML and/or lacunar infarcts). Subsequently, the above mentioned acute and subacute 
clinical symptoms of SVD were assessed by standardized structured assessments (a 
questionnaire for TIA and stroke21; for cognition the Cognitive Failures Questionnaire22; for 
gait the Falls Questionnaire23 and the Freezing of Gait Questionnaire24) Subjects who were 
eligible because of a lacunar syndrome were included only > 6 months after the event to 
avoid acute effects on the outcomes. 
To be able to detect incident dementia and parkinsonism we applied the following exclusion 
criteria: (a) presence of dementia25 and (b) parkinson(-ism)2627. In addition patients with (c) 
intracranial hemorrhage; (d) life expectancy of less than six months; (e) intracranial space 
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occupying lesion, (f) (psychiatric) disease interfering with cognitive testing or follow-up, (g) 
recent or current use of acetylcholine-esterase inhibitors, neuroleptic agents, L-dopa or 
dopa-a(nta)gonists, (h) non-SVD related WML (e g multiple sclerosis), (ι) prominent visual or 
hearing impairment, (j) language barrier, (k) MRI contraindications or known claustrophobia 
were excluded All participants signed an informed consent form The Medical Review Ethics 
Committee region Arnhem-Nijmegen approved the study 
Follow-up 
After 5 and 10 years all participants alive will be contacted for the prospective assessment of 
possible outcome events This evaluation is currently being prepared for July 2011 
Between 2006 and 2011 we contacted all participants every year by letter for an update on 
their address information and telephone number and for their survival status 
In 2011 all participants alive will be invited by letter and subsequently contacted by telephone 
to visit our research centre During their visit to the research centre a cognitive, gait, 
balance and parkinsonian signs assessment, a structured interview, physical examination, 
neurological examination, and an extensive MRI protocol, an electrocardiogram and an 
ultrasonography of the carotid arteries will be performed All tests will be performed by the 
same two trained neurology residents and all MRI scans will take place on the same scanner 
Outcome events 
Primary measures of outcome of the study are incident dementia and parkinsonism 
according to international diagnostic criteria2527, as well as all-cause mortality and death 
from all vascular causes, non-fatal stroke, and non-fatal myocardial infarction 
Secondary outcome measures are defined as change from baseline examination in cognitive 
function, gait and balance and parkinsonian signs 
Incident outcome events are to be identified by three different approaches 
1 During the follow-up a structured questionnaire on the possible occurrence on 
these outcome events is administered to each participant When an incident event 
is suspected the treating physician will be contacted for the most recent information 
on that particular outcome event 
2 When a participant died before follow-up, the general practitioner will be contacted 
for the most recent information on the cause of death and presence of primary 
outcome events In case of presence of primary outcome events the treating physician 
will be contacted for the most recent information available 
3 When during follow-up assessment participants' test results are suggestive for 
incident dementia or parkinsonism, subjects will be referred to our outpatient clinic 
In case the diagnosis is established according to the international criteria, this will be 
considered an incident case 
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All outcome events will be adjudicated independently by two specialised physicians, if the 
two classifications differ, the outcome event will be discussed and consensus will be made 
Assessment of cognitive and motor outcomes 
Two trained residents in neurology will administer the complete outcome assessment 
Cognitive assessment We will use an extensive neuropsychological test battery that 
encompasses items from other large scale epidemiological studies that cover virtually all 
cognitive domains 1028 A measurement of global cognitive function will be assessed by the 
Mini Mental State Examination (MMSE)29 The verbal memory function will be assessed 
by the three-trial version of the Rey Auditory Verbal Learning Test (RAVLT), a test used to 
evaluate the ability to acquire and retain new verbal information 30 Visuospatial memory will 
be administered by the Rey's Complex Figure Test (RCFT), that consists of three subtasks the 
copy trial, the immediate recall trial, within 3 minutes and the delayed recall trial, after 30 
minutes31 To evaluate speed of mental processes four tests will be used, the Stroop test 
(three subtasks)32, the Paper and Pencil Memory Scanning Task (four subtasks)33, the Symbol-
Digit Substitution Task, which is a modified version of the Symbol Digit Modalities Test34 and 
a verbal fluency task in which as many animals as possible have to be named within 60 
seconds, followed by as many professions within 60 seconds To evaluate attention, the 
verbal series attention test (VSAT) will be used 35 To register subjective cognitive failures we 
will administer the Cognitive failures questionnaire (CFQ)22 The tests will be carried out in 
quiet rooms and a stopwatch will be used in timed tests 
Assessment of gait, balance and parkinsonian signs All participants will perform a tandem 
walk by walking ten steps heel to toe (registering intact, one side step, more side steps, 
impossible) A quantitative gait analysis will be performed with a 5 6-meter long, 0 89-meter 
wide electronic walkway (GAITRite® MAP/CIR Ine , Havertown, PA) with sensor pads (12 7 
mm apart from each other) connected to a computer This system has strong concurrent 
validity and test-retest reliability, also in older people 36 The participants walk twice at self-
selected gait speed on low-heeled shoes They start two meters before the carpet and walk 
until two meters behind it in order to measure steady-state walking 
We will use a widely used modified version of the original Tmetti test with 17 items 9 for 
body balance (score 0-16) and 8 for gait (score 0-12), with a maximum score of 28 37 It 
grades balance while sitting, standing with eyes open and closed, nudging and turning, 
gait initiation, stride length and width and symmetry Functional mobility will be classified 
by using the widely-used TUG-test which is a timed test during which the participant is 
asked to rise from a standard armchair, walk 3 m, turn, walk back and sit down again 3e Each 
participant will perform the test three times To evaluate parkinsonian signs we apply the 
Unified Parkinson's Disease Rating Scale (UPDRS), the motor score 39 Finally disease severity 
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will be assessed with the Hoenhn and Yahr stage assessing40 For the evaluation of gait and 
balance we will also administer the Freezing of gait questionnaire (FOG), a questionnaire 
consisting of 16 items regarding gait and falls and the Falls questionnaire 2324 
Assessment of other variables 
assessment of activities of daily living As a measure of disability the Barthel Index will be 
used " The activities of daily living will be assessed by the instrumental activities of daily 
living questionnaire 42 
Demographics and life style Standardized questionnaires on demographics, education 
(classified using 7 categories, 1 being less than primary school and 7 reflecting an academic 
degree)43, marital status, living conditions, and life style habits (alcohol consumption, 
smoking, exercise) will be administered Alcohol consumption is defined as units per day 
and the age at which alcohol consumption had started (and if stopped) was noted Cigarette 
smoking behaviour is defined as the number of pack-years, calculated as the number of 
packs of cigarettes smoked per day multiplied by the number of years a participant had 
smoked Exercise is expressed in the metabolic equivalent value (MET) according to accepted 
standards, where 1 MET is proportional to the energy expended while sitting quietly ^ 
Vascular risk factors and cardiovascular disease With the aid a of structured, standardized 
questionnaire each participant will be asked for a history of hypertension, diabetes 
mellitus, atrial fibrillation, TIA, stroke, myocardial infarction, coronary artery bypass graft, 
per-cutaneous transluminal coronary angiography, aortic prothesis, vascular prothesis, 
carotid endarterectomy2421 and migraine45 The presence of a family history of myocardial 
infarction, cerebrovascular disease and diabetes mellitus in next of km will be recorded 
Current medication Current medication use will be noted and classified according to the 
Anatomical therapeutic chemical (ATC) classification system (World Health Organization, 
WHO Collaborating Centre for drug statistics and methodology, http //wwwwhocc no/ 
atcddd/) 
Depressive symptoms A standardized structured questionnaire used in previous large scale 
epidemiological studies will be used to assess for the history of depressive symptoms, 
normal reactions to stressful events or normal grief will carefully be excluded 46 In case of a 
depressive episode, age of onset, the medical advice and medication use will be registered 
We defined 'depression' as those depressive episodes that have required attention of a 
general practitioner, psychologist, or psychiatrist This definition includes minor depression, 
as well as more severe depression syndromes such as major depression and bipolar 
depression 46 
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In addition participants will be screened for depressive symptoms by means of the Mini 
International Neuropsychiatrie Interview (MINI), part A, which is a short diagnostic 
structured interview based on the DSM IV"Additionally, presence of actual depressive 
symptoms will be assessed by two self report questionnaires, the Center of Epidemiologic 
Studies Depression Scale (CES-D)48 and the Hospital Anxiety and Depression Scale (HADS)49 
Sleep problems For the assessment of sleep disorders we will use the SCOPA-Sleep scale50 
and for fatigue the Checklist on Individual Strength (CIS20R)51 
Quality of life The overall health status (quality of life) will be assessed with the Short Form 
SefSF-BS)5253 
Physical Examination Height and weight will be measured without shoes in light clothing 
The body mass index (BMI) is calculated as weight divided by height (in meters) squared The 
maximal waist circumference will be measured without shirt, in standing position, between 
the lowest rib and the iliac crest, at the end of normal expiration M Blood pressure and pulse 
rate will be measured in triplicate in supine position after 5 minutes rest Subsequently one 
measurement is performed after 1 minute in upright position 3 
Primary reflexes The presence of the glabella , snout and grasp reflex, the applause sign55 
and the plantar response will be registered 
Muscle strength The strength of the biceps, hand grip, iliopsoas, quadriceps and foot 
extensor muscles on both sides will be measured by the medical research council scale 
(MRC) and by a dynamometer (Citec® hand-held dynamometer)56 
Sensory system will be assessed by a quantitative measurement by vibration tuning fork 
(Rydel-Seiffer®) on both first toes and both medial malleolus, also registering ankle oedema 
and ankle jerks 
MRI scanning and processing 
MRI scanning will be performed on a 1 5-Tesla Magnetom scanner (Siemens, Erlangen, 
Germany) The scanning protocol includes whole brain 3D T l magnetization-prepared rapid 
gradient-echo (MPRAGE) sequence (TR/TE/TI 2250/3 68/850ms, flip angle 15°, voxel size 
1 0x1 0x1 0mm), FLAIR pulse sequences (time repetition [TR]TE/TI 9000/84/2200 ms, voxel 
size 1 0x1 2x6 0mm (including slice gap of 1 mm), transversal T2* weighted gradient echo 
sequence (TR/TE 800/26ms, voxel size 1 3x1 0x6 0mm (including slice gap of 1 0 mm), DTI 
(TR/TE 10100/93ms, voxel size 2 5x2 5x2 5mm, 4 unweighted scans, 30 diffusion weighted 
scans, with non co-linear orientation of the diffusion-weighting gradient, and b value 900s/ 
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mm2) and resting state imaging using a gradient echo EPI (TR/TE 2400/40ms, voxel size 
3 5x3 5x4 4mm (including slice gap of 0 4mm)) During resting state, subjects will be told 
not to concentrate on any particular subject, but just to relax with their eyes closed The 
complete scanning protocol takes 31 minutes 
White matter lesions All images will be evaluated without prior notice of any clinical 
parameter WML are defined as hypermtense lesions on FLAIR MRI without corresponding 
cerebrospinal fluid like hypo-intense lesions on the T l weighted image Gliosis surrounding 
lacunar and territorial infarcts is not considered to be WML57 Total WML volume is calculated 
by an m-house developed, validated technique 
Brain volumetry Normalization parameters to the ICBM152 linear template (as provided 
with SPM5, Wellcome Department of Cognitive Neurology, University College London, UK) 
and gray and 
white matter tissue and cerebrospinal fluid probability maps is computed by using SPM5 
unified segmentation routines on the T l MPRAGE images 58 Total grey and white matter 
volumes are calculated by summing all voxel volumes that have a p>0 5 for belonging to 
the tissue class Total brain volume is taken as the sum of total grey- and total white matter 
volume Co-registration parameters of the FLAIR image to the T l image are computed 
(SPM5 mutual information co-registration) and used to bring both the FLAIR and WML 
segmentation images into the subject's (anatomical) reference frame Transformed images 
will visually be checked for co-registration errors Subsequently, the WML segmentations 
are resampled to and combined with the white matter maps to yield to a WML map (the 
intersection of WML and white matter) and NAWM map (the complement of WML m white 
matter) m the T l reference space Total brain volume is taken as the sum of total gray and 
white matter 
Lacunar and territorial infarcts Lacunar infarcts are defined as hypo-intense areas > 2mm 
and < 15mm on FLAIR and T l , ruling out enlarged perivascular spaces (< 2 mm, except 
around the anterior commissure, where perivascular spaces can be large) and mfraputammal 
pseudolacunes [57] Territorial infarcts are defined as hypomtense lesions on FLAIR and on 
T l images >15mm 57 
Microbleeds Microbleeds are defined as small, homogeneous, round foci of low signal 
intensity on T2* weighted images of less than 10 mm m diameter59 Microbleeds are counted 
per hemisphere separately In addition they are classified as cortical/subcortical including the 
periventricular white matter and deep portions of the centrum semiovale (frontal, parietal, 
occipital and temporal separately), m the basal ganglia, including caudate nucleus, internal 
and external capsule, globus pallidus, thalamus and putamen, mfratentonal including the 
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cerebellar hemispheres, pons and medulla oblongata 59 Lesions are not considered to be 
microbleeds when they are symmetric hypomtensities in the globus pallidus, most likely 
calcifications or iron deposits, flow voids artifacts of the piai blood vessels or hyposignals 
in T2* inside a lesion compatible with an infarct, likely to be hemorrhagic transformation 59 
Diffusion tensor imaging The diffusion weighted images of each participant are realigned 
on the unweighted image using mutual information based Matlab (The Mathworks, Ine ) 
routines from SPM5 Then, the diffusion tensor and its eigenvalues are computed using an 
SPM5 add-on (http //sourceforee net/proiects/spmtools)60 Unphysical spurious negative 
eigenvalues of the diffusion tensor were set to zero, after which the tensor derivatives the FA 
and MD are calculated 61 The mean unweighted image is used to compute the co-registration 
parameters to the anatomical T l image (SPM5 mutual information co-registration), which 
are then applied to all diffusion weighted images and results All images are visually checked 
for motion artefacts and coregistration errors 
Electrocardiogram 
An electrocardiogram (ECG) will be performed and evaluated by a standardized assessment 
by an experienced cardiologist, registering frequency, cardiac rhythm, cardiac ectopias, 
cardiac axis, conduction time over the PQ, QRS and QTC intervals, conduction disturbances, 
left ventricle hypertrophy, pathologic Q's, infarction, repolansation disturbances and acute 
ischemia A final diagnosis is defined as normal, abnormal without clinical significance, 
abnormal with clinical consequences or pathologic ECG with immediate consultation of a 
cardiologist when necessary 
Ultrasonography of the carotid arteries 
All ultrasound measurements will be performed by three experienced and specific trained 
clinical neurophysiology technicians A carotid ultrasound assessment at which the intima 
media thickness (IMT) is measured m the distal left and right carotis communis, near the 
bulbus, will be performed All measurements will be performed using a phased array real-
time scanner (Philips i-u22, The Netherlands) with a 17-5 MHz broadband linear transducer 
Two-dimensional ultrasound imaging of the carotid artery will be performed to measure the 
IMT The IMT will be automatically measured by QLab® qualification software (V 4 2 1 ) An 
edge detection algorithm identified the lumen/mtima and the media/adventitia interfaces 
within a region of interest over a 10mm long segment and calculated the average thickness 62 
The same cognitive, motor, gait and balance assessment, structured interview and 
assessment of other variables and the same ancillary investigation were performed at 
baseline in 2006 
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Statistical analysis 
Sample size calculation. Based on the literature we expect about 60 incident dementia 
cases during the five year follow up (absolute risk 4-5%/year), as about half of our study 
population has a relatively high degree of WML.63 We expect that each SD increase in MD 
increases this absolute risk of dementia by 2% per year. To detect this increased risk with a 
high probability of 90% at the 5% significance level we will need 380 participants at the end 
of the follow up, so therefore we included 500 participants at baseline and hope to end up 
with 400 participants at follow-up protocol (taking into account an expected loss to follow 
up of about 20%). 
Analysis of primary outcome measures. We will analyze mean baseline MD and FA and 
change in MD and FA on follow up imaging in relation to incident dementia and parkinsonism 
by Cox proportional hazard models adjusted for age, sex, education, depressive symptoms, 
total brain volume, white matter lesion volume and lacunar infracts, where appropriate. 
Discussion 
The RUN DMC study is a large prospective cohort study on causes and consequences of 
structural and functional changes in the integrity of the cerebral white matter (in both the 
WML and the NAWM) as assessed by conventional MRI as well as new techniques, such as 
DTI and resting state fMRI, among elderly with cerebral SVD, starting to include participants 
for the follow-up protocol in July 2011. 
Numerous studies have shown that WML observed on conventional MRI are related to 
vascular risk factors and have reported associations with cognitive and motor decline and 
found these relations to be rather weak.34810'16To the best of our knowledge there are no 
prospective cohort studies on individuals with cerebral SVD investigating the development 
of incident dementia and parkinsonism in relation to white matter changes assessed by DTI 
and resting state fMRI. 
Strengths of the RUN DMC study include the prospective fashion of the study in which all 
vascular risk factors, clinical and imaging measures will be followed up after five years, and 
the large and well-established protocol used to explore demographics, vascular risk factors, 
and cognitive and motor function. The tests chosen are furthermore widely accepted and 
have been proven specific and sensitive in this population with structural brain changes. 
Another strength is the fact that it is a single centre study. Moreover, the complete study 
protocol will take place in one research centre with the use of a single scanner and only two 
investigators performing all investigations. 
In conclusion, the RUN DMC study has the potential to further unravel the causes and 
consequences of changes in white matter integrity in elderly with cerebral SVD by using 
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new imaging techniques, DTI and resting state fMRI When proven, changes in white matter 
integrity assessed by these techniques might function as a surrogate endpoint for cognitive 
and motor function in future therapeutic trials of vascular risk factors m SVD 
The execution and completion of the follow-up of our study will ultimately unravel the role 
of SVD on the microstructural integrity of the white matter in the transition from "normal" 
aging to cognitive and motor decline and impairment and eventually to incident dementia 
and parkinsonism 
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Abstract 
Background Cerebral small vessel disease (SVD), including white matter lesions (WML) 
and lacunar infarcts, is related to cognitive impairment Cerebral microbleeds (MB) are 
increasingly being recognized as another manifestation of SVD and are also related to 
cognitive functìon However, it remains unclear whether this relation is independent of 
WML and lacunar infarcts, and if location of MB plays a role We investigated the relation 
between the presence, number, and location of MB and cognitive performance, adjusted for 
WML and lacunar infarcts 
Methods Presence, number and location of MB were rated on a gradient echo T2*-weighted 
MRI in 500 non-demented elderly with SVD Cognitive performance was assessed in different 
domains Analyses were adjusted for age, sex, education, depressive symptoms, total brain 
volume, WML volume, lacunar and territorial infarcts 
Results Mean age was 65 6 years (SD 8 8) and 57% were male MB were present in 10 4% of 
the participants Subjects with MB were significantly older, had a higher WML volume and 
more lacunar infarcts (p< 001) Presence and number of MB were related to global cognitive 
function (β - 10,p= 008, β- 20,p= 002), psychomotor speed (β - 10,p= 012, β- 19,p= 006) 
and attention (β - 10,p= 02, β- 205,p= 001) The relations with cognitive performance were 
mainly driven by frontal, temporal and strictly deep located MB 
Conclusions Frontal and temporal located MB correlate with cognitive performance in non-
demented elderly independent of coexisting other SVD related lesions MB are clinically not 
silent and may help to understand the role of vascular disease in cognitive decline 
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Introduction 
Cerebral small vessel disease (SVD) related lesions, including white matter lesions (WML) and 
lacunar infarcts, are common in the elderly Cerebral SVD is an important cause of cognitive 
impairment in elderly, eventually leading to dementia in some12 Cerebral microbleeds 
(MB) are increasingly recognized as another manifestation of SVD 34 Radiologically they are 
characterized as small, homogeneous, round foci of low signal intensity on gradient echo 
(GRE)T2*sequences Histopathological analysis shows that these are perivascular collections 
of hemosiderin deposits5 Accumulating evidence suggests that the distribution of MB 
may reflect the underlying pathological changes, lobar MB are presumably attributable 
to cerebral amyloid angiopathy (CAA), whereas MB in the deep/mfratentonal regions are 
considered to represent hypertensive microangiopathy467 
Although considered to be clinically silent, MB have been related to cognitive impairment810 
This has predominantly been investigated in memory clinic patients, usually without taking 
location of MB into account and without quantitative WML adjustment "As MB virtually 
always coexist with WML and lacunar infarcts, its relation with cognitive performance 
should be assessed independent of manually segmented WML and number of lacunar 
infarcts, at different lobar and deep locations Due to the typical profile of 'subcortical' 
cognitive impairment in patients with SVD with psychomotor slowing due to impaired 
executive function, déficits of attention, planning and set-shifting, and episodic memory 
disturbances12, we hypothesized that MB in frontal and temporal regions have the strongest 
relation with cognitive function Therefore we wanted to investigate the relation between 
the presence, number, and location of MB and cognitive performance, independent of 
coexisting WML and lacunar infarcts 
Materials and Methods 
Study population 
The Radboud University Nijmegen Diffusion tensor and Magnetic resonance Cohort (RUN 
DMC) study prospectively investigates the risk factors and clinical consequences of brain 
changes as assessed by MRI among 503, 50-85 year old non-demented elderly with cerebral 
SVD13 
On the basis of established research criteria SVD was defined as the presence of lacunar 
infarcts and/or WML 14 Symptoms of SVD include acute symptoms, such as TIAs or lacunar 
syndromes, or subacute manifestations, such as cognitive, motor (gait) disturbances 
and/or depressive symptoms 12 As the onset of cerebral SVD is often insidious, clinically 
heterogeneous, and typically with mild symptoms, it has been suggested that the selection 
of subjects with cerebral SVD in clinical studies should be based on the more consistent brain 
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imaging features " Accordingly, m 2006, consecutive patients referred to the Department 
of Neurology between October 2002 and November 2006, were selected for participation 
Inclusion criteria were (a) age between 50 and 85 years, (b) cerebral SVD on neuroimagmg 
(WML and/or lacunar infarcts)12 
Exclusion criteria were (a) dementia15 (b) parkinson(-ism)16 (c) life expectancy of less than 
six months, (d) intracranial space occupying lesion, (e) (psychiatric) disease interfering with 
cognitive testing or follow-up, (f) recent/current use of acetylcholine-esterase inhibitors, 
neuroleptic agents, L-dopa or dopa-a(nta)gonists, (g) WML or SVD mimics (e g multiple 
sclerosis and irradiation induced gliosis), (h) prominent visual or hearing impairment, (ι) 
language barrier, (j) MRI contraindications or known claustrophobia 
Patients were selected for participation by a three step approach After reviewing medical 
records, 1004 individuals were invited by letter, 727 were eligible after contact by telephone 
of whom 525 agreed to participate During these three steps, patients excluded because 
of dementia were diagnosed according to the Diagnostic and Statistical Manual for Mental 
Disorders, version IV15, with formal cognitive assessment First, patients were excluded 
based on the clinical information and cognitive assessment obtained by reviewing the 
medical records Second, during contact by telephone, patients were excluded when a 
close informant told us that the eligible person was admitted to a nursing home because 
of dementia, diagnosed by a neurologist of geriatrician Third, during their visit to our 
research center, all subjects underwent extensive cognitive assessment and questionnaires 
about their social functioning, they were excluded because of dementia if they fulfilled the 
previously mentioned criteria (n=4) In 18 individuals one of the other exclusion criteria 
were found during their visit to our research center, yielding a response of 71 3% (503/705) 
All participants signed informed consent The Medical Review Ethics Committee region 
Arnhem-Nijmegen approved the study 
MRI 
All subjects underwent a 1 5T MRI The protocol included, among other sequences, 3-D 
T l MPRAGE (TR/TE/TI 2250/3 68/850ms, flip anglelSe, voxel size 1 0x1 0x1 0mm), FLAIR 
pulse sequences (TR/TE/TI 9000/84/2200ms, voxel size 1 0x1 2x5 0mm, mterslice gap 
1mm) and transversal T2*-weighted gradient echo sequences (TR/TE 800/26ms, voxel size 
1 3x1 0x6 0mm, mterslice gap 1mm)7 
MRI analysis 
White matter lesions, lacunar and territorial infarcts White matter signal hypermtensities 
on FLAIR images, which were not, or only faintly, hypo-intense on Tl-weighted images, were 
considered WML, except for gliosis surrounding infarcts 17WML were manually segmented 
on FLAIR images by two trained raters Total WML volume was calculated by summing the 
segmented areas multiplied by slice thickness Lacunar infarcts were defined as hypo-intense 
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areas with a diameter >2mm and <15mm with low signal intensity on T l and FLAIR, ruling 
out enlarged perivascular spaces and infraputaminal pseudolacunes.17 All imaging analyses 
were performed by raters blinded to clinical information. In a random sample of 10%, inter-
rater variability for total WML volume yielded an intra-class correlation coefficient of 0.99; 
intra- and inter-rater reliability for the lacunar infarcts yielded a weighted kappa of 0.80 
and 0.88. Territorial infarcts are defined as hypointense lesions on FLAIR and on T l images 
>15mm.17 
Microbleeds. MB are defined as small, homogeneous, round focal areas of very low signal 
intensity on T2*-weighted images of less than 10 mm in diameter.4 sThey were categorized in 
lobar (cortical gray and subcortical or periventricular white matter), deep (deep gray matter, 
including the basal ganglia and thalamus, the white matter of the corpus callosum, internal, 
external and extreme capsule), and infratentorial (brainstem and cerebellum).4 8 Lesions are 
not considered to be MB when they are symmetric hypointensities m the globus pallidus, 
most likely calcifications or iron deposits, flow voids artifacts of the piai blood vessels or 
hyposignals in T2* inside a lesion compatible with an infarct, likely to be hemorrhagic 
transformation."8 MB were rated by two trained raters, in a 10% random sample, intra- and 
mterrater reliability yielded an intraclass correlation coefficient of 0.79 and 0.99 for total 
number of MB and 0.94 and 1.00 for individual locations. 
Total brain volume and intracranial volume. Gray (GM) and white matter (WM) tissue and 
cerebrospinal fluid (CSF) probability maps were computed using SPM5 unified segmentation 
routines on the TI MPRAGE images (Wellcome Department of Cognitive Neurology, 
University College London, UK). Total GM, WM and CSF volumes were calculated by summing 
all voxel volumes that had a p>0.5 for belonging to the tissue class. Total brain volume (TBV) 
was taken as the sum of total GM and WM. Intracranial volume (ICV) was a summation of 
all tissue classes, i.e. total GM, WM and CSF volume. To normalize for head size, TBV was 
expressed as percentage of total ICV. 
Measurement of cognitive function 
Cognitive function was measured with a neuropsychological test battery that proved to be 
sensitive and suitable for this purpose in other, large epidemiological studies.1 The tests 
used are described in detail elsewhere.13 In short, we calculated compound scores for 
seven cognitive domains. Global cognitive function was evaluated by the Mini Mental State 
Examination and the Cognitive Index. The Cognitive Index is a compound score that was 
calculated as the mean of the z-scores of the 1-letter subtask of the Paper-Pencil Memory 
Scanning Task, the mean of the reading subtask of the Stroop test, the mean of the Symbol-
Digit Substitution Task and the mean of the added score on the three learning trials of the Rey 
Auditory Verbal Learning Test (RAVLT) and the delayed recall of this last test.1 Verbal memory 
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is a compound score of the mean of two z-scores from the RAVLT, one for the added scores 
of the three learning trials of this test, and one for the delayed recall of this test Visuospatial 
memory is a compound score of the mean of the z-scores of the immediate recall trial and 
the delayed recall trial of the Rey Complex Figure Test Psychomotor speed was calculated as 
the mean of the z-scores of the 1-letter subtask of the Paper-Pencil Memory Scanning Task, 
the reading subtask of the Stroop test and the Symbol-Digit Substitution Task 1 Fluency was 
calculated from the mean of the z-scores of both verbal fluency tasks Concept shifting was 
calculated as the z-score of the third subtask of the Stroop Attention is a compound score 
of the z-score of the total time of the Verbal Series Attention Test.1 
Other measurements 
Age, sex, education, depressive symptoms, WML volume, lacunar infarcts, territorial infarcts 
and normalized TBV were considered possible confounders Depressive symptoms were 
present if a subjects had a score >16 on the Center of Epidemiologic Studies on Depression 
Scale (CES-D) and/or the present use of anti-depressive medication 18 
For assessment of vascular risk factors, structured questionnaires were used together 
with measurements of blood pressure taken on separate occasions The risk factors 
included presence of hypertension (mean blood pressure >140/90 mmHg and/or use 
of anti-hypertensive medications) diabetes (treatment with antidiabetic medications), 
hypercholesterolemia (treatment with lipid-lowermg drugs) and smoking status 
Statistical Analysis 
Baseline characteristics were presented as means ± standard deviation (SD) and for the 
skewed distributed parameters the median and interquartile range was calculated Baseline 
characteristics were compared between subjects with and without MB by age- and sex-
adjusted ANCOVA 
The relation between the presence and number of MB and cognitive performance was 
investigated using multiple linear regression analysis adjusted for age, sex, education, 
depressive symptoms, WML volume, number of lacunar infarcts, territorial infarcts and TBV 
normalized for head size " 
Second, the relation between the of location of MB and cognitive performance was studied 
both in the previously described model and next, with adjustments for MB at other locations 
Bonferrom corrections were applied 
The relation between location and cognitive performance was also investigated with the 
subjects divided into 4 groups (no MB, strictly lobar, deep/mfratentonal and mixed) using 
analysis of covanance adjusting for the same covanates 
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Table 1 Baseline Characteristics 
Participants 
Demographics 
Age, yr 
Male' 
MMSE 
Only primary education* 
Depressive symptoms* 
Hypertension* 
Diabetes mellitus* 
Hypercholesterolemia * 
Smokers, current* 
Smokers, former* 
Neuroimaging 
TBV, mL 
ICV, mL 
WML volume, mL 
Lacunar infarcts* 
Territorial infracts* 
n=500 
65 6 (8 8) 
284(56 8) 
28 1 (1 6) 
49(9 8) 
168 (33 6) 
367(73 4) 
74 (14 8) 
236(47 2) 
75(15 0) 
277(55 4) 
1093 7 (120 8) 
1677 6(156 7) 
7 1(3 4,18 1)t 
171(34 2) 
59(118) 
Microbleeds 
Yes(n=52) 
69 8(8 0) 
32 (61 5) 
28 0(17) 
4(7 7) 
19(36 5) 
43(82 7) 
7(13 5) 
26(50 0) 
6(115) 
33(63 5) 
1108 0(127 9) 
1709 2 (178 9) 
25 2 (12 1,45 5) 
38(73 1) 
6(115) 
No (n=448) 
65 1 (8 7) 
252(56 2) 
28 1(1 6) 
45 (10 0) 
149(33 3) 
324 (72 3) 
67(15 0) 
210(46 9) 
69(15 4) 
244 (54 5) 
1092 0(120 1) 
1672 8(153 3) 
6 4(3 3,15 1) 
133(29 7) 
53(118) 
p-valuet 
<001 
47 
63 
18 
64 
57 
50 
98 
76 
67 
25 
09 
<001 
<001 
52 
Data represent Ν of subjects*(%), mean(SD), or median (interquartile range)t 
^Analysis of covanance, adjusted for age and sex 
MMSE Mini Mental State Examination, TBV total brain volume, ICV intracranial volume, WML white matter lesions 
Results 
For the present study three subjects were excluded because of MRI artifacts, resulting m a 
final study population of 500 subjects. MB were present m 10 4% of the population, 48.1% 
had one MB, 21.1% had two MB, 15 4% had 3 to 5 MB and 15 4% had >5 MB Thirty-one 
(59 6%) individuals had strictly lobar MB, seven (13.5%) had isolated deep/mfratentonal 
MB Subjects with MB were significantly older (p< 001), had a higher WML volume (p< 001) 
and a higher proportion of subjects with MB had lacunar infarcts compared to those without 
MB(p<001) (Table 1) 
The presence of MB was related to the cognitive index, psychomotor speed and attention 
A higher number of MB was independently related to a lower performance on cognitive 
performance (Table 2) 
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Table 2 Relation between presence and number of microbleeds (MB) 
and cognitive performance 
MMSE 
Cognitive index 
Verbal memory 
Visuospatial memory 
Psychomotor speed 
Fluency 
Concept shifting 
Attention 
Presence of MB 
-03 
- .10** 
-08 
-07 
-10* 
-.01 
-.06 
-10* 
Number of MB 
-05 
- 2 0 * * 
-.17* 
-.12 
- 1 9 * * 
-13 
-09 
- 2 5 * * 
Data are standardized 3 values, adjusted for age, sex, education, depressive symptoms, 
WML volume, lacunar intacts, territorial infracts and TBV 
*p<05, **p<01 
The relation between MB and cognitive performance was mainly driven by frontal and 
temporal located MB. Deep MB were related to global cognitive function, psychomotor 
speed and attention. (Table 3) Additional adjustment for MB at other locations did not alter 
the magnitude of the relations. 
Only those with strictly deep and mixed MB performed worse on global cognitive function 
(p=.013), psychomotor speed (p=.002) and attention (p=.001) compared to those without 
MB. 
Table 3 Relation between location of microbleeds and cognitive performance 
Microbleeds 
Location 
Lobar 
Frontal 
Parietal 
Occipital 
Temporal 
Deep 
Basal ganglia 
Thalamus 
Infratentonal 
Ν 
osubjects 
45 
23 
20 
13 
16 
13 
8 
8 
2 
Global cognitive 
function 
MMSE 
-06 
-04 
-.02 
-.05 
-09 
-08 
-.02 
-06 
-.05 
Cognitive 
index 
-17* 
-.18* 
-13* 
-13 
-14* 
-.14* 
-08 
-08 
-08 
Cognitive performance 
Memory function 
Verbal 
memory 
-.16* 
-14* 
-.10 
-.12 
-.14* 
- 1 1 
-.06 
-08 
-.08 
Visuospatial 
memory 
-17* 
-.26* 
-10 
-08 
-19* 
-.06 
-04 
-05 
-03 
Psychomotor 
speed 
-16* 
-18* 
-.12* 
-.10 
-.11 
-13* 
-.06 
-.05 
-06 
Executive funtion 
Fluency 
-13 
-.12 
-.04 
-.13 
-.14 
-.10 
-06 
-.02 
-05 
Concept 
shifting 
-09 
-.06* 
-05 
-04 
-13 
-.04 
-.02 
-.01 
-.03 
Attention 
-.24* 
-30* 
-08 
-03 
-22* 
-.28* 
-.35* 
-.11 
-.06 
Data are standardized β values, adjusted for age, sex, education, depressive symptoms, WML volume, lacunar infacts, territorial infracts and TBV 
* Significant after Bonferroni correction p< 05 
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Discussion 
The presence and number of MB, especially those located in the frontal and temporal lobe, 
but also strictly deep located MB, interfere with cognitive performance, independent of 
other manifestations of SVD 
The relation between MB and cognitive performance has been demonstrated before in 
population based cohorts, memory clinic cohorts and a cohort from a neurovascular clinic " 
Strong elements of our study are that we examined for the first time the effect of MB at 
different lobar and at deep locations, independent of quantitatively assessed WML, rather 
than a semi-quantitative assessment, in which a ceiling effect of this other parameter of SVD 
could result in residual confounding Furthermore we extensively adjusted for other possible 
confounders We intentionally did not adjust for vascular risk factors such as hypertension 
as they were considered to be an earlier part of the causal chain between MB and cognitive 
performance Finally, other major strengths of our study included the large sample size, 
the extensive assessment of cognitive function, the single centre design, the use of a single 
scanner use and the high response rate 
A limitation is the cross-sectional nature of the study, which prevented us from proving 
causality. Furthermore, MRI techniques on the detection of MB have improved, which may 
have resulted m underestimation of the actual number of MB m our population, which may 
have affected the effect size, but not the association with cognitive performance.3 However, a 
recent study on the clinical relevance of the improved detection techniques for MB m terms 
of associations with clinical characteristics, vascular risk factors and other MRI markers of 
SVD, did not find stronger relations (or more variance explained) between cognition and MB 
detected with susceptibility-weighted imaging (SWI) compared toT2*-weighted imaging 19 
We found that MB were related to cognitive performance, independent of WML and lacunar 
infarcts Furthermore location played a role in the associations These findings, together 
with results from pathological studies showing that MB are frequently characterized by 
surrounding microstructural damage20, suggest that they have direct effect on cognitive 
performance rather than simply reflecting the presence of other markers of SVD, as our 
findings are independent of WML volume and lacunar infarcts 
It is hypothesized that the distribution of MB reflects the underlying etiology Lobar MB have 
been attributed to CAA, whereas MB m the deep/mfratentonal regions (with or without 
lobar MB) have been associated with hypertensive microangiopathy.467 We found that the 
relation between MB and lower cognitive performance was mainly driven by MB located in 
the frontal and temporal lobes A recent report on the distribution of lobar MB taking lobar 
volumes and clustering effects into account found that lobar MB are significantly more often 
located in the temporal lobe.21 This suggests that the relation observed between temporal 
located MB and lower cognitive performance might, at least m part, be explained by the 
higher number of MB m this region, compared to other regions if one would take the volume 
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of the temporal lobe into account As the temporal lobe is known to be more affected by 
CAA, our findings are therefore suggestive of CAA as underlying etiology However we also 
found a relations between the strictly deep located MB and a lower cognitive performance, 
favoring multiple causes rather than a single cause for cognitive impairment in patents with 
MB(andSVD) 
The underlying mechanisms of the pathologic association between MB and cognitive 
function are unknown However, histopathologic studies have shown that the presence of 
MB indicate widespread damage of arterioles by hypertension or by amyloid deposition, as 
well as surrounding gliosis or even frank necrosis or infarction, resulting m microstructural 
damage of the surrounding white matter5 20 In this way MB may disrupt white matter tracts 
relevant for cognitive function leading to damage to the neural networks, superimposed to 
the effects of often co-occurring WML and lacunar infarcts This tissue damage, not visible 
on conventional MRI, can be assessed in future studies with rather new techniques such as 
diffusion tensor imaging or resting state MRI 
In conclusion, we found that presence, number of cerebral MB, independent of coexisting 
WML and lacunar infarcts, correlate with cognitive performance in non-demented elderly, 
this relation is mainly driven by the frontal and temporal located MB, but also by strictly 
deep located MB These results suggest that MB are clinically not as silent as they are 
considered to be and in that way might help us to understand the role of vascular disease 
m cognitive decline Follow-up should identify whether the presence at baseline and/or 
increase of MB over time predict future cognitive decline and development of dementia, 
and whether location of these MB plays a role m this relation 
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Chapter 5 
Presence, number and location of cerebral 
microbleeds are associated with subjective 
cognitive complaints 
Submitted as: 
van Norden AGW, de Laat KF, Gons RAR, Kessels RPC, van Dijk EJ, de Leeuw F-E. Cerebral 
microbleeds are related to subjective cognitive failures. The RUN DMC study. 
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Abstract 
Background Cerebral small vessel disease (SVD), including white matter lesions (WML) and 
lacunar infarcts, is related to objective cognitive impairment but also to subjective cognitive 
failures (SCF). SCF have reported to be an early predictor of dementia. Cerebral microbleeds 
(MB) are another manifestation of SVD and have been related to cognitive impairment, but 
the role of MB m SCF has never been studied. We therefore investigated whether MB are 
related to SCF among non-demented elderly with SVD, independent of coexisting WML and 
lacunar infarcts. 
Methods The RUN DMC study is a prospective cohort study among 503 older people with 
cerebral SVD aged between 50-85years. All participants underwent FLAIR and T2* scanning. 
SCF, subjective memory (SMF) and subjective executive failures (SEF) were assessed. The 
relation between SCF and the presence, number and location of MB was assessed by linear 
regression analyses adjusted for age, sex, education, depressive symptoms, cognitive 
function, total brain volume, territorial infarcts, WML and lacunar infarcts. 
Results MB were present in 11%. We found a relation between the presence, total number 
and lobar located MB and SCF, SMF and SEF and the reported progression of these failures, 
especially in participants with good objective cognitive function. 
Conclusion MB are related to SCF independent of coexisting WML and lacunar infarcts, 
especially in those with good objective cognitive performance. These results suggest that 
MB are associated with the earliest manifestations of cognitive impairment. MB may help us 
understand the role of the ever expanding spectrum of SVD in cognitive impairment. 
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Introduction 
Subjective cognitive failures (SCF) including memory complaints are frequently reported by 
older people Despite considerable controversy whether these complaints predict objective 
cognitive failures12, some have shown these complaints to be predictive of dementia 34 
Cerebral SVD, which includes WML and lacunar infarcts, is very common in the elderly 
Both hospital- and population-based studies have shown that SVD is related to cognitive 
impairment, and in some may ultimately lead to dementia 56 In some studies, SCF have been 
related to SVD, although these relations are rather weak 710 
Cerebral microbleeds (MB) are increasingly recognized as another manifestation of SVD 1112 
Although generally considered to be clinically silent, a study m a neurovascular clinic 
population first showed a relation between MB and cognitive impairment13 More recent 
studies found the same relation m population based- and memory clinic cohorts " 1 5 It might 
be that MB, as they virtually always coexist with WML and lacunar infarcts, are related to 
SCF as well " 1 2 We therefore wanted to investigate whether MB are associated with SCF in 
a non-demented SVD population, m the absence of detectable cognitive impairment and 
independent of other manifestations of SVD (WML and lacunar infarcts) As SCF have been 
strongly related to depressive symptoms189 and associated with hippocampal volume1016, 
we wanted to investigate this relation independent of these covanates 
Methods 
Study population 
The Radboud University Nijmegen Diffusion tensor and Magnetic resonance imaging Cohort 
(RUN DMC) study prospectively investigates the risk factors and clinical consequences 
of brain changes among 503, 50-85 years old non-demented elderly with cerebral SVD 
The selection procedure of the participants and study protocol were described in detail 
previously 17 
In short, on the basis of established research criteria SVD was defined as the presence of 
lacunar infarcts and/or WML 18 Symptoms of SVD include acute symptoms, such as TIAs or 
lacunar syndromes, or subacute manifestations, such as cognitive, motor (gait) disturbances 
and/or depressive symptoms 19 Accordingly, in 2006, consecutive patients referred to the 
Department of Neurology between October 2002 and November 2006, were selected for 
participation Inclusion criteria were (a) age between 50 and 85 years, (b) cerebral SVD on 
neuroimagmg (WML and/or lacunar infarcts) The mam exclusion criteria were dementia20, 
(psychiatric) disease interfering with cognitive testing or follow-up, WML or SVD mimics and 
MRI contraindications or known claustrophobia All participants signed an informed consent 
form The Medical Review Ethics Committee region Arnhem-Nijmegen approved the study 
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Conventional MRI scanning protocol 
All participants underwent a 1 5-T MRI The protocol included, among other sequences, 
the following whole brain scans 3D T l MPRAGE imaging, FLAIR pulse sequences and a 
transversal T2* weighted gradient echo sequence 17 
Conventional MRI analysis 
WMLvolume, lacunar infarcts and MB White matter signal hypermtensitieson FLAIRimages, 
which were not, or only faintly, hypo-intense on Tl-weighted images, were considered WML, 
except for gliosis surrounding infarcts 21 WML were manually segmented on FLAIR images, 
total WML volume was calculated by summing the segmented areas multiplied by slice 
thickness Lacunar infarcts were defined as hypo-intense areas with a diameter >2mm and 
<15mm with low signal intensity on T l and FLAIR 21 All imaging analyses were performed 
by raters blinded to clinical information In a random sample of 10%, mter-rater variability 
for total WML volume yielded an mtra-class correlation coefficient of 0 99, intra- and mter-
rater reliability for the lacunar infarcts yielded a weighted kappa of 0 80 and 0 88 Territorial 
infarcts were defined as hypomtense lesions on FLAIR on T l images >15mm 21 
MB were defined as small, homogeneous, round focal areas of very low signal intensity 
on T2* weighted images of less than 10 mm in diameter1214 They were categorized into 
lobar, deep, and mfratentonal1 2" Lesions were not considered to be MB when they 
were symmetric hypomtense in the globus palhdus, calcifications or iron deposits, flow 
voids artifacts or hyposignals m T2* inside a lesion compatible with an infarct, likely to be 
hemorrhagic transformation 1 2 " 
Hippocampus and intracranial volumetry One experienced investigator, blinded to clinical 
data, manually segmented the left and right hippocampus on the MPRAGE image using 
the interactive software program "ITK-SNAP"22 Anatomical boundaries were determined 
in coronal sections with the aid of neuroanatomical atlases2324, actual segmentation was 
performed using a previously published protocol25 in which segmentation was performed 
from posterior to anterior17 Inter-rater studies on a random sample of 10% showed an mtra-
class correlation coefficient for the left hippocampus of 0 73, and for the right hippocampus 
of 0 79 Intra-rater studies on this sample showed an mtra-class correlation coefficient for 
the left and right hippocampus of 0 97 and 0 96, respectively 
For the same image, gray (GM) and white matter (WM) tissue and cerebrospinal fluid 
(CSF) probability maps were computed using SPM5 unified segmentation routines on the 
T l MPRAGE images (Wellcome Department of Cognitive Neurology, University College 
London, UK) Total GM, WM and CSF volumes were calculated by summing all voxel volumes 
that had a p>0 5 for belonging to the tissue class Intracranial volume (ICV) was a summation 
of all tissue classes, ι e total GM, WM and CSF volume 
Hippocampal volume (HV) measurements were normalized to the total ICV The normalized 
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hippocampal volume (NHV) is defined as NHV=ICVrii χ HV /ICV , where ICVm is the average 
total ICV of all participants, ICV the ICV of the participant and the HV the hippocampal 
volume of the participant26 
Subjective Cognitive Failures 
Information on SCF was assessed by a 15-item semi-structured interview,16 which is an 
adaption of the Cognitive Failures Questionnaire " Responses were added to a sumscore for 
SCF with a maximum of 25 According to previous studies, subjective failure in remembering, 
word finding, planning, concentration, or slowness in thought had a higher weight m the 
sumscores (score range 0-3, none, mild, moderate, severe), than the 10 other items (0-1) 
SCF were considered present when a participant reported at least one moderate problem 
(score 2 or higher) on an item having a score range of 0-3 or a score of 1 on dichotomous 
items16 In addition we assessed whether participants reported progression m failures of 
remembering, word finding, planning, concentration, or slowness of thought over the past 5 
years 1SSCF were subdivided into subjective memory failures (SMF) and subjective executive 
failures (SEF) SMF were considered present if failures were reported in 1 or more of the 10 
items concerning memory problems, SEF were considered present if failures m planning, 
concentration, and slowness of thought were reported 16 
Objective Cognitive Performance 
Cognitive performance was assessed by a standardized neuropsychological test battery that 
has been described in detail elsewhere 17 Performance across tests was made comparable 
by transforming raw test scores into z-scores We used the Mini-Mental State Examination 
(MMSE) and a compound score for global cognitive function, this was calculated as the 
mean of the z-scores of the one-letter subtask of the Paper-and-Pencil Memory Scanning 
task, the reading subtask of the Stroop test, the Letter-Digit Substitution Task, the added 
score of the three learning trials of the three-trial version of the Rey Auditory Verbal learning 
test, and the delayed recall of this test 5 1 7 
Other measurements 
Age, sex, education, depressive symptoms (score >16 on the Center of Epidemiologic 
Studies on Depression Scale (CES-D) and/or the present use of anti-depressive medication), 
WML volume, lacunar infarcts, territorial infarcts and normalized hippocampal volume 
were considered possible confounders 2e For assessment of vascular risk factors, structured 
questionnaires were used together with measurements of blood pressure taken on separate 
occasions The risk factors included presence of hypertension (mean blood pressure >140/90 
mmHg and/or use of anti-hypertensive medications), diabetes (treatment with antidiabetic 
medications), hypercholesterolemia (treatment with lipid-lowermg drugs) and smoking 
status 
Table 1 Baseline Characteristics 
Subjective cognitive failures 
Total (n=497) Yes(n=450) No (n=47) p-value* 
Demographics 
Age (y) 
Male 
Subjects with only primary education 
Subjects wi th depressive symptomst 
Subjects wi th hypertension* 
Subjects wi th diabetes mellitus^ 
Subjects wi th hypercholesterolemia§ 
Smokers, current 
Smokers, former 
Cognition 
MMSE 
Neuroimaging 
Subjects wi th microbleeds 
Lobar 
Deep 
Strictly lobar 
Strictly deep 
Mixed 
Intracranial volume, mL 
Hippocampal volume, mL 
White matter lesions volume, mL 
Subjects wi th lacunar infarcts 
Subjects wi th territorial infarcts 
65 6 (8 8) 
281(56 5) 
47 (9 5) 
166(33 4) 
365(73 4) 
73(14 7) 
234(47 1) 
74(14 9) 
276(55 5) 
66 1 (8 6) 
251(55 7) 
45 (10 0) 
160(35 6) 
334(74 2) 
70 (15 6) 
219 (48 7) 
65 (14 4) 
249 (55 3) 
28 1(16) 28 1(16) 
61 1 (9 0) 
30 (63 8) 
2(4 3) 
6 (12 8) 
31(66 0) 
3(6 4) 
15(319) 
9(19 1) 
27(57 4) 
<001 
26 
65 
003 
91 
13 
06 
58 
41 
28 4 (13) 24 
52(10 5) 
45 (9 1) 
13 (2 6) 
31(6 2) 
7(14) 
14 (2 8) 
1677 9(157 1) 
6 8(10) 
7 2 (3 4 18 2) 
170(34 2) 
58(117) 
47 
40 
12 
27 
7 
13 
1676 0(155 7) 
6 7(10) 
7 1(3 4-19 0) 
155 
56 
5 
5 
1 
4 
0 
1 
1695 4 (168 1) 
7 2(11) 
8 0(4 5-13 5) 
15 
2 
53 
36 
92 
33 
54 
88 
38 
002 
89 
61 
20 
Data represent mean (SD), number (%) or median (interquartile range)*Analysis of covariance, adjusted for age and sex, 
where appropriate tDehned as CES-D score>16 and/or the use of antidepressive medication *Blood pressure > 140/90 
mm Hg and/or use of antihypertensive drugs tUsmg oral glucose-lowering drugs or insulin §Using lipid-lowermg drugs 
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Statistical Analyses 
Baseline characteristics were presented as mean ± standard deviation (SD) and the median 
and interquartile range for skewed distributed parameters. Demographic characteristics 
were compared between subjects with and without SCF by age and sex adjusted analysis of 
covariance (ANCOVA). 
The relation between presence and total number of MB (and by lobar and deep MB) and 
the sumscore of SCF, SMF and SEF was investigated using multiple linear regression analysis 
adjusted for age, sex, education, depressive symptoms, MMSE, WML volume, number of 
lacunar infarcts, territorial infarcts and normalized hippocampal volume. In addition we 
analyzed whether progression of failures was related to number of MB. In a second model 
we adjusted for MB at other locations. 
Participants who reported SCF were considered having severe SCF, when in the upper 
tertile of the SCF score, the others were classified as mild. SMF and SEF were categorized 
accordingly. 
To investigate whether the level of objective cognitive performance modified the association 
between number of MB and severity of SCF, SMF and SEF, we analyzed (ANCOVA) this relation 
stratified by objective performance, according to tertiles of the cognitive index, the lowest 
tertile reflecting the worst cognitive performance, adjusted for all previous confounders. 
Results 
The final sample consisted of 503 participants (response 71.3%) , three were excluded 
because of MRI artifacts and three because of an incomplete SCF interview. Demographic 
characteristics are shown in Table 1. SCF were reported by 91% of the participants (n=450), 
88% reported SMF (n=439) and 61% reported SEF (n=303). Participants reporting SCF were 
older (p<.001), had more depressive symptoms (p=.003) and a smaller hippocampal volume 
(p=.002), than those without, independent of age and sex. 
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Table 2 Relation between number of microbleeds and subjective failures (sumscores) and 
progression of failures 
Number of Microbleeds 
Subjective cognitive failures 
Progression of SCF 
Subjective memory failures 
Progression of SMF 
Subjective executive failures 
Progression of SEF 
Total (n=497) 
20(010) 
22 ( 010) 
16 ( 050) 
28(001) 
22 ( 006) 
43 ( 000) 
Lobar 
20 ( 010) 
17 ( 049) 
18 ( 028) 
25 ( 004) 
20(011) 
38 ( 000) 
Deep 
13 ( 102) 
23 ( 006) 
07(418) 
24 ( 005) 
18(025) 
37 ( 000) 
Data represent standardized 3 values (p-value) adjusted for age, sex, education, depressive symptoms, cognitive function 
(MMSE), WML volume, number of lacunar infarcts, territorial infarcts and normalized hippocampal volume 
SCF and SMF were associated with lower objective cognitive performance (p<.05 and p=.02, 
respectively), independent of age, sex, education, depressive symptoms, WML volume, 
lacunar infarcts, hippocampal volume and MB. 
The presence of MB was, independent of objective cognitive function and coexisting 
WML and lacunar infarcts, related to SCF (ß=0.14, p<.05) and SEF (ß=0.15, p<.05) and the 
progression of these failures. We found no relation with the presence of MB and SMF. 
Table 2 illustrates the relation between the total number of MB and SCF, SMF and SEF, 
independent of other manifestations of SVD. Lobar MB were related to SCF, SMF and SEF, 
especially those in the temporal (ß=0.18, p=.02; ß=0.15, p<.05; ß=0.20, p<.01, respectively) 
and frontal lobe (ß=0.19, p=.02; ß=0.14, p=.09; ß=0.20, p=.01, respectively). Deep MB were 
related to SEF (ß=0.18, p=.025). Progression of failures was related to total number of 
MB. Additional adjustment for MB at other locations did not change the magnitude of the 
associations. 
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Figurel Mean number of microbleedsforparticipantswith mild andseveresubjectivefailures. 
Mean number of microbleeds for participants with mild and severe subjective cognitive, 
memory and executive failures. Participants are dichotomized in good and poor objective 
cognitive performance. Analysis are adjusted for age, sex, education, depressive symptoms, 
white matter lesion volume, number of lacunar infarcts, territorial infarcts and normalized 
hippocampal volume
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Figure 1 shows the mean number of MB m strata of objective cognitive performance for 
participants with mild and severe failures In participants with good cognitive performance 
those with severe SCF had a higher number of MB compared to those with mild failures 
(p= 005) The same was found for participants with severe SMF (p< 001) and severe SEF 
(p= 02) In subjects with poor cognitive performance no relations were found between 
those with mild or severe subjective failures and number of MB 
Discussion 
We found that cerebral MB, independent of other manifestations of SVD, WML and lacunar 
infarcts, were related to SCF, m elderly with cerebral SVD This relation was most evident 
m participants with good objective cognitive performance, and independent of depressive 
symptoms and hippocampal volume 
Major strengths of this study included its large sample size and single-center design, with 
a high response rate, extensive assessment of cognitive function by only two investigators 
and the use of a single MR scanner We were able to investigate the effect of MB on SCF 
independent of WML, lacunar and territorial infarcts and hippocampal volume and in the 
absence of objective cognitive impairment We intentionally did not adjust for vascular risk 
factors such as hypertension as they were considered to be an earlier part of the causal 
chain between MB and SCF 
A limitation is the cross sectional design of our study Although we included questions on 
progression of SCF over the past 5 years and demonstrated relations between progression 
of failures and presence and number of MB, the cross-sectional nature prevents us from 
proving causality However, the RUN DMC study has a longitudinal design and follow-up 
assessments on SVD and cognitive performance are already planned 17 Another limitation 
might be the MRI technique we used to detect the MB As MRI techniques on the detection 
of MB have improved11, we might have underestimated the actual number of MB m our 
population This may have affected the effect size, but not the direction of the association 
with SCF However, a recent study on the clinical relevance of the improved detection 
techniques for MB in terms of associations with clinical characteristics, vascular risk factors 
and other MRI markers of SVD, did not find stronger relations (or more variance explained) 
for MB detected with susceptibility weighted images (SWI) compared to T2* weighted 
imaging " 
Another issue is the relatively high proportion of reported SCF (91%) compared to other 
studies 7 β 3 0 This might be explained by the method we used to determine SCF Instead of 
spontaneous reporting complaints we actively asked for it, which potentially results m higher 
prevalence of complaints Another explanation could be that we included subjects with SVD, 
which is characterized by, among other things, subacute cognitive symptoms19, and as a 
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result are more likely to express complaints. A third explanation might be the relatively high 
prevalence of depressive symptoms (33%) in our cohort, which was significantly higher in 
those with complaints (36%) compared to those without (12%) (p=.003). 
The relation between WML and SCF has been investigated before and was found to be weak 
and mainly demonstrated in people with severe WML71016, whereas the relation between MB 
and SCF has not been investigated before. This study offers the first indication that another 
manifestation of cerebral SVD, i.e. cerebral MB, contributes to SCF, independently of WML 
and lacunar infarcts. Therefore our finding that a higher number of MB was related to severe 
SCF compared to subjects with only mild SCF is of interest. These results, together with 
those from pathology studies showing that MB are frequently characterized by surrounding 
microstructural damage31, suggest that they independently contribute to SCF rather than 
simply reflecting the presence of other markers of SVD, as our findings are independent of 
WML volume and lacunar infarcts. The underlying mechanisms of the pathologic association 
between MB and cognitive function are unknown. Histopathologic studies have shown that 
MB indicate widespread damage of arterioles by hypertension or by amyloid deposition, as 
well as surrounding gliosis and infarction, resulting in microstructural damage.3132 MB may 
disrupt white matter tracts that are important for cognitive function, i.e. in the temporal 
lobe, where we found a relation with SCF and which is no predilection site for WML.33 This 
tissue damage, not visible on conventional MRI, may be investigated using relatively new 
techniques as DTI or resting state MRI. 
Importantly, the relation between MB and severe SCF was especially demonstrated in those 
participants with a good objective cognitive performance. This supports the hypothesis 
that SCF may be a prelude to subtle cognitive deterioration that may, in the end, even 
progress to dementia23, but that in its preclinical stage is difficult to assess using available 
neuropsychological instruments. In that way SCF may serve as an early marker of cerebral 
pathology in participants with SVD as they may be a sensitive tool and early predictor to 
identify those at risk for dementia, m the absence of objective cognitive impairment. The 
prevalence of MB was found to increase after follow-up assessment and MB present at 
baseline predict the development of new MB.34 Possibly, the presence and increase of MB 
over time influence the relation between SCF and the development of dementia years later, 
although this hypothesis has to be investigated in a longitudinal study design. 
We found no relation between mean number of MB and SCF in participants with poor 
objective cognitive performance. This could be due to a type II error, or due to the fact that 
true objective cognitive impairment obscures reporting of subjective cognitive disturbances. 
It is suggested that strictly lobar-located MB are attributable to amyloid angiopathy, whereas 
MB in the deep/infratentorial regions (with or without lobar MB) reflect hypertensive 
microangiopathy.1235 Except for SEF we did not find relations between deep located MB 
and cognitive complaints, although this could be due to a power problem, as only seven 
participants had strictly deep MB. A recent report on the distribution of lobar MB, taking 
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lobar volumes and clustering effects into account, found that lobar MB are significantly 
more often located in the temporal lobe, a region known to be more affected by amyloid 
angiopathy.36 Especially MB in the frontal and temporal lobe were related to SCF. Our 
findings are therefore in agreement with the notion that amyloid angiopathy may be the 
underlying etiology. 
In conclusion, we found that cerebral MB are related to SCF in non-demented older people 
with SVD, independent of coexisting WML and lacunar infarcts. These results suggest that 
MB are clinically not as silent as they are usually considered to be and in that way might help 
us to understand the role of vascular disease in cognitive decline. Follow-up examination 
should identify whether progression of failures coincides with these radiologic findings of 
SVD manifestations and whether this parallels objective cognitive impairment. 
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Abstract 
Background Subjective cognitive failures (SCF) and subjective memory failures (SMF) have 
reported to be an early predictor of Alzheimer's disease (AD) and have been attributed to 
white matter lesions (WML) Surprisingly, the relation with hippocampal atrophy has only 
sparsely been investigated, which would have been obviously since AD is characterized by 
hippocampal degeneration Previous studies on this are rare, limited in sample size and did 
not adjust for WML 
Objective To determine the relation between SCF and hippocampal volume in strata of 
objective cognitive performance among non-demented elderly with incidental WML 
Methods The RUN DMC study is a prospective cohort study among 503 subjects with WML 
aged between 50 and 85 years All subjects underwent FLAIR and T l MRI scanning The 
amount of SCF and SMF was rated by the Cognitive Failure Questionnaire Cognitive function 
was assessed by a cognitive screening battery Volumetric measures of hippocampus and 
WML were manually performed We assessed the relation between hippocampal volume 
and SCF and SMF adjusted for age, sex, education, depression, total brain volume and WML 
volume 
Results Subjects with SCF and SMF had lower hippocampal volumes than those without 
(p= 01 and p= 02) This was most noteworthy in subjects with good objective cognitive 
performance (ptrend= 007 and ptrend= 03), and not in those with poor objective cognitive 
performance 
Conclusion SCF are associated with lower hippocampal volume, even in subjects without 
objective cognitive impairment and independent of WML SCF has a radiological detectable 
pathological-anatomical substrate 
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Introduction 
Clinicians are often confronted with elderly who report subjective cognitive complaints 
including memory complaints such as forgetting appointments m the near future or recent 
occurrences Despite considerable controversy,12 several studies have found a relation 
between these subjective cognitive complaints and objective cognitive impairment, such as 
loss of executive and memory function as assessed by neuropsychology in non-demented 
elderly3" More noteworthy, subjective complaints in individuals with normal cognition as 
assessed by formal neuropsychological testing predict Alzheimer's disease (AD) years after 
initial subjective complaints 5 Hence, these subjective complaints, distinguished m memory 
complaints and executive complaints, could be the earliest sign of cognitive dysfunction and 
might be a sensitive tool to identify those at risk for AD 
Early m its course, AD is characterized by a slowly progressive memory deficit due to gradual 
hippocampal degeneration, ultimately resulting in hippocampal atrophy6 The memory 
deficit is often accompanied by loss of executive function, presumably caused by frontal 
grey matter atrophy, but also by white matter lesions (WML)78 Neuropathological studies 
indicate that hippocampal atrophy and WML may be present years or even decades before 
cognitive symptoms become detectable 9 " 
Depressive symptoms are also often present during early AD There is an ongoing debate 
whether these symptoms influence or even cause cognitive complaints or whether a pre 
stage of Alzheimer pathology is responsible for the cognitive complaints, despite spared 
cognition during formal testing 12412 However, the presence of depressive symptoms 
is usually not taken into account m studies that assessed the relation between cognitive 
complaints, objective cognitive function and their underlying pathological substrate 
We hypothesized that subjective memory complaints and subjective executive complaints 
are already neuroradiologically characterized by hippocampal atrophy and WML, even m 
subjects without any objective cognitive impairment Only a few studies have addressed 
this issue Two large population-based studies found that WML were related to cognitive 
complaints, but did not adjust for hippocampal volume 412 Besides that, WML were rated 
semi-quantitatively or by automated segmentation, potentially leading to underestimation 
of the actual WML burden 13 Conversely, other studies related hippocampal volume to 
subjective memory complaints, without taking the degree of WML into account121415 in 
addition, most studies did not adjust for depressive symptoms, being a potential confounder 
We therefore wanted to investigate whether subjective cognitive complaints on both the 
memory and executive domain were associated with hippocampal and WML volume in 503 
independent living healthy elderly with incidental WML 
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Methods 
Study population 
This study is embedded within the Radboud University Nijmegen Diffusion tensor and 
Magnetic resonance imaging Cohort (RUN DMC) study. The RUN DMC study prospectively 
investigates causes and cognitive and motor consequences of longitudinal functional and 
structural changes in the brain of individuals with incidental WML. Baseline investigations 
took place in 2006. Consecutive subjects, aged between 50-85 years, who visited the 
neurology outpatient clinic between October 2002 and October 2006 and who underwent 
routine diagnostic brain imaging, for reasons not related to the cognitive and motor study 
outcome (including collapses, mild traumatic brain injury, vertigo, chronic head pain or 
cranial nerve palsy), were eligible for participation. Exclusion criteria were any abnormality 
on the routine diagnostic brain imaging, that could interfere with the outcome (space 
occupying lesions, hemorrhages, large-artery infarcts), MRI-contra-indications and prevalent 
dementia. Subjects were selected in strata of age (5 years), sex and WML severity according 
to the ARWMC scale.16 Upon agreement to participate in the study they underwent an 
extensive MRI protocol as part of the study on which all MRI measures reported here were 
based (see below). In 2006, 1004 subjects were selected for possible participation. On the 
basis of MRI contra-indications and the other exclusion criteria 299 subjects were excluded. 
The final sample consisted of 705 subjects of whom 503 agreed to participate (response 
71.3%). Each participant signed an informed consent. The Medical Review Ethics Committee 
region Arnhem-Nijmegen approved the study. 
MRI acquisition 
All subjects underwent a 1.5 Tesla MRI scanning on the same Magnetom Sonata scanner 
(Siemens, Erlangen, Germany). The scanning protocol included whole brain T l 3D MPRAGE 
imaging (TR/TE/TI 2250/3.68/850 ms; flip angle 15?; voxel size l.Oxl.Oxl.O mm) and FLuid 
Attenuated Inversion Recovery (FLAIR) image (TR/TE/TI 9000/84/2200 ms; voxel size 
1.0x1.2x6.0 mm (including gap of 1 mm); NEX=2). 
Hippocampus and intracranial volume 
One experienced investigator blinded to clinical data, total WML volume and FLAIR images 
(IvU), manually segmented left and right hippocampus on the MPRAGE image using 
the interactive software program "ITK-SNAP".17 Anatomical boundaries were coronally 
determined with neuroanatomical atlases1819 and actual segmentation was performed using 
a previously published protocol.20 In short: segmentation was performed from posterior to 
anterior. The posterior border of the hippocampus was identified in the slice before the level 
in which the crurae formces appeared in full view. The anterior border of the hippocampus 
was defined as the slice in which the hippocampus was no longer present, and the amygdala 
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fully covered the hippocampus 20 u The superior border was the inferior horn of the lateral 
ventricle, the inferior border was determined by the white matter The lateral border was 
defined by the temporal horn of the lateral ventricle and the white matter adjacent to the 
hippocampus 
Volumes were calculated for the left and right hippocampus separately by summing all voxel 
volumes of the segmented areas Intra-rater studies on a random sample of 50 MRI scans 
showed an mtra-class correlation coefficient for the left hippocampus of 0 73, and for the 
right hippocampus of 0 79 
For the same image, gray (GM) and white matter (WM) tissue and cerebrospinal fluid (CSF) 
probability maps were computed using SPM5 routines (Wellcome Department of Cognitive 
Neurology, University College London, UK) Total GM, WM and CSF volumes were calculated 
by summing all voxel volumes that had a p> 5 for belonging to the tissue class Intra-cramal 
volume (ICV) was taken as the sum of total GM, WM and CSF13 
WML volume 
WML were manually segmented on transversal FLAIR images WML were defined as hyper-
mtense lesions on FLAIR MRI and not cerebrospinal fluid like hypo-intense lesions on T l -
weighted image WML volume was calculated in the same fashion as for the hippocampi 
Gliosis surrounding lacunar and territorial infarctions was not considered to be WML 1623 
Two trained raters (IvU, LvO) segmented all scans For the total WML volume the inter-rater 
mtra-class correlation coefficient was 0 98 m a random sample of 50 scans 
Subjective Cognitive Failures 
Information on Subjective Cognitive Failures (SCF) was assessed by a 15 items semi-structured 
interview based on the Cognitive Failure Questionnaire 'iU (Table 1) Responses were added 
to a sum-score for SCF with a maximum of 25 According to previous studies, subjective 
failure in remembering, word finding, planning, concentration, or slowness in thought had 
a higher weight in the sum-scores (score range of 0-3 none-mild-moderate-severe), than 
the ten other items (0-1) SCF were considered present when a subject reported at least one 
moderate problem (score 2 or higher) on an item having a score range of 0-3 or a score of 1 
on dichotomous items " In addition we assessed whether subjects reported progression of 
remembering, word finding, planning, concentration or slowness of thought over the past 
5 years (part of the Subjective Cognitive Failures Questionnaire, Table 1) Progression was 
defined as obvious progression of at least one failure or little progression on more than one 
of these failures" 
SCF were subdivided in subjective memory failures (SMF) and subjective executive failures 
(SEF) SMF were considered present if failures were reported in one of the 10 items concerning 
memory problems, SEF were considered present if failures in planning, concentration and 
slowness m thought were reported 4 
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Table 1 Subjective Cognitive Failures Questionnaire (n=500) 
Question Score 
range 
0-1 
0-1 
%with 
problems 
Memory problems 
Do you consider yourself as forgetful' 
Have you experienced any progression on this i tem'* 
Do you experience word-finding problems' 
Have you experienced any progression on this i tem'* 
Do you ever forget names of family members or friends' 
Do people tell you that you tell stories twice' 
Do you ever forget occurrences of the past one or two days' 
Do you worry about forgetfulness' 
Do you experience hinder in everyday-life because of forgetfulness' 
Do you ever misplace items at odd locations, leave the stove 
burning, or forget how to use everyday appliances' 
Do you ever forget appointments' 
Do you ever lose your way in your neighbourhood or do not 
recognise a person that is actually well acquainted' 
Related executive problems 
Have you experienced problems with planning of activities' 
Have you experienced any progression on this i tem'* 
Do you have concentration problems' 
Have you experienced any progression on this i tem'* 
Do you think or act more slowly than you used t o ' 
Have you experienced any progression on this i tem'* 
Remaining problems 
Do you feel more exhausted than you used t o ' 
Do you ever feel so depressed that you lose interest in l i fe' 
0-3 
0-2 
0-3 
0-2 
0-1 
0-1 
0-1 
0-1 
0-1 
0-1 
0-1 
0-1 
54 2% 
56 0% 
61 8% 
26 7% 
59 2% 
39 2% 
32 2% 
42 2% 
37 8% 
11 2% 
21 2% 
10 2% 
0-3 
0-2 
0-3 
0-2 
0-3 
0-2 
15 2% 
41 7% 
39 6% 
48 1% 
47 4% 
52 1% 
30 2% 
22 8% 
* Percentage of participants with subjective failure on the accompanying item who reported little (score 1) or obvious 
(score 2) progression over the past 5 years on that particular item 
Objective cognitive performance 
Cognitive performance was assessed by a standardized neuropsychological test battery 
that has been used in other large-scale epidemiological studies of cognition in healthy 
elderly.82526 The tests were administered by two trained investigators (AvN, KdL) and 
included the Mini Mental State Examination (MMSE),27 a 15 words verbal learning test,28 an 
abbreviated Stroop test consisting three subtasks,29 the Paper and Pencil Memory Scanning 
Task,30 a verbal fluency task in which as many animals as possible had to be named within 60 
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seconds31 and the Symbol-Digit Substitution Task, which is a modified version of the Symbol 
Digit Modalities Test32 
Performance across tests was made comparable by transforming the raw test scores into 
z-scores as described elsewhere 33 z-scores of the tests that had higher scores representing 
worse performance, like the speed score, were inverted (-z) From these z-scores we 
calculated compound scores for cognitive function, memory function and executive function, 
as described previouslys In short compound score for cognitive function was calculated as 
the mean of the z-scores of the 1-letter subtask of the Paper-and-Pencil Memory Scanning 
Task, the reading subtask of the Stroop test, the Letter-Digit Substitution Task, the added 
score of the three learning trials of 15 words verbal learning test and the delayed recall of 
this test9 A compound score for memory function was calculated by taking the mean of 
two z-scores of the 15 words verbal learning test, one for the added scores on the three 
learning trials, and one for the delayed recall9 The compound score for executive function 
was calculated as the mean of the z-scores of the verbal fluency test, the Symbol-Digit 
Substitution Task and the interference subtask of the Stroop test 
If the test assistant encountered problems, a code was given for test status and the result was 
not used m the calculation of the z-scores Separate codes were given for lack of motivation 
(2 7%), presence of a physical handicap (1 2%), or deviation from the instructions (2 9%) 
For 465 subjects (93%) reliable compound scores could be calculated 
Other measurements 
The following characteristics were considered as possible confounders age, sex, education 
(according to Verhage)34 and depressive symptoms Depressive symptoms were considered 
present when a subject had a score >16 on the Center of Epidemiologic Studies on Depression 
Scale (CES-D)35 36 and/or the use of anti-depressive medication 36 ICV was also considered as 
a potential confounder 
Statistical analysis 
Statistical analyses was performed with the use of SPSS 14 0 for Windows Demographic 
characteristics were compared between subjects with or without SCF by sex- and age-
adjusted analysis of covanance (by so called "forced entry") (ANCOVA) (Table 2) 
Mean hippocampal and WML volume, and the proportion of subjects with severe WML 
(highest quintile)4 were calculated for subjects with or without SCF, SMF or SEF by ANCOVA 
(Table 3) All assumptions for ANCOVA were verified for each analysis 
Next, we calculated the mean hippocampal and WML volume in subjects with and without 
SCF by severity of the failures (ANCOVA) Subjects who reported no SCF, as defined earlier, 
were considered having "No SCF" The group with SCF was dichotomized at the upper tertile 
of the SCF-score, which reflected "Severe SCF", the lower two tertiles were defined as 
"Moderate SCF" SMF and SEF were categorized accordingly 
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To investigate whether the level of objective cognitive performance modified the 
association between hippocampal or WML volume and severity of SCF, we analyzed this 
relation stratified by objective performance, according to fertiles of the compound score for 
cognitive function (poor, moderate or good).4 
Finally, we investigated whether progression of failures was related to hippocampal or WML 
volume. 
For the trend analysis of the ANCOVA results, groups of severity of failures (none, moderate, 
severe) were considered as a continuous variable in a multiple linear regression model. 
Age, sex, education, depressive symptoms, ICV and where appropriate WML volume and 
hippocampal volume were put together into the model (so called "forced entry"). 
Table 2 Characteristics of the 500 subjects who completed the SCF Questionnaire with or 
without subjective cognitive failures 
Characteristic 
Age (years) 
Sex (male/female) 
Subjects with only primary education 
MMSE 
CES-D 
Subjects with depressive symptoms ' 
Subjects with CES-D >16 
Subjects with anti-depressive medication 
Subjective cognitive failures (SCF) 
Sum-score on the SCF questionnaire 
Subjects with SCF 
Sum-score of sub-questionnaire on SMF 
Subjects with SMF 
Sum-score of sub-questionnaire on SEF 
Subjects with SEF 
Subjects with SCF reporting its progression 
Total 
(n=500) 
65 6 (8 8) 
281/219 
47 (9 4%) 
28 2 (1 6) 
10 9 (9 4) 
166 (33%) 
139 (28%) 
62 (12%) 
8 5(5 7) 
453 (91%) 
5 4(3 5) 
442 (88%) 
2 5 (2 3) 
304 (61%) 
194 (43%) 
Subjective cognitive failures 
Yes(n=453) 
66 1 (8 7) 
251/202 
45 (9 9%) 
28 1(16) 
11 4 (9 3) 
160 (35%) 
135 (30%) 
59 (13%) 
9 3(5 2) 
5 9(3 1) 
2 8 (2 3) 
No(n=47) 
61 1 (8 7) 
30/17 
2 (4 3%) 
28 4(16) 
6 1 (9 4) 
6 (13%) 
4 (9%) 
3 (6%) 
0 5(5 2) 
0 4(3 1) 
0 2(2 2) 
P* 
<001 
244 
654 
249 
<001 
003 
003 
271 
<001 
<001 
<001 
Values are means (SD) or η (%) 'ANCOVA adjusted for age and sex, where appropriate ' Defined as CES D scores 
Ì16 and/or the use of anti-depressive medication (n=498) MMSE Mini Mental State Examination, CES-D Centre of 
Epidemiological Studies on Depression Scale, SCF Subjective Cognitive Failures, SMF Subjective Memory Failures, SEF 
Subjective Executive Failures 
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Results 
Of the 503 subjects one was excluded because of an automatic segmentation problem and 
two because of an incomplete SCF questionnaire. The presence of depressive symptoms 
was assessed in 498 subjects. Demographic characteristics are shown in Table 2. Subjects 
reporting SCF were older (p<.001) and had more depressive symptoms (p=.003) adjusted 
for age and sex. Subjective failures on all three domains (SCF, SMF and SEF) were associated 
with reduced objective performance, independent of depressive symptoms, WML and 
hippocampal volume (p<.01). 
Table 3 illustrates that subjects with SCF had a lower hippocampal volume than those 
without (p=.01). Subsequent analysis showed that this was also evident in subjects with 
SMF (p=.01) and SEF (p=.07). Additional adjustment for WML volume did not significantly 
change the effect. No relation was found between SCF and WML volume (p>.l), except 
for subjects reporting SEF who more often had severe WML (25%) than those who did not 
(15%; p=.05). 
Table 3 Mean hippocampal and WML volume (SD) for subjects with and without subjective 
cognitive failures (SCF), subjective memory failures (SMF) and subjective executive failures 
(SEF).* 
SCF 
SMF 
SEF 
Present 
Absent 
Present 
Absent 
Present 
Absent 
Hippocampal volume 
6 7(0 9) 
7.1(1.1)* 
6.7(1.0) 
7.0(1.0)' 
6 7(0 9) 
6.9(1.0) 
WML volume 
14 4(19 2) 
14 6(12 0) 
14 4(19 4) 
14.3(116) 
15 1(19 8) 
13.4(16 5) 
η {%) severe WML 
94(21%) 
6 (13%) 
91 (21%) 
9 (16%) 
71 (24%) 
29 (15%) ' 
'Numbers represent milliliters, adjusted for age, sex, education, depressive symptoms, intracranial volume, WML volume 
and hippocampal volume where appropriate ' ρ <.02, ' ρ = 05, WML White matter lesions 
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There was also a relation of decreasing hippocampal volume by increasing severity (no, 
moderate and severe failures) of SCF (p =.024), SMF (p =01) and SEF (p =.07). 
'
 x l c r e n d " * r trend ' ^ t r e n d ' 
In figure 1 hippocampal volumes are given in strata of actual cognitive performance for 
subjects with severe, moderate and no SCF. The difference in hippocampal volume across 
these different groups with SCF was most apparent in subjects with a good cognitive 
performance (ptrend=.005). This relation was also found for SMF (ptrend=.024; figure 2), with 
borderline significance for subjects with moderate memory performance (ptr(;nd=.076). 
Additional adjustment for WML did not change the magnitude of the associations. These 
relations were not found for WML volume, in neither of the objective cognitive strata, nor 
in the whole group analysis. Progression of failures was not associated with hippocampal 
volume, nor with WML volume. 
• No SCF 
OM»d«r«.SCF 
OStmrtSCF 
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Figure 1 Mean hippocampal volume for subjects without, moderate and severe Subjective 
Cognitive Failures (SCF), in strata of objective cognitive performance (tertiles of compound 
score for cognitive function). Adjusted for age, sex, education, depressive symptoms, ICV 
and WML volume no SCF (good n=26; moderate n = l l ; poor n=10); moderate SCF (good 
n=90; moderate n=100; poor n=91); severe SCF (good n=40; moderate n=44; poor n=54) 
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Figure 2 Mean hippocampal volume for subjects without, moderate and severe Subjective 
Memory Failures (SMF), in strata of objective memory performance (tertiles of compound 
score for memory function). Adjusted for age, sex, education, depression, ICV and WML 
volume no SMF (good n=28; moderate n=15; poor n=15); moderate SMF (good n=97; 
moderate n=95; poor n=94); severe SMF (good n=39; moderate n=52; poor n=54) 
Discussion 
We found that SCF were associated with lower hippocampal volume, independent of 
depressive symptoms and WML volume, in elderly with incidental WML. This relation was 
most evident in subjects with intact cognition as revealed by neuropsychological testing. 
In our study the proportion of subjects reporting SCF (91%) and SMF (88%) was higher than in 
other studies, which reported percentages between 26 and 72%.3A12 A possible explanation 
for our relatively high frequency might be the method used to determine SCF. SCF were not 
identified through spontaneous reporting, but by actively asking for it, potentially resulting 
in a higher degree of reported failures. Another explanation could be that all subjects were 
recruited through our outpatient clinic, rather than being community-based. Consequently, 
we have included people who once sought medical help and who therefore are more likely 
to express complaints simply because they had visited an outpatient clinic. Nonetheless, 
our study cohort represents a typical outpatient population that was being investigated for 
reasons that frequently lead to the discovery of WML among healthy, independent living 
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elderly. We intentionally included subjects with incidental WML as advising these subjects 
reflect every day clinical practice. These advices have currently been limited by the fact 
that most studies on this topic have a different design. It is important to realize that most 
knowledge on causes and consequences of WML is based on either population-based 
studies or patients with more advanced stages of dementia, that may not be applicable 
to patients with incidental WML. These studies have improved our understanding on the 
etiology and consequences of WML, but results may not be applicable to individuals who 
visit an outpatient clinic. Acquiring more data on causes and consequences of WML in this 
particular group is an important goal of the RUN DMC study. 
A third explanation for the difference in SCF reporting, is that the high percentage of SCF 
may be related to the relatively high proportion of subjects reporting depressive symptoms 
(33%) in our cohort compared to percentages reported in a systematic review (0.4-35%)," 
and we were able to adjust for that. 
The strength of this study includes the fact that it is a large, single centre study with a high 
response; its structured and extensive assessment of cognitive functioning performed by 
only two investigators; the use of a single MR scanner; the use of a reliable and sensitive 
volumetric assessment of WML instead of a visual rating scale;13 the use of a single expert 
who segmented the hippocampus with high inter-rater agreement, blinded to all clinical and 
radiological data; and the opportunity of extensive adjustment for possible confounders. 
Our results are in agreement with two recent studies, which reported reduced hippocampal 
volumes in subjects with memory complaints as compared to controls.121"15 The unique 
aspect of our study was the inclusion of depressive symptoms and WML volume as 
covariates, since they are related to SCF,24·25 and to hippocampal atrophy.38 
Importantly, the relation between lower hippocampal volume and SCF and SMF was 
demonstrated in subjects with good objective performance. This may provide an underlying 
patho-anatomical explanation for the frequently observed SCF and may therefore function 
as an early marker for the development of diseases characterized by memory loss, including 
AD and its attendant neuropathological substrates such as hippocampal atrophy."1"15 
Since memory impairment is mainly related to hippocampal neurodegeneration,639 it is 
conceivable that SCF and SMF are also primarily related to hippocampal atrophy rather than 
WML. As lower hippocampal volume is associated with future conversion to AD,"0 SCF can 
serve as an early predictor of AD, even in the absence of objective cognitive impairment. 
In our study, SCF and SMF were not related to WML volume. This in accordance with another 
study," whereas other studies did report an association between WML and cognitive 
complaints."1225 However, some methodological considerations of these studies should be 
discussed. Most importantly, they did not adjust for hippocampal volume, which obviously 
appears to be related to SCF and SMF. In addition, the first study25 had a relatively small 
sample (n=60) and in the other study" the severity of WML was scored semi-quantitatively, 
potentially leading to an underestimation of the actual WML burden. This effect may 
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especially be present among those with severe WML, because of ceiling effects in semi-
quantitative rating scales Yet, in our study severe WML were more frequently observed m 
subjects reporting SEF than those who did not This is m line with previous studies that found 
WML to be primarily related to executive functions and speed/motor control domains 7 36 
We found no relation between hippocampal atrophy and SCF or SMF m subjects with 
moderate or poor objective cognitive performance, this may be due to a type II error A 
previous study found a similar association for WML in relation to reported progression of 
SCF4 It has been suggested that the relation between SCF and objective performance may 
be disproportional in subjects with poor cognitive performance, simply because of their 
cognitive impairment and inability to judge their own cognitive function 
Subjective cognitive failures may already have a radiological fingerprint with an underlying 
patho-anatomical explanation Future studies should identify whether progression of 
failures coincides with these radiological observations and whether this parallels objective 
cognitive decline 
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Abstract 
Background Cerebral small vessel disease (SVD) is very common in elderly and related to 
cognition, although this relation is weak This might be because the underlying pathology of 
white matter lesions (WML) is diverse and cannot be properly appreciated with conventional 
FLAIR MRI In addition, conventional MRI is not sensitive to early loss of microstructural 
integrity of the normal appearing white matter (NAWM), which might be an important 
factor Diffusion tensor imaging (DTI) provides alternative information on microstructural 
white matter integrity and we have used this to investigate the relation between white 
matter integrity, m both WML and NAWM, and cognition among elderly with cerebral SVD 
Methods The RUN DMC study is a prospective cohort study among 503 independently 
living, non-demented elderly with cerebral SVD aged between 50-85 years All subjects 
underwent MRI and DTI scanning WML were segmented manually We measured mean 
diffusivity (MD) and fractional amsotropy (FA), as assessed by DTI in both WML and NAWM 
Results Inverse relations were found between MD in the WML and NAWM and global 
cognitive function (ß=-11, p< 05, ß=-18, p< 001), psychomotor speed (ß=-15, p< 01, 
ß=- 18, p< 001), concept shifting (ß=- 11, p< 05, ß=-10, p< 05) and attention (ß=- 12, p< 05, 
ß=-15, p< 001) In subjects with severe WML, DTI parameters m the WML and NAWM are 
related to cognitive performance 
Conclusion DTI parameters in both WML and NAWM correlate with cognitive performance, 
independent of SVD DTI may be a promising tool in exploring the mechanisms of cognitive 
decline and could function as a surrogate marker for disease progression in therapeutic 
trials 
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Introduction 
Cerebral small vessel disease (SVD) includes white matter lesions (WML) and lacunar infarcts 
and is very common in the elderly. Both patient and population based studies have shown 
that cerebral SVD is an important cause of cognitive impairment, and may ultimately lead 
to dementia in some.12 Despite the high prevalence of WML and lacunar infarcts in the 
population over 50 years of age (90% and 20% respectively),3" surprisingly few individuals 
develop cognitive decline or dementia.2 Apparently there are other factors apart from 
the SVD visible on conventional MRI that determine the transition from intact cognitive 
performance to cognitive decline in some, while leaving the cognition unaffected in most. 
As identical appearing WML on conventional MRI are actually histopathologically 
heterogeneous5, it could be that only WML with the highest lost of structural integrity are 
related to cognitive impairment. It is also important to realize that only a small proportion of 
the white matter (usually less than a few percent) is affected by SVD, even among individuals 
with severe SVD. As conventional MRI is not sensitive to early loss of microstructural integrity 
in the normal appearing white matter (NAWM), possible changes in this largest part of the 
white matter cannot be assessed. The integrity of the NAWM might be an important factor 
for a better understanding of the relation between white matter integrity and cognitive 
performance and decline. 
These limitations of conventional MRI can potentially be overcome with the use of 
Diffusion Tensor Imaging (DTI) which allows the assessment of the microstructural integrity 
of the whole white matter.67 DTI provides two scalar parameters: mean diffusivity (MD), 
a measure of the magnit ude of diffusion of water averaged in all spatial directions, and 
fractional anisotropy (FA) measure, which provides information about the directionality of 
water diffusion. A reduction in FA and increase in MD are believed to represent reduced 
microstructural integrity in SVD.8 We therefore hypothesized a relation between the degree 
of structural integrity of WML and NAWM and cognitive performance. 
Studies on CADASIL and multiple sclerosis showed a relation between DTI parameters in 
WML and NAWM and cognitive function,9·10 whereas only a few studies investigated this 
relation in individuals with SVD.1114 Most of these studies had small sample sizes (n<105) 
and did not adjust for possible confounders. In addition, most studies addressed only few 
cognitive domains of the spectrum observed in WML related cognitive decline. Recently a 
population based cohort study demonstrated a relation between microstructural integrity 
of both the WML and NAWM and cognitive function.15 
In this study we report on the relation between various domains of cognitive function and the 
structural integrity of both the WML and NAWM, as assessed by DTI, in 503 independently living, 
non-demented elderly with cerebral SVD. We hypothesized that a higher MD and lower FA in the 
WML as well as in the NAWM are related to cognitive function. The second aim was to determine 
whether these associations in the NAWM are independent of WML and lacunar infarcts. 
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Methods 
Study population 
The Radboud University Nijmegen Diffusion tensor and Magnetic resonance imaging Cohort 
(RUN DMC) study, is a prospective cohort study that investigates risk factors and clinical 
consequences of functional and structural brain changes among elderly with cerebral SVD 
Cerebral SVD is characterized on neuroimagmg by either WML or lacunar infarcts 
Symptoms of SVD include acute symptoms, such as TIAs or lacunar syndromes, or subacute 
manifestations, such as cognitive, motor (gait) disturbances and/or depressive symptoms16 
As the onset of cerebral SVD is often insidious, clinically heterogeneous, and typically with 
mild symptoms, it has been suggested that the selection of subjects with cerebral SVD m 
clinical studies should be based on the more consistent brain imaging features17 Accordingly, 
in 2006, consecutive patients referred to the Department of Neurology between October 
2002 and November 2006, were selected for participation Inclusion criteria were (a) age 
between 50 and 85 years, (b) cerebral SVD on neuroimagmg (WML and/or lacunar infarcts) 
Subsequently, the above mentioned acute or subacute clinical symptoms of SVD were 
assessed by standardized structured assessments Patients who were eligible because of a 
lacunar syndrome were included only > 6 months after the event to avoid acute effects on 
the outcomes 
Exclusion criteria were (a) dementia18 (b) parkmson(-ism)19(c) life expectancy of less than 
six months, (d) intracranial space occupying lesion, (e) (psychiatric) disease interfering with 
cognitive testing or follow-up, (f) recent/current use of acetylcholine-esterase inhibitors, 
neuroleptic agents, L-dopa or dopa-a(nta)gonists, (g) WML or SVD mimics (e g multiple 
sclerosis and irradiation induced gliosis), (h) prominent visual or hearing impairment, (ι) 
language barrier, (j) MRI contraindications or known claustrophobia 
From 1004 invited individuals by letter, 727 were eligible after contact by phone of whom 
525 agreed to participate In 22 individuals exclusion criteria were found during their visit to 
our research center, yielding a response of 71 3% (503/705) 
All participants signed an informed consent form The Medical Review Ethics Committee 
region Arnhem-Nijmegen approved the study 
Conventional MRI scanning protocol 
All participants underwent a 1 5-Tesla MRI scanning on the same Magnetom scanner 
(Siemens, Erlangen, Germany) The protocol included the following whole brain scans 3D 
T l MPRAGE imaging (TR/TE/TI 2250/3 68/850ms, flip anglelSe, voxel size 1 0x1 0x1 0mm), 
FLAIR pulse sequences (TR/TE/TI 9000/84/2200ms, voxel size 1 0x1 2x5 0mm, mtershce gap 
1 mm), DTI (TR/TE 10100/93ms, voxel size 2 5x2 5x2 5mm, 4 unweighted scans, 30 diffusion 
weighted scans with b-value 900s/mm2) The complete protocol took 31 minutes 
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Conventional MRI analysis 
White matter signal hyperintensities in both supra and infratentorial regions on FLAIR scans, 
which were not, or only faintly, hypo-intense on T l weighted images, were considered 
WML, except for gliosis surrounding infarcts.20 WML were manually segmented on FLAIR 
images by two trained raters. Total WML volume was calculated by summing the segmented 
areas multiplied by slice thickness. Lacunar infarcts were defined as hypo-intense areas 
with a diameter >2mm and <15mm with low signal intensity on T l and FLAIR, ruling out 
enlarged perivascular spaces and infraputaminal pseudolacunes.20 All imaging analyses were 
performed by raters blinded to clinical information. In a random sample of 10%, inter-rater 
variability for total WML volume yielded an intra-class correlation coefficient of 0.99; intra-
and inter-rater reliability for the lacunar infarcts yielded a weighted kappa of 0.80 and 0.88. 
Normalization parameters to the ICBM152 linear template (as provided with SPM5; 
Wellcome Department of Cognitive Neurology, University College London, UK) and gray 
(GM) and white matter (WM) tissue and cerebrospinal fluid (CSF) probability maps were 
computed by using SPM5 unified segmentation routines on the T l MPRAGE images.21 Total 
GM, WM and CSF volumes were calculated by summing all voxel volumes that had a p>0.5 
for belonging to the tissue class. Total brain volume (TBV) was taken as the sum of total GM 
and WM. Intracranial volume (ICV) was a summation of all tissue classes, i.e. total GM, total 
WM and CSF volume. To normalize for head size, TBV was expressed as percentage of total 
ICV. 
Co-registration parameters of the FLAIR image to the T l image were computed (SPM5 
mutual information co-registration) and used to bring both the FLAIR and WML segmentation 
images into the subject's (anatomical) reference frame. Transformed images were visually 
checked for co-registration errors. Subsequently, the WML segmentations were resampled 
to and combined with the white matter maps to yield to a WML map (the intersection of 
WML and white matter) and NAWM map (the complement of WML in white matter) in the 
T l reference space. 
DTI analysis 
Affine distortion in our DW images from residual eddy-currents were minimized during MR 
acquisition and did not require further correction using post-processing methodology.22 
The diffusion weighted images of each subject were realigned on the unweighted image 
using mutual information based co registration routines from SPM5. Then, the diffusion 
tensor6 and its eigenvalues were computed using an SPM5 add-on (http://sourceforge.net/ 
projects/spmtools). Unphysical spurious negative eigenvalues of the diffusion tensor were 
set to zero, after which the tensor derivatives the MD and FA were calculated.23 The mean 
unweighted image was used to compute the co-registration parameters to the anatomical 
reference T l image (SPM5 mutual information co-registration), which were then applied 
to all diffusion weighted images and dérivâtes. All images were visually checked for motion 
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artefacts and co registration errors, which resulted in a final sample of 499 subjects because 
of the exclusion four due to technical artefacts. The mean MD and FA were then calculated 
in both the WML and NAWM. 
Measurement of cognitive function 
Cognitive function was measured with a neuropsychological test battery that proved to 
be sensitive and suitable for this purpose in other, large epidemiological studies.[1] The 
tests included the Mini Mental State Examination (MMSE)24, and the Rey Auditory Verbal 
Learning Test (RAVLT)25. To evaluate speed of mental processes we used the Stroop test26, 
the Paper-Pencil Memory Scanning Task27, the Symbol-Digit Substitution Task28 and a verbal 
fluency task in which as many animals followed by as many professions as possible had to 
be named within 60 seconds. Attention was measured by the verbal series attention test 
(VSAT).29 To evaluate visuospatial memory we used the Rey's Complex Figure Test (RCFT).30 
Performance across tests was made comparable by transforming the raw test scores into 
z-scores as described elsewhere.1 
Subsequently, we calculated compound scores for seven cognitive domains. Global cognitive 
function was evaluated by the MMSE and the Cognitive Index. The Cognitive Index is a 
compound score that was calculated as the mean of the z-scores of the 1-letter subtask of 
the Paper-Pencil Memory Scanning Task, the mean of the reading subtask of the Stroop test, 
the mean of the Symbol-Digit Substitution Task and the mean of the added score on the 
three learning trials of the RAVLT and the delayed recall of this last test.1 Verbal memory is 
a compound score of the mean of two z-scores from the RAVLT; one for the added scores of 
the three learning trials of this test, and one for the delayed recall of this test. Visuospatial 
memory is a compound score of the mean of the z-scores of the immediate recall trial and 
the delayed recall trial of the RCFT. Psychomotor speed was calculated as the mean of the 
z-scores of the 1-letter subtask of the Paper-Pencil Memory Scanning Task, the reading 
subtask of the Stroop test and the Symbol-Digit Substitution Task.1 Fluency was calculated 
from the mean of the z-scores of both verbal fluency tasks. Concept shifting was calculated 
as the z-score of the third subtask of the Stroop. Attention is a compound score of the 
z-score of the total time of the VSAT.1 
Other measurements 
Age, sex, level of education31, depressive symptoms, lacunar infarcts and TBV were 
considered possible confounders. Depressive symptoms were present if a subject had a 
score >16 on the Center of Epidemiologic Studies on Depression Scale (CES-D) and/or the 
present use of anti-depressive medication.32 The living conditions of every participant were 
administered. 
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Statistical Analysis 
Baseline characteristics were presented as mean ± standard deviation (SD) and for the 
skewed distributed parameters the median and interquartile range were calculated. 
The relation between DTI parameters in WML and NAWM, WML volume and lacunar infarcts 
with cognitive performance was assessed by means of linear regression analysis. Regression 
coefficients are presented as standardized beta's. 
To investigate if the burden of WML was an intermediate in this relation we analyzed this 
in strata (tertiles) of WML volume. All analyses were adjusted for age, sex, education, 
depressive symptoms, TBV normalized for head size, lacunar infarcts and WML whenever 
appropriate. All data were analyzed using SPSS statistical software, version 16.0. 
Table 1 Baseline characteristics of the RUN DMC study population 
Demographic and clinical characteristics 
Number of participants 
Age at admission (yrs) 
Age at enrolment (yrs) 
50-60 yrs (number, %) 
60-70 yrs (number, %) 
70-85 yrs (number, %) 
Disease duration (yrs)t 
Sex ( % male) 
% only primary education 
Depressive symptoms (number, %)t 
Neuro-imaging characteristics 
Total brain volume (ml) 
Total white matter volume (ml) 
Total white matter lesion volume (ml) 
Total normal appearing white matter volume (ml) 
Presence lacunar infarcts (number, %) 
499 
64 2 ± 8 8 
65 6 ± 8 8 
161(32) 
161(32) 
177(36) 
1 4 ± 1 1 
56 5 
10 
168(34) 
1093.1(121 1) 
464 4 (66 5) 
7.1(3 4,18 1) 
450 3 (70 3) 
171 (34) 
Numbers represent means (SD), percentages or medians (mter-quartile range) tDefined as age at enrolment-age at 
admission Φ Depressive symptoms defined as CES-D (Center of Epidemiologic Studies Depression Scale) > 16 and/or 
present use of anti depressants 
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Results 
Demographics and neuro-imaging characteristics of 499 subjects are shown in Table 1. 
Mean age of the population was 65.6 years (SD 8.8) and 56.5% were male. In Table 2 the 
test scores of the cognitive test battery are shown. The mean MMSE of the study population 
was 28.1 (SD 1.6). 
In the WML, MD was related to global cognitive function (MMSE:ß=-.12/p=.02; cognitive 
index:ß=-.ll,p=.01) and executive function (psychomotor speed:ß=-.15,p<.01; concept 
shifting:ß=-.ll,p=.02; attention:ß=-.12,p=.02). (Table 3) MD in the WML did not significantly 
correlate with either of the memory domains and fluency. FA in the WML was only related 
with concept shifting and attention (ß=.09,p=.03; ß=.ll,p=.01). In the NAWM, MD was related 
to all cognitive domains independent of the WML load (Table 3). The FA in the NAWM was 
related with the cognitive index (ß=.ll,p=.002), verbal memory (ß=.ll,p=.01), psychomotor 
speed (ß=.12,p<.001), concept shifting (ß=.10,p=.03) and attention (ß=0.16,p=.001), again 
independent of WML volume. 
Stratification on tertiles of WML severity revealed a relation between the MD in the WML 
with all cognitive domains, except for verbal memory performance and fluency, in subjects 
with severe WML, not in those with mild or moderate WML. (Table 4) The FA in the WML 
was related to the MMSE (ß=.17,p<.05), the cognitive index (ß=.12,p<.05), visuospatial 
memory (ß=.16,p<.05), psychomotor speed (ß=.16;p<.01), concept shifting (ß=.18,p<.05), 
and attention (ß=.27,p<.001) in subjects with severe WML, whereas no significant relations 
were found in subjects with mild or moderate WML. Identical correlations were found in 
the NAWM between MD and FA and cognitive performance in subjects with severe WML, 
except for concept shifting and the cognitive index. 
WML volume was related to MMSE (ß=-.ll,p=.02), visuospatial memory (ß=-.14,p=.004), 
psychomotor speed (ß=-.09,p=.05), concept shifting(ß=-.09,p=.04) and attention (ß=-.13, 
p=.003). We did not find a relation between cognitive performance and presence or number 
of lacunar infarcts. 
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Table 2 Cognitive test scores 
Mini Mental State Examination (range 0-30) 28 1 (1 6) 
15 word verbal learning task (no of words recalled) 
Immediate recall trial 1 5 1 (1 7) 
Immediate recall trial 2 7 3 (2 2) 
Immediate recall trial 3 8 7(2 5) 
Total trial 1-3 21 1 (5 8) 
Delayed recall 6 0 (3 1) 
Delayed recognition 27 0 (3 2) 
Stroop test (time in sec ) 
trial 1 (words) 25 8 (6 3) 
trial 2 (colours) 33 2 (7 7) 
trial 3 (concept-shifting) 63 8 (22 1) 
Paper and Pencil memorv scanning task (time in sec ) 
1 character 45 0(13 4) 
2 characters 62 3 (19 7) 
3 characters 77 4(26 5) 
Symbol digit substitution task (no in 60 sec ) 27 1 (9 7) 
Fluency (no in 60 seconds) 
Animals 22 0(6 5) 
Jobs 16 5 (5 3) 
Verbal series attention test 
total time (sec ) 90 6 (32 9) 
total faults (no ) 2 1 (2 7) 
Rey Complex Figure Test (range 0-36) 
Copy trial 33 5(3 4) 
Immediate recall trial 18 2(6 8) 
Delayed recall trial 18 1 (6 6) 
Numbers represent means (SD) 
Table 3 The relation between DTI parameters in both the white matter lesions and the normal appearing white matter and cognitive 
performance. 
White Matter Lesions Normal appearing white matter 
Mean Diffusivity Fractional Amsotropy Mean Diffusivity Fractional Amsotropy 
Global cognitive function 
MMSE 
Cognitive Index 
Memory 
Verbal memory 
Visuospatial memory 
Executive Function and Attention 
Psychomotor Speed 
Fluency 
Concept Shifting 
Attention 
-.12 (-.21 t o - 0 1 ) * 
-.11 (-.16 to-.02) · 
-08 (-17 to .02) 
-09 (-.16 to 01) 
-15( -21 to - .06 )** 
-09 (-18 to 01) 
- 11 (-.20 to- .02)* 
-.12 (-.22 to-.02)* 
06 (-02 to 15) 
.03 (-.03 to 09) 
04 (-.04 to .12) 
03 (-.05 to .10) 
.02 (-.04 to .09) 
.03 (-.05 to .11) 
09 ( 0 1 to 17)* 
.11 (02 to 20)* 
-.17 (-.29 to -.47)* 
•18 (-.22 to .06)** 
-.18 (-.28 to-.06)** 
-.13 (-.21 to .02)* 
-.18 ( - 2 4 t o - 0 6 ) * * 
• 11 (-21 t o - 0 2 ) * 
•10 (-16 t o - 0 6 ) * 
-.15 (-27 to -03)** 
.06 (-.21 to .16) 
11 (.04 to 17)** 
.11 ( 0 1 to .19)* 
.10 (-.01 to 19) 
12 ( 0 4 to 18)** 
.07 (-03 to 15) 
10 (.01 to 19)* 
16 ( 0 6 to .25)** 
Numbers represent standardized ß's and are adjusted for age, sex, education, depressive symptoms, total brain volume normalized for head size, lacunar infarcts and in the NAWM 
also for white matter lesions 
* p< 05, ** p< 01 
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Discussion 
In this large cohort of patients with cerebral SVD, we found that the microstructural integrity, 
of both WML and NAWM, as assessed by DTI, is related to global cognitive function, 
memory and executive function In the NAWM this relation persisted even after controlling 
for presence of SVD on conventional MRI 
In contrast to previous DTI studies we measured MD and FA using a whole brain voxel-
based analysis differentiating between NAWM and WML, whereas others investigating the 
relation between cognitive decline and WML used whole brain histogram approach, not 
accounting for the absence or presence of WML, or region of interest (ROI) analyses933 A 
ROI provides a local estimate of possible changes in the microstructure within the brain, not 
necessarily reflecting the structural integrity of the remainder of the white matter However, 
this whole-brain analysis does not allow dissociating between specific brain areas in relation 
to cognitive performance As cognitive function is the resultant of the integrated action of 
many parts of the brain we wanted to investigate the structural integrity of the global white 
matter with respect to cognitive performance, rather than a ROI approach In addition an 
overall assessment is less prone to partial volume artefacts 
The co-registration of different image types and their co-registration to standard space could 
be a methodological limitation of our study Two co-registration steps should be discerned, 
ι e from the FLAIR to T l and from the mean-bO to T l 
Furthermore, two sources of error should also be discerned, ι e contrast differences 
between the source and target image and geometric distortion differences between source 
and target The contrast source of error in our study should be minimal, as normalized mutual 
information was used a cost function to compute the optimal co-registration parameters 
The distortions m the FLAIR and T l images are both minimal and of no concern in general 
There can be significant distortion differences between the DW images and the T l and 
these will increase the variability of our analyses Ideally one would therefore like to first 
correct the distortions in the DW images before co-registering them to the T l , which would 
require one to have information on these distortions, e g from measured field maps We 
did not acquire such field maps, but we did visually inspect all co-registrations for optimality 
and found no apparent inaccuracies or errors These local misalignments will, if anything, 
underestimate the strengths of the relations found Major strengths of this study included 
its large sample size and use of novel imaging techniques, such as DTI Furthermore, our 
study is a single centre study, with a high response rate and all subjects examined by only 
two investigators Another strength is the manual segmentation of the WML without prior 
knowledge of the clinical data 
The relation between DTI parameters and cognitive function was investigated with extensive 
adjustments for possible confounders as education, depressive symptoms, TBV, and SVD on 
FLAIR 
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Adjustment for SVD visible on conventional MRI is important in order to determine whether 
DTI, on top of conventional MRI measures, explains more of the variance in the relation 
between DTI measures and cognitive performance or whether it represents the same 
degree of white matter damage There are only a few studies adjusting for WML volume, 
two adjusted for WML as measured by a visual scale,1233 two other studies adjusted for 
WML volume but had a small sample sizes (n=36 and n=42)and did not adjust for depressive 
symptoms, another well known confounder in the relation between white matter pathology 
and cognitive performance " " 3 3 
A limitation is the cross-sectional nature of our study, which prevents us from proving 
causality The RUN DMC study had a longitudinal design and follow-up is already planned to 
evaluate the effect of progression of SVD on (changes in) cognition 34 
Our findings are in agreement with other studies relating DTI parameters to cognitive 
function in individuals with symptomatic SVD, however these studies had a small sample 
size and depressive symptoms were not taken into account111314 Recently a population 
based cohort study demonstrated a relation between microstructural integrity of both the 
WML and NAWM and cognitive function 15 They did not adjust for depressive symptoms A 
longitudinal study of normal aging demonstrated a correlation between MD and working 
memory and showed that DTI is sensitive to detect microstructural change over a 2-year 
period 35 
The relation between DTI parameters of the WML and NAWM and cognitive performance 
has also been investigated in individuals with WML other than sporadic vascular WML, such 
as multiple sclerosis, CADASIL and auto immune mediated WML9103637 Our results are in 
accordance with their results, however, they had small sample sizes (n <105) and did not, or 
rather selective adjust for possible confounders 
The relation between DTI parameters and cognitive performance has also been studied in 
subjects with mild cognitive impairment (MCI) and Alzheimer's Disease (AD) In most of 
these studies, subjects with SVD were excluded 3819 Although the assessment of cognitive 
performance was limited and the sample sizes were relatively small, they all demonstrated 
a significant increase m MD and decrease in FA in cogmtively impaired subjects Two studies 
did not exclude subjects with WML4041 One study found a clear inverse relation between 
MD in the posterior ungulate gyrus and the MMSE However, they did not report whether 
MD was measured in WML or NAWM and did not adjust for WML volume 40 
The relation between DTI parameters and cognitive performance has also been investigated 
in healthy elderly without severe WML4243 They demonstrated a relation between lower FA 
in the pencallosal frontal region and in the genu of the corpus callosum and the relationship 
between perceptual speed and episodic retrieval reaction time and FA m the frontoparietal 
white matter and reaction time 4243 
In our study, the relation between cognitive performance was less pervasive for FA than 
for MD This could be due to the fact that the value of MD is relatively independent of 
Table 4 The relation between DTI parameters in white matter lesions and the normal appearing white matter and cognitive performance 
in subjects with mild, moderate and severe white matter lesions (defined as tertiles of the distribution). 
White Matter Lesions 
Mild WML 
Global Cognitive Function 
MMSE 
Cognitive Index 
Memory 
Verbal memory 
Visuospatial memory 
Mean Diffusivity 
04 (- 17 to 25) 
03 ( -11 to 17) 
11 ( -10 to .32) 
03 (- 15 to 20) 
Executive Function and Attention 
Psychomotor speed 
Fluency 
Concept Shifting 
Attention 
- 07 (- 23 to 08) 
- 10 (- 32 to 10) 
- 0 3 (-.19 to .13) 
04 (- 16 to 26) 
Moderate WML 
-.04 (- 16 to .25) 
-.08 (-.22 to .07) 
-.11 (-30 to 09) 
-.05 (- 23 to .13) 
- 0 7 (-23 to 10) 
01 (-.19 to 21) 
03 (-.16 to 23) 
- 0 5 (-26 to 16) 
Severe WML 
- 1 8 (-39 t o - 0 1 ) * 
- 1 9 (-29 t o - 0 6 ) * * 
-13 (-30 to 04) 
- 2 3 ( -41 t o - 0 6 ) * * 
-.23 (-.35 t o - 0 8 ) * * 
- 07 (- 23 to .09) 
- 2 4 (-.45 t o - 0 7 ) * * 
- 2 8 (-.50 t o - 1 2 ) * * 
Fractional Anisotropy 
Mild WML Moderate WML 
.01 (- 12 to 15) 
.02 (-07 to .11) 
.03 (-.11 to .16) 
- 03 (- 14 to 08) 
- 01 (-.11 to .09) 
.08 (-06 to 22) 
.06 (-.05 to 16) 
11 (-03 to 25) 
00 (-17 to 17) 
- 0 3 (-.15 to 09) 
01 (-15 to 17) 
- 02 (- 18 to 13) 
- 0 6 ( -21 to 08) 
- 0 6 (-23 to .11) 
06 (- 10 to 23) 
-.02 (-.19 to .15) 
Severe WML 
17 ( 0 1 to .35)* 
12 ( 0 1 to .23)* 
.10(-.05to.26) 
.16 ( 0 1 to 32)* 
16 ( 0 4 to .27)** 
02 (- 12 to 16) 
18 (.02 to 35)* 
32 (16 to .49)** 
Normal appearing white matter 
Mild WML 
Global Cognitive Function 
MMSE 
Cognitive Index 
Memory 
Verbal memory 
Visuospatial memory 
Mean Diffusivity 
-.03 (- 28 to 22) 
-.19 (-35 t o - 0 1 ) · 
- 08 (- 34 to 16) 
-08 (-29 to 13) 
Executive Function and Attention 
Psychomotor speed 
Fluency 
Concept Shifting 
Attention 
-.19 (-37 t o - 0 2 ) * 
- 0 7 (-33 to 17) 
-.07 (-26 to 13) 
.12 (-10 to .40) 
Moderate WML 
- 05 (- 17 to .26) 
- 1 0 (-25 to 07) 
- 15 (-38 to 01) 
- 0 9 (-.16 to 10) 
- 0 7 (-18 to 24) 
- 0 3 (-18 to 22) 
- 0 3 (-17 to .22) 
08 (- 11 to 32) 
Severe WML 
- 2 4 (-44 t o - 0 4 ) * 
- 1 7 (-27 t o - 0 2 ) * * 
-.16 (-32 to - .02)* 
- 2 2 (-39 t o - 0 5 ) * 
-.23 (-35 t o - 0 8 ) * * 
- 1 6 (-32 t o - 0 1 ) * 
- 12 (- 32 to 07) 
-.36 (-56 t o - . 19 ) * * 
Fractional Anisotropy 
Mild WML 
03 (- 16 to 23) 
11 (-.02 to 24) 
12 (-07 to 32) 
13 (-02 to 29) 
08 (-06 to 22) 
22 (.04 to 43)* 
11 (- 04 to 26) 
03 (-16 to 23) 
Moderate WML 
- 0 2 (-.18 to 15) 
11 (- 02 to 22) 
15 (- 01 to 30) 
05 (-19 to 10) 
08 (-.05 to .22) 
-05 ( -21 to 11) 
09 (- 07 to 24) 
09 (-08 to 25) 
Severe WML 
.13 (-.03 to .29) 
11 ( 00 to .20) 
.07 (-.07 to 21) 
16 ( 0 1 to 29)* 
. 1 7 ( 0 5 t o . 2 7 ) * * 
15 ( 02 to 30)* 
15 ( -01 to 31) 
27 (.12 to 42)* * 
Numbers represent standardized ß's and are adjusted for age, sex, education, depressive symptoms, total brain volume normalized for 
head size and lacunar infarcts * p< 05, ** p< 01 
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the location measured m the brain whereas FA values very much depend on the degree of 
white matter organisation and thus on the location m which it is measured 36 In addition, 
because of the voxel size m which the DTI parameters are measured multiple fibres are 
present within a single voxel, that may all have different destinations Due to this mtervoxel 
incoherence the measured FA within a voxel may be low and does not necessarily reflect an 
underlying lower structural integrity7 These factors are likely to be important in the strength 
of the relation between FA and cognitive performance In addition, correlations m the WML 
may be harder to demonstrate as WML constitute a very small proportion (± 1%) of the 
whole white matter 
Our findings suggest that the structural integrity of the NAWM should also be taken 
into account when investigating the relation between SVD and cognitive function, as 
microstructural pathology extends in the NAWM beyond the detection limit of conventional 
FLAIR imaging In addition our findings show that especially m those with severe WML, 
damage to the microstructural integrity of the NAWM is related to impairment of cognitive 
performance This suggests a positive relation between WML load and severity of damage 
to the NAWM, which is demonstrated before44 This is m line with our understanding of 
the underlying neuropathological changes that occur m the "NAWM", corresponding with 
mild tissue changes, with lower myelin density and a looser but largely preserved axonal 
network and glial cell density45 Microstructural changes m the NAWM are postulated to 
reflect remote effects m tracts damaged by the WML themselves and/or white matter 
changes that have not yet become visible on conventional MRI This is supported by the 
finding of an increased blood-brain barrier permeability m the NAWM m subjects with 
SVD46 This suggests that the microstructural changes of the white matter detected by DTI 
have important clinical consequences 
Another issue is that other studies have shown that particularly lacunar infarcts drive the 
association between WML and cognitive performance and incident dementia 2 We tried to 
overcome this issue to the best of our ability by rating all lacunar infarcts and adjusting 
for them m the statistical analysis We found a relation between the structural integrity 
of both NAWM and WML and cognitive performance, independent from SVD visible on 
FLAIR MRI DTI could therefore serve as an additional tool to conventional MRI in order 
to investigate cognitive dysfunction The relation of DTI parameters within the WML with 
cognitive performance and impairment may explain why subjects with identical WML on 
FLAIR differ in cognitive performance Future studies should prospectively investigate the 
predictive value of DTI parameters for incident cognitive decline or dementia When proven, 
DTI could possibly be a surrogate marker for disease progression, and can as such be used 
in therapeutic trials 
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Abstract 
Background Cerebral small vessel disease (SVD) and hippocampal atrophy are related to 
verbal memory failures, and may ultimately result in Alzheimer's disease (AD) However, 
verbal memory failures are often present before structural changes on conventional 
MRI appear Changes m micro-structural integrity of the hippocampus, which cannot be 
detected with conventional MRI, may be the underlying pathological substrate With DTI 
we investigated the relation between the microstructural integrity of the hippocampus and 
verbal memory performance in 503 non-demented elderly with SVD 
Methods The RUN DMC study is a prospective cohort study among 503 non-demented 
elderly with cerebral SVD aged between 50 and 85 years All participants underwent T l 
MPRAGE, FLAIR and DTI scanning and the Rey Auditory Verbal Learning Test After manual 
segmentation of the hippocampi, we calculated the mean diffusivity (MD) and fractional 
amsotropy (FA) in both hippocampi The relation between memory performance and 
hippocampal DTI parameters was adjusted for age, sex, education, depressive symptoms, 
hippocampal and WML volume and lacunar infarcts 
Results We found inverse relations between hippocampal MD and verbal memory 
performance (ß=-0 22,p< 001), immediate recall (ß=-0 22,p< 001), delayed recall (ß=-
0 20,p< 001), and forgetting rate (ß=-0 13,p= 025), most outspoken in participants with a 
normal hippocampal volume 
Conclusion Microstructural integrity of the hippocampus assessed by DTI is related to verbal 
memory performance in elderly with SVD, also in participants with an intact appearing 
hippocampus Changes m hippocampal micro-structure may be an early markerof underlying 
neurodegenerative disease, before macro-structural (ι e , volumetric) changes occur 
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Introduction 
Cerebral small vessel disease (SVD) includes white matter lesions (WML) and lacunar infarcts. 
The prevalence of SVD in the general population over 60 years is high.12 Both patient and 
population based studies have shown that cerebral SVD is an important cause of verbal 
memory failure and may ultimately result in cognitive decline associated with Alzheimer's 
disease (AD) in some.35 
In brains of patients with AD, atrophy of the hippocampus is one of the first observed 
changes.6 Interestingly, the progression of hippocampal atrophy is related to the presence 
and progression of cerebral SVD.7 8 Generally, its presence is supportive for the diagnosis of 
AD and indicative for future development of AD in patients with mild cognitive impairment 
(MCI).9·10 Hippocampal atrophy underlies the profound deficit in the consolidation of 
memory in ADU, i.e. long-term encoding and storage of relevant new information. 
However, these macroscopic structural hippocampal changes on conventional MRI occur 
at a relatively late stage and are usually preceded by clinical symptoms including subjective 
cognitive failures, verbal memory decline and problems m other cognitive domains.12 
Conceptually, there must be changes in the microstructural integrity of the hippocampus 
before macroscopic loss of volume occurs. Diffusion tensor imaging (DTI) can provide more 
detailed information on the micro-structural integrity of the hippocampus. DTI provides 
amongst other possibilities, two scalar parameters: mean diffusivity (MD), a measure of the 
magnitude of diffusion of water averaged in all spatial directions, and fractional anisotropy 
(FA), which provides information about the directionality of water diffusion.13 " DTI is usually 
used to assess microstructural integrity of the white matter in which damage to the white 
matter has found to be accompanied by an increase in MD and a decrease in FA,1516 but 
there are a number of reports showing its usefulness in the assessment of (predominantly) 
gray matter structures.17 20 There is some evidence of a higher diffusion in the hippocampus 
in MCI and AD patients that is independent of hippocampal atrophy and white matter 
lesions (WML).1719 
More importantly, two studies have shown that hippocampal MD measures were superior 
to volume measures in predicting clinical progression to dementia in MCI patients.1820 
However, to date the role of hippocampal DTI measurements has never been investigated 
in the light of specific processes of verbal memory function in non-demented elderly, 
focusing on encoding, storage and retrieval. And to detect early changes in hippocampal 
microstructure even before macrostructural changes occur and the relation with early 
impairment of verbal memory. 
In the present study the relation between hippocampal DTI measures and verbal memory 
processes is examined, independent of hippocampal volume and SVD, in 503 non-demented, 
independently living elderly with cerebral SVD, aged between 50 and 85 years. 
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Methods 
Study population 
The Radboud University Nijmegen Diffusion tensor and Magnetic resonance imaging Cohort 
(RUN DMC) study is a prospective cohort study that was designed to investigate risk factors 
and cognitive, motor and mood consequences of functional and structural brain changes 
as assessed by structural MRI, DTI and resting state fMRI among independently living non-
demented elderly with cerebral SVD 
In people with cerebral SVD symptoms are due to either complete (lacunar syndromes) or 
incomplete infarction (WML) of subcortical structures, that might lead to acute symptoms 
as transient ischaemic attacks (TIAs) or lacunar syndromes, or subacute manifestations as 
cognitive, motor (gait) and/or mood disturbances 21As the onset of cerebral SVD is often 
insidious, clinically heterogeneous, and typically with mild symptoms, it has been suggested 
that the selection of people with cerebral SVD in clinical studies should be based on the 
more consistent brain imaging features22 
Accordingly, in 2006, consecutive individuals who visited the department of neurology 
between October 2002 and November 2006 were selected for possible participation 
Inclusion criteria were (a) age between 50 and 85 years, (b) cerebral SVD on neuroimagmg 
Subsequently, the above mentioned acute and subacute clinical symptoms of SVD were 
assesed by standardized structured assessments Patients who were eligible because of a 
lacunar syndrome were included only > 6 months after the event to avoid acute effects on 
the outcomes 
Exclusion criteria were (a) dementia and (b) parkinson(-ism) according to the international 
diagnostic criteria,2325 (c) life expectancy of less than six months, (d) intracranial space 
occupying lesion, (e) (psychiatric) disease interfering with cognitive testing or follow-up, 
(f) recent or current use of acetylcholine-esterase inhibitors, neuroleptic agents, L-dopa or 
dopa-a(nta)gonists, (g) WML mimics (e g multiple sclerosis and irradiation induced gliosis), 
(h) prominent visual or hearing impairment, (ι) language barrier, (j) MRI contraindications 
or known claustrophobia 
From 1004 invited individuals by letter, 727 were eligible after contact by phone of whom 
525 agreed to participate In 22 individuals exclusion criteria were found during their visit to 
our research center (14 with unexpected claustrophobia, one died before MRI scanning, one 
was diagnosed with multiple sclerosis, m one there was a language barrier, one participant 
fulfilled the criteria for Parkinson's disease and four met the dementia criteria),23 " yielding 
a response of 71 3% (503/705) These 503 individuals had symptoms of TIA or lacunar 
syndrome (n=219), cognitive disturbances (n=245), motor disturbances (n=97), depressive 
symptoms (n=100) or a combination thereof All participants signed an informed consent 
form The Medical Review Ethics Committee region Arnhem-Nijmegen approved the study 
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Conventional MRI scanning protocol 
All participants underwent a 1 5-Tesla MRI scanning on the same Magnetom scanner 
(Siemens, Erlangen, Germany) The protocol included the following whole brain scans T l 
3D MPRAGE imaging (TR/TE/TI 2250/3 68/850ms, flip anglelS?, voxel size 1 0x1 0x1 0mm), 
Fluid-attenuated inversion recovery (FLAIR) pulse sequences (TR/TE/TI 9000/84/2200ms, 
voxel size 1 0x1 2x5 0mm, with an mterslice gap of 1 mm),Diffusion Tensor Imaging (DTI) 
(TR/TE 10100/93ms, voxel size 2 5x2 5x2 5mm, 4 unweighted scans, 30 diffusion weighted 
scans with b-value 900s/mm2) The complete protocol took 31 minutes 
Conventional MRI Analysis 
Hippocampus and intracranial volumetry One experienced investigator, blinded to clinical 
data (IvU), manually segmented the left and right hippocampus on the MPRAGE image using 
the interactive software program "ITK-SNAP"26 Anatomical boundaries were determined 
m coronal sections with the aid of neuroanatomical atlases,2728 actual segmentation was 
performed using a previously published protocol29 in which segmentation was performed 
from posterior to anterior The posterior border of the hippocampus was identified in the 
slice before the level m which the crurae fornices appeared in full view The anterior border of 
the hippocampus was defined as the slice in which the hippocampus was no longer present, 
and the amygdala fully covered the hippocampus (General Brain Segmentation Method 
and Utilization, Version 3 Center for Morphometric Analysis, 2004)29 30 The superior border 
was the inferior horn of the lateral ventricle, the inferior border was determined by the 
white matter boundary The lateral border was defined by the temporal horn of the lateral 
ventricle and the white matter adjacent to the hippocampus 
Volumes were calculated for the left and right hippocampus separately by summing all voxel 
volumes of the segmented areas Inter-rater studies on a random sample of 10 percent 
showed an mtra-class correlation coefficient for the left hippocampus of 0 73, and for 
the right hippocampus of 0 79 Intra-rater studies on this sample showed an mtra-class 
correlation coefficient for the left and right hippocampus of 0 97 and 0 96, respectively 
For the same image, gray (GM) and white-matter (WM) tissue and cerebrospinal fluid (CSF) 
probability maps were computed using SPM5 routines (Wellcome Department of Cognitive 
Neurology, University College London, UK) Total GM, WM and CSF volumes were calculated 
by summing all voxel volumes that had a p>0 5 for belonging to the tissue class Intracranial 
volume (ICV) was taken as the sum of total GM, WM and CSF volume 
Hippocampal volume (HV) measurements were normalized to the total ICV The normalized 
hippocampal volume (NHV) is defined as NHV=ICVm χ HV /ICV , where ICVm is the average 
total ICV of all participants, ICV is the ICV of the participant and the HV is the hippocampal 
volume of the participant31 
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WML volumetry WML were manually segmented on transversal FLAIR images WML were 
defined as hyper-intense lesions on FLAIR and not CSF like hypo-intense lesions on T l -
weighted image 32 Two trained raters, blinded for all clinical, cognitive and DTI information, 
segmented all scans WML volume was calculated as lesion surface multiplied by slice 
thickness Inter-rater variability was determined in a random sample of ten percent and 
yielded an intra-class correlation coefficient of 0 99 for total WML volume The FLAIR image 
was used to compute the co-registration parameters to the anatomical T l image, which 
were then applied to the segmentation results All images were visually checked for co-
registration errors 
Lacunar infarcts Lacunar infarcts were defined as hypo-intense areas > 2mm and <15mm on 
FLAIR and T l , ruling out enlarged perivascular spaces (< 2 mm, except around the anterior 
commissure, where perivascular spaces can be large) and mfraputammal pseudolacunes32 
Evaluation of infarcts was performed by a resident in neurology blinded to all clinical data 
with a good mtra-rater variability with a weighted kappa of 0 80 In ten percent of the scans 
mter-rater variability was calculated with a weighted kappa of 0 88 
Diffusion Tensor Imaging analysis 
The diffusion weighted images of each patient were realigned on the unweighted image 
using mutual information based co-registration routines from SPM5 Then, the diffusion 
tensor13 and its eigenvalues were estimated using linear regression (spurious negative 
values were set to zero), after which the tensor dérivâtes MD and FA were calculated 33 
The mean unweighted image was used to compute the co-registration parameters to the 
anatomical T l image (SPM5 mutual information co-registration), which were then applied 
to all diffusion weighted images and dérivâtes The mean MD and FA were then calculated m 
both hippocampi All images were visually checked for motion artifacts and co-registration 
errors, especially for not including pen-hippocampal CSF 
Measurement of cognitive function 
Cognitive function was assessed by two trained investigators (AvN, KdL) For this sub-study, 
the Mini Mental State Examination (MMSE) (range O-SO)34 was used as an index of overall 
cognitive performance The three-trial version of the Rey Auditory Verbal Learning Test 
(RAVLT)35 was administered to examine episodic memory formation 
We defined five memory indices based on RAVLT performance (e g , immediate recall, 
learning rate, forgetting rate, delayed recall and delayed recognition), as described 
previously36 Immediate recall was calculated by the mean of the total number of words 
remembered in the three learning trials of the RAVLT Learning rate was also determined 
by the three learning trials of the RAVLT, m which a learning curve was estimated with the 
following formula ((trial 2- trial l / tnal l ) plus (trial 3-trial 2/trial2))/2 Delayed recall was 
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the number of words recalled thirty minutes after the learning trials Forgetting rate, as a 
measure of decay over time, was obtained by the scores in the delayed recall trial corrected 
for the score obtained in the third learning trial (delayed recall-trial3/trial3) The delayed 
recognition score was calculated by computing the total of each correctly recognized word 
(the 15 target words among 15 new distracter items) thirty minutes after the learning trials 
Performance across tests was made comparable by transforming the raw test scores into 
z-scores as described elsewhere,3 for which the assumption of normality of the distribution 
was examined For data reduction purposes, a compound score for global verbal memory 
function was calculated, as described previously,3 by taking the mean of two z-scores from 
the RAVLT, one for the added scores on three learning trials of this test, and one for the 
delayed recall of this test If the test assistant encountered problems, a code was given for 
test status and the result was not used in the calculation of the ζ scores Separate codes 
were given for lack of motivation (0 8%) or not following the instructions (0 9%) For 98% of 
all participants reliable compound scores for global verbal memory performance could be 
calculated without any recording of test problems 
Other measurements 
The following characteristics were considered possible confounders age, sex, educational 
level (classified using 7 categories, 1 being less than primary school and 7 reflecting an 
academic degree)37 and depressive symptoms Depressive symptoms were dehned as a 
score >16 on the Center of Epidemiologic Studies on Depression Scale (CES-D)3839 and/or 
current use of anti-depressive medication 39 
Statistical analysis 
Statistical analyses was performed with SPSS 16 0 for Windows (SPSS Ine , Chicago, IL, USA) 
Baseline characteristics were summarized as means (standard deviations, SD) or proportions, 
for skewed variability parameters the median and the mter-quartile range was calculated 
We used multiple linear regression analyses to investigate the relation between hippocampal 
DTI (FA/MD) parameters (left and right separately) and global verbal memory performance 
as well as with sub-processes of verbal memory performance Adjustments were made 
for potential confounders including age, sex, educational level, depressive symptoms, 
hippocampal and WML volume and the presence of lacunar infarcts Next, we calculated 
estimated mean scores of global verbal memory performance per tettile of hippocampal 
MD by analysis of covanance (ANCOVA), adjusted for the same potential confounders In 
order to identify whether these microstructural changes precede macroscopic hippocampal 
volume loss we investigated the relation (linear regression analysis) between hippocampal 
DTI measures and global verbal memory performance stratified on low (lowest tertile of the 
distribution) versus normal hippocampal volume (upper two tertiles) adjusting for the same 
confounders as the previous analysis If so, we would expect a significant relation between 
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hippocampal DTI measures and global verbal memory performance, particularly in the 
group with still intact (normal) hippocampal volumes. Regression coefficients are presented 
as standardized beta-values. 
All assumptions for ANCOVA analysis were tested and verified for all measures. For the 
trend analysis of the ANCOVA results, tertiles of hippocampal MD were considered as a 
continuous variable in a multiple linear regression model. 
Table 1 Baseline characteristics of the 499 participants 
Demographic characteristics 
Age (years) 65 6 (8 8) 
Sex (male, η (%)) 282 (56 5%) 
Participants with only primary education 49 (9 8%) 
CES-D 110(9 4) 
Participants with depressive symptoms * 166 (33%) 
Cognitive function 
MMSE 28 1(16) 
Rey auditory verbal learning test number of words recalled 
Immediate recall 
Trial 1 5 1 (1 8) 
Trial 2 7 2 (2 3) 
Trial 3 8 6 (2 6) 
Total trial 1-3 20 9 (6 0) 
Learning rate 0 36 (0 24) 
Delayed recall 5 8 (3 1) 
Forgetting rate - 034 (0 25) 
Delayed recognition 26 7 (3 5) 
Neuroimaging characteristics 
WML volume 7 1(3 4,18 1) 
Normalized hippocampal volume 6 8 (0 9) 
Left normalized hippocampal volume 3 5 (0 5) 
Right normalized hippocampal volume 3 3 (0 5) 
Presence of lacunar infarcts (n, %) 171 (34) 
Values are means (SD),n (%), medians (mter-puartile range) or ml for the neuroimaging characteristics 
* Defined as CES-D scores >16 and/or the current use of anti-depressive medication MMSE Mini Mental State 
Examination CES-D Centre of Epidemiological Studies on Depression Scale WML White matter lesions 
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Results 
Of the 503 participants three were excluded because of DTI motion artefacts and one because 
of an automatic segmentation problem that could not be solved manually. Demographic 
and neuroimaging characteristics of 499 participants are shown in table 1. Mean age of the 
population was 65.6 years (SD 8.8), 56.5% were male and mean MMSE was 28.1 (SD 1.6). 
In an univariate analysis all confounding variables were related to global memory 
performance and hippocampal DTI parameters (p<.05). The relation between left and right 
hippocampal DTI parameters and the performance on global verbal memory as well as on 
the sub-processes of memory is shown in Table 2. 
Table 2 The relation between hippocampal DTI parameters and the sub-processes of verbal 
memory function as measured with the Rey Auditory Verbal Learning Test (RAVLT). 
Global verbal memory 
performance 
Immediate memory 
Trial 1 
Trial 2 
Trials 
Total trials 1-3 
Learning rate 
Delayed recall 
Forgetting rate*** 
Delayed recognition 
Left 
MD 
-0.18** 
-016** 
-0 16** 
-0 18** 
-0.19** 
-0 08 
-0.16** 
-0 10 
-0 17** 
FA 
0 10* 
0 03 
0 07 
0 12* 
0 09* 
0 02 
0 09* 
0 04 
0 03 
Hippocampus 
Right 
MD 
-0 2 1 * * 
-0 12* 
-0 18** 
-0 20** 
-0 19** 
-0 01 
-0 20** 
-0 15* 
-0 14* 
FA 
0.04 
0.01 
0 03 
0.09* 
0.06 
0 05 
0 03 
0 03 
0 01 
Total 
MD 
-0.22** 
-0.16** 
-0.19** 
-0.21** 
-0 2 1 * * 
0 04 
-0 20** 
-0 14* 
-0 17** 
FA 
0 07 
0 03 
0.06 
0 12* 
0.08 
0.04 
0 06 
0 01 
0 02 
Numbers represent regression coefficients (standardized beta's), adjusted for age, sex, educational level, depressive 
symptoms, hippocampal and WML volume and the presence of lacunar infarcts *p< 05, **p< 01 *** Higher test scores 
reflect a less negative forgetting rate, ι e a better performance 
In this analysis we did not find a relation between global verbal memory performance and 
hippocampal volume (p>.05). Adding hippocampal MD in the analysis showed a significant 
relation with global memory performance (left p=.002; right p<.001; total p=.002). MD in the 
left and right hippocampus showed a significant relation with the compound score of the 
global verbal memory performance (β=-0.18/ p=.001 and β=-0.21, p<.001). Analyses of the 
specific components of the RAVLT demonstrated significant relations with immediate recall 
(β=-0.19, p=.001 and β=-0.19, p<.001), delayed recall (β=-0.16, p=.005 and β=-0.20, p<.001) 
Table 3 The relation between hippocampal DTI parameters and global verbal memory performance in participants with low and normal 
hippocampal volume 
Hippocampus 
Left Right Total 
M D FA MD FA MD FA 
Global verbal memory performance 
Low hippocampal volume (n=166) -0.20(044) 0.11 (.169) -0 13(162) 0 03(706) -0 19(0 073) 0 07 (.368) 
Normal hippocampal volume (n=333) -0 15 ( 020) 0 08 ( 108) -0.24 (< 001) 0 05( 390) -0 21 (0 002) 0 07 ( 194) 
Numbers represent regression coefficients standardized beta's (p values), adjusted for age, sex, educational level, depressive symptoms, hippocampal and WML volume and the 
presence of lacunar infarcts Low hippocampal volume is defined as the lowest tertile of the hippocampal volume distribution. Normal hippocampal volume is defined as the upper 
two tertiles of the hippocampal volume distribution 
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and delayed recognition (ß=-0 17, p= 003 and ß=-0 14, p= 013) and the MD of the left and 
right hippocampus, independent of the confounders The MD in the right hippocampus 
and total hippocampus showed a relation with forgetting rate (ß=-0 15, p= 013 and ß=-
0 14, p= 027) The relation between hippocampal FA values and memory performance 
was less evident, but were most outspoken for the left hippocampus (Table 2) We did not 
find essential differences in standardized betas and p-values between men and women 
separately performing the same analyses We could not demonstrate a sex difference in 
lateralization of verbal memory performance There was no relation between hippocampal 
DTI parameters and learning rate 
When stratified on tertiles of hippocampal MD, higher MD values, represented by a higher 
MD fertile, for both left and right hippocampus were related to worse performances on 
immediate recall (ptrend= 001 and Plrend< 001), delayed recall (ptrend= 006 and p(rend= 001) 
and forgetting rate (ptrend= 057 and Ptrend= 035) after adjusting for possible confounders 
(Figure 1) Again, no significant relation was found for the learning rate 
Table 3 shows the relation between hippocampal DTI parameters and global verbal memory 
performance m participants with a low or normal hippocampal volume 
The relation was most striking for MD values m participants with normal hippocampal 
volumes for left (ß=-0 15, p= 02), right (ß=-0 24, p< 001 ) and total (ß=-0 21, p= 002) 
hippocampus, independent of earlier mentioned confounders This relation was also found 
for MD in the left hippocampus m participants with a low hippocampal volume The FA of 
the hippocampus m participants with low or normal hippocampal volume did not correlate 
with global memory function 
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Figure la Mean scores on sub-processes of memory performance per tertile of hippocampal 
MD adjusted for age, sex, educational level, depressive symptoms, hippocampal and WML 
volume and the presence of lacunar infarcts. 
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Discussion 
Our findings demonstrate that early changes in hippocampal integrity are related to 
reduced global verbal memory function, specifically immediate and delayed recall, delayed 
recognition and forgetting rate, independent of depressive symptoms, hippocampal and 
WML volume and lacunar infarcts, in 499 participants with cerebral SVD These findings are 
in line with the notion that the hippocampus is crucial for the acquisition of new knowledge 
that has to be recalled (ι e , episodic memory formation) Our data demonstrate that micro-
structural integrity of the hippocampus beyond the detection limit of conventional MRI 
is related with episodic memory formation The findings clearly show episodic memory 
formation - specifically the encoding and storage of new information - are related to 
hippocampal integrity Although it is difficult to isolate encoding as a process using a standard 
word-list paradigm, the encoding stage is most prominently reflected m the immediate 
recall index of the RAVLT3640 We demonstrate that hippocampal integrity is related to 
immediate recall, which is in line with neuroimaging studies showing that the hippocampus 
is implicated in verbal encoding, predicting later successful recall " Storage of information 
is reflected by various indices on the RAVLT36 In general, successful recall after learning 
depends on adequate storage of information However, the forgetting rate (delayed free 
recall performance compared to the amount of previously learned information) may also be 
confounded by a retrieval deficit, ι e the inability to access previously stored information 
Cued-recall paradigms have been developed to facilitate access to previously acquitted 
information (e g , the recognition trial on the RAVLT) Our findings show a relation between 
hippocampal integrity and free delayed recall, forgetting rate and delayed recognition, 
clearly showing a crucial role for the hippocampus m the storage of information that is 
independent from a retrieval deficit These findings support recent neuroimaging evidence 
indicating that the hippocampus is crucial for successful performance on recognition 
memory paradigms4242 With respect to lateralization effects, our results suggest a mild 
lateralization for hippocampal DTI measures and verbal memory performance This is m line 
with previous findings from functional neuroimaging studies and lesion studies 41 Additional 
analyses on possible sex differences m lateralization of verbal memory performance 
showed no significant findings related to sex Research investigating the effects of sex on 
lateralization of verbal (memory) function shows some mixed results, with some studies 
demonstrating sex differences in which men have a left predominance and women a more 
bilateral representation 44 However, these findings have not been replicated in an extensive 
meta-analysis demonstrating no consistent evidence for more bilateral representation of 
verbal function m women than men45 as well as m a functional MR imaging study46 
Some methodological issues need to be considered Although our data are derived from 
the largest DTI study thus far, they are cross-sectional m nature preventing us from drawing 
conclusions with respect to causality Follow-up examination of this cohort is already 
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planned, to investigate whether early microstructural changes in the hippocampus correlate 
with the development of hippocampal atrophy, MCI and eventually AD 
We found that the relation between FA and memory performance is less strong than for MD 
This may be due to the fact that FA is a measure reflecting the dominant directionality of 
diffusion of water Because of the size of our region of interest (the hippocampus), multiple 
fibers are present that may all have different directions, which influence the FA Due to that 
mtra-hippocampal fiber incoherence low FA may not necessarily reflect underlying lower 
structural integrity " In contrast, MD is affected by fiber crossing to a lesser extent because 
it reflects magnitude of water diffusion which is not influenced by direction Subsequently, 
MD remains relatively constant " This might be the explanation for the lack of finding with 
FA but not with MD These complications m the analyses of FA in the hippocampus were also 
reported by others looking at MCI and AD patients17 In that study, they tried to take this into 
account by considering smaller regions of interest m the hippocampus, but still found a low 
sensitivity for FA values m contrast to MD " 
The strengths of our study include its large size with a high response of over 70% In addition 
it is a single-centre study m which MRI data were identically acquired on a single scanner 
and the hippocampus and WML were assessed volumetrically m a reliable, sensitive and 
objective way by two trained experts, who were blinded to all clinical data Furthermore we 
used extensive adjustment for possible confounders such as educational level, depressive 
symptoms, a well known confounder in cognitive performance m elderly with SVD39, 
hippocampal and WML volume and lacunar infarcts 
To the best of our knowledge there are no other studies investigating the relation between 
hippocampal DTI parameters and verbal memory function m non-demented elderly A few 
studies have assessed DTI measurements m the hippocampus of MCI and AD patients2047 In 
line with these studies we found support for the notion that the structural integrity change 
already produces decrements in verbal memory performance before hippocampal volume 
does DTI parameters in the hippocampus were found to discriminate between early phases 
of cognitive decline (MCI) and normal aging Patients with more advanced cognitive decline 
(ι e , AD) could only be discriminated based on their lower hippocampal volume compared 
to controls and not by differences m diffusivity19 The same investigators also found that high 
diffusivity in the hippocampus and low hippocampal volume were related to an increased 
risk for conversion of MCI in AD, with diffusivity being a stronger predictor than volume 18 
In these studies additional adjustments were made only for age, sex and education Specific 
processes of episodic memory performance as in our study, which represent a more 
sensitive measure for cognitive decline than a clinical diagnosis of MCI or AD based on 
clinical diagnostic criteria2448 were not taken into account A further difference with our 
study was the mean age of their study group that was around 80 years18 Furthermore they 
demonstrated that baseline hippocampal MD is associated with conversion to AD rather 
than hippocampal volume " Others demonstrated a higher sensitivity of hippocampal 
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DTI parameters than hippocampal volume measures in the diagnosis of MCI20 However, 
participants with relevant cerebrovascular disease (e g cortical infarcts, multiple lacunar 
infracts and leukoaraiosis) were excluded m these studies in contrast to our study 
Consequently, these may have a limited external validity as over 50% of AD patients have 
WML to some extent"9 In our study population, SVD was present in some degree in all 
participants, making our findings more representative 
Interestingly, the relation between hippocampal integrity and verbal memory function was 
also found in participants without loss of hippocampal volume as assessed by structural MRI 
While there is abundant evidence that episodic memory formation is impaired by patients 
with hippocampal lesions or atrophy, such as early AD, and functional neuroimagmg studies 
also indicate a crucial role for the medial temporal lobe including the hippocampus11, this 
is the first study to demonstrate, using DTI, such a relationship m older people without 
apparent hippocampal pathology using DTI This may indicate that microstructural changes 
assessed by DTI m the hippocampus indeed precede structural changes as assessed by 
conventional MRI, this must be unraveled by the follow up examination 
The relation between DTI parameters and verbal memory function was less striking 
m participants with low hippocampal volumes This could be because at the time that 
atrophy occurs, the structural changes (atrophy) are more prominently correlated with 
verbal memory performance than the microstructural changes This line of reasoning is 
m agreement with the results of others demonstrating that diffusion parameters of the 
hippocampus can differentiate between MCI and controls, but could not classify AD (19), as 
well as studies showing that hippocampal DTI parameters in patients with MCI correlated 
with disease progression to AD 1B" 
Future studies should prospectively investigate the predictive value of DTI parameters of 
the hippocampus before the development of hippocampal atrophy and incident cognitive 
decline and dementia To extrapolate our results future studies should include participants 
from the general population When proven, DTI of the hippocampus could possibly play a 
role as a surrogate marker for disease progression, and could as such be used in therapeutic 
trials 
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Loss of cingular integrity is associated with 
memory performance 
Submitted as: 
van der Holst HM, van Norden AGW, de Laat KF, van Uden IWM, van Oudheusden UB, Zwiers 
MP, Morris DG, Kessels RPC, de Leeuw FE. Microstructural integrity of the cingulum is related 
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Abstract 
Background Cerebral small vessel disease (SVD) is related to verbal memory failures. An 
important structure for verbal memory is the mid and posterior part of the cingulum bundle. 
Verbal memory failures are often present before structural changes on conventional MRI 
are seen. Changes in the microstructural integrity of the cingulum assessed with diffusion 
tensor imaging (DTI) beyond detection with conventional MRI may precede macrostructural 
changes and be related with verbal memory failures. 
Objective To investigate the relation between cingular microstructural integrity and verbal 
memory performance in 503 non-demented elderly with cerebral SVD. 
Methods The RUN DMC study is a prospective cohort study in elderly (50-85 years) with 
cerebral SVD. All participants underwent T l MPRAGE, FLAIR and DTI scanning and the Rey 
Auditory Verbal Learning Test. Mean diffusivity (MD) and fractional anisotropy (FA) were 
assessed in six different cingular regions of interests (ROIs). Linear regression analysis 
was used to assess the relation between verbal memory performance and cingular DTI 
parameters, with appropriate adjustments. 
Results We found inverse relations between MD of the left mid and posterior cingulum 
(superior-posterior and inferior-posterior ROI) and overall verbal memory (ß=-.13, p=.006; 
ß=-.10, p=.029 and ß=-.12, p=.004), immediate recall (ß=-.13, p=.008;ß=-.13, p=.008 and ß=-
.10, p=.015) and delayed recognition (ß=-.20, p<.0005;ß=-.18, p<.0005 and ß=-.14, p=.002), 
independent of confounders. This relation remained significant in participants with an intact 
hippocampal structural integrity. 
Conclusion Microstructural integrity of the mid and posterior cingulum assessed by DTI is 
related to verbal memory performance in elderly with SVD, especially in participants with 
intact hippocampal structural integrity. 
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Introduction 
Cerebral small vessel disease (SVD) includes white matter lesions (WML) and lacunar infarcts 
and is a frequent finding on magnetic resonance imaging (MRI) scans of elderly people 1 
Several, patient- and population based studies, have shown that cerebral SVD is related 
to verbal memory failure and may eventually result in cognitive decline and dementia m 
some 23 Cerebral SVD is also associated with hippocampal atrophy,45 one of the first signs 
observed on conventional MRI scans of patients with (Alzheimer's) dementia However 
hippocampal atrophy as seen on conventional MRI is usually preceded by clinical symptoms 
of cognitive decline More recent studies also showed involvement of the white matter in 
cognitive impairment67 Specifically, the cmgulum bundle, a white matter bundle which 
connects the medial temporal lobe (MTL) structures (e g hippocampus) and the posterior 
cmgulate cortex, is an important structure for verbal memory performance 810 It is expected 
that macroscopic changes of the cmgulum are preceded by changes in the microstructural 
integrity of this white matter bundle This can be revealed using a noninvasive MRI technique, 
diffusion tensor imaging (DTI), which provide detailed information on the microstructural 
integrity of brain structures " 1 2 Two DTI parameters are of special interest mean diffusivity 
(MD), a measure of water diffusion averaged m all spatial directions, and fractional 
amsotropy (FA), which provides information about the directionality of water diffusion Loss 
of mircostructural integrity is accompanied by an increase in MD and a decrease m FA 13 
There is increasing evidence that DTI parameters are an earlier marker of cognitive decline 
in comparison to volume measures " 1 5 Many DTI studies in patients with cognitive decline 
and dementia have shown loss of microstructural integrity of the cmgulum 91619 
The relation between loss of structural integrity of the cmgulum and gray matter structures 
as the hippocampus and cognitive decline has not been clarified Some studies have 
suggested that hippocampal atrophy is related to cmgulum integrity m (Alzheimer's) 
dementia (AD),102022 whereas others did not find this relation 23 The majority of previous 
DTI studies focused on the cmgulum adjacent to the posterior cmgulate cortex Most of 
them found that loss of structural integrity of the cmgulum begins near medial temporal 
structures and then progresses to the posterior cmgulum with AD progression, supporting 
the posterior-anterior hypothesis of progression of AD pathology24 Furthermore, a recent 
study showed that posterior cmgulum integrity was associated with cognitive function 
(including verbal and visuospatial memory, as well as executive functioning) in older adults 
without dementia 16 Less or no relations were found for the anterior cmgulum integrity and 
cognitive function,1625 probably because the anterior cmgulum is not directly part of the 
posterior neuronal network that subserves episodic memory26 
To the best of our knowledge the role of angular DTI measurements and the specific 
processes of verbal memory function, focusing on encoding, storage and retrieval of verbal 
information, have never been investigated m non-demented elderly with cerebral SVD 
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We hypothesized that loss of microstructural integrity of the mid and posterior cmgulum 
is related to impaired verbal memory performance We examined this in six different 
regions from the posterior to the anterior cmgulum in order to get information about 
regional distribution patterns in respect to verbal memory Furthermore we investigated 
the influence of hippocampal structural integrity on this relation This study is part of the 
Radboud University Nijmegen Diffusion tensor and Magnetic resonance imaging Cohort 
(RUN DMC) study that included 503 non-demented, independently living elderly with 
cerebral SVD, aged between 50 and 85 years 
Methods 
Study population 
The Radboud University Nijmegen Diffusion tensor and Magnetic resonance imaging Cohort 
(RUN DMC) study prospectively investigates the risk factors and clinical consequences 
of brain changes among 503, 50-85 years old non-demented elderly with cerebral SVD 
The selection procedure of the participants and study protocol were described m detail 
previously27 
In short, on the basis of established research criteria SVD was defined as the presence of 
lacunar infarcts and/or WML 28 Accordingly, in 2006, consecutive patients referred to the 
Department of Neurology between October 2002 and November 2006, were selected 
for participation Inclusion criteria were (a) age between 50 and 85 years, (b) cerebral 
SVD on neuroimagmg (WML and/or lacunar infarcts) The mam exclusion criteria were 
dementia (American Psychiatric Association, 2000), (psychiatric) disease interfering with 
cognitive testing or follow-up, WML or SVD mimics and MRI contraindications or known 
claustrophobia All participants signed an informed consent form The Medical Review 
Ethics Committee region Arnhem-Nijmegen approved the study 
Conventional MRI Scanning Protocol 
All participants underwent a 1 5-T MRI scanning The protocol included, among other 
sequences, the following whole brain scans T l 3D MPRAGE imaging, fluid-attenuated 
inversion recovery (FLAIR) pulse sequences, DTI27 
Conventional MRI Analysis 
Hippocampus and intracranial volumetry One experienced investigator, blinded to clinical 
data (IvU), manually segmented the left and right hippocampus on the MPRAGE image using 
the interactive software program "ITK-SNAP"29 Anatomical boundaries were determined m 
coronal sections with the aid of neuroanatomical atlases,3031 and actual segmentation was 
performed using a previously published protocol32 m which segmentation was performed 
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from posterior to anterior27 Interrater studies on a random sample of 10% showed 
an intraclass correlation coefficient for the left hippocampus of 0 73 and for the right 
hippocampus of 0 79 Intrarater studies on this sample showed an intraclass correlation 
coefficient for the left and right hippocampus of 0 97 and 0 96, respectively For the same 
image, gray (GM) and white-matter (WM) tissue and cerebrospinal fluid (CSF) probability 
maps were computed using SPM5 unified segmentation routines (Wellcome Department 
of Cognitive Neurology, University College London, UK)33 Total GM, WM, and CSF volumes 
were calculated by summing all voxel volumes that had a Ρ > 0 5 for belonging to the tissue 
class Intracranial volume (ICV) was taken as the sum of total GM, WM, and CSF volume 
Hippocampal volume (HV) measurements were normalized to the total ICV The normalized 
hippocampal volume (NHV) is defined as NHV = ICVm χ HV /ICV , where ICVm is the average 
total ICV of all participants, ICV is the ICV of the participant, and the HV is the HV of the 
participant M 
WML volumetry WML was manually segmented on transversal FLAIR images WML were 
defined as hypermtense lesions on FLAIR, which were not, or only faintly, hypomtense on 
Tl weighted images, except for gliosis surrounding infarcts 35 WML volume was calculated 
as lesion surface multiplied by slice thickness Two trained raters, blinded for all clinical, 
cognitive, and DTI information, segmented all scans Interrater variability was determined in 
a random sample of ten percent and yielded an intraclass correlation coefficient of 0 99 for 
total WML volume The FLAIR image was used to compute the co-registration parameters 
to the anatomical T l image, which was then applied to the segmentation results All images 
were visually checked for co-registration errors 
Lacunar infarcts Lacunar infarcts were defined as hypomtense areas >2 mm and <15 mm on 
FLAIR and T l , ruling out enlarged perivascular spaces (<2 mm, except around the anterior 
commissure, where perivascular spaces can be large) and infraputammal pseudolacunes35 
Evaluation of infarcts was performed by a trained rater blinded to all clinical data with good 
intrarater variability with a weighted κ of 0 80 In 10% of the scans, mterrater variability was 
calculated with a weighted κ of 0 88 
DTI Analysis 
The diffusion-weighted images of each participant were realigned on the unweighted image 
using mutual information based co-registration routines from SPM5 Then, the diffusion 
tensor11 and its eigenvalues were estimated using linear regression (spurious negative 
values were set to zero), after which the tensor dérivâtes MD and FA were calculated 36 
The mean unweighted image was used to compute the co registration parameters to the 
anatomical T l image (SPM5 mutual information co-registration), which was then applied to 
all diffusion-weighted images and dérivâtes 
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MD and FA values of the cingulum were measured in six bilateral regions of interest (ROIs) 
in the cingulum bundle as illustrated in figure 1. An experienced neurologist (FEdL) blinded 
to subject information used FSLView37 to overlay an histological atlas (Juelich Histological 
Atlas)38; over the MNI152 standard brain, in order to manually mark out the center 
coordinates of the ROIs in the different locations of the cingulum and the parahippocampal 
region (based on neuroanatomy data from the literature)39 
We marked out 5 ROIs on a sagital slice of the cingulum. The cingulum was divided in 4 
parts: anterior, middle, posterior and parahippocampal section.40 The center of ROI C was 
placed at the centre of the middle curve of the cingulum fibers, just above the body of the 
corpus callosum: this is the middle cingulate region. We placed the center of the 2 anterior 
ROIs (ROI A and B) before the middle curve of the cingulum (around the rostrum and genu 
of the corpus callosum) and the 2 posterior ROIs (ROI D and E) nearby the dorsal curve of 
the cingulum fibers (around the splenium of the corpus callosum). The center of the sixth 
ROI (ROI F) was placed in the parahippocampal cingulum on the medial temporal portion 
of the cingulum fibers. The center coordinates of each ROI were mirrored with respect to 
the mid-sagital plane to obtain these same regions in both cerebral hemispheres. The ROI 
center coordinates were mapped back to the individual DTI space of each subject using the 
inverse of the SPM5 unified T l normalization parameters.33 ROIs were defined as 6 mm 
diameter spheres (volume of 0.056 mL) around the DTI-space center coordinates. We used 
a modest ROI size to ensure that all ROIs included only white matter (which was visually 
checked). FA and MD values within each ROI were averaged. Furthermore, the mean MD 
was calculated in both hippocampi. All images were visually checked for motion artifacts 
and co-registration errors, especially for not including perihippocampal CSF. 
Figure 1 Location of the six (Α-F) regions of interest (ROIs) in the left cingulum bundle and 
parahippocampal cingulum in a sagital plane. 
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Measurement of cognitive function 
Cognitive function was assessed by two trained investigators (AvN and KdL) For this 
substudy, the Mini-Mental State Examination (MMSE) (range, 0-30)41 was used as an index 
of overall cognitive performance The three-trial version of the Rey Auditory Verbal Learning 
Test (RAVLT)42 was administered to examine episodic memory formation To evaluate speed 
of mental processes we used the Stroop test43, the Paper-Pencil Memory Scanning Task44, 
the Symbol-Digit Substitution Task45 The Rey's Complex Figure Test (RCFT)46 was included 
as an index of visuospatial construction (copy trial) and incidental learning (immediate and 
delayed recall) 
We defined four memory indices based on RAVLT performance (overall verbal memory 
performance, immediate recall, delayed recall, and delayed recognition), as described 
previously4748 Immediate recall was calculated by the mean of the total number of words 
remembered in the three learning trials of the RAVLT Delayed recall was the number of 
words recalled 30 mm after the learning trials The delayed recognition score was calculated 
by computing the total of each correctly recognized word (the 15 target words among 15 
new distracter items) 30 mm after the learning trials Performance across tests was made 
comparable by transforming the raw test scores into z-scores as described elsewhere for 
which the assumption of normality of the distribution was examined 48 For data reduction 
purposes, a compound score for overall verbal memory performance was calculated, as 
described previously2 by taking the mean of two z-scores from the RAVLT, one for the added 
scores on three learning trials of this test and one for the delayed recall of this test 
For visuospatial memory and psychomotor speed we also calculated compound scores 
Visuospatial memory is a compound score of the mean of the z-scores of the immediate 
recall trial and the delayed recall trial of the Rey's Complex Figure Test Psychomotor 
speed was calculated as the mean of the z-scores of the 1-letter subtask of the Paper-
Pencil Memory Scanning Task, the reading subtask of the Stroop test and the Symbol-Digit 
Substitution Task4β 
Other measurements 
The following characteristics were considered possible confounders age, sex, educational 
level and depressive symptoms (49) Depressive symptoms were defined as a score >16 on 
the Center of Epidemiologic Studies on Depression Scale and/or current use of antidepressive 
medication 5 0 5 1 
Structural quality of the hippocampus 
As it has been demonstrated that a combination of high diffusivity in the hippocampus and 
low hippocampal volume is related to conversion to AD m MCI patients,14 we composed 
a score for hippocampal quality using both parameters Both diffusivity and volume were 
given a score ranging from 1 (poor lowest fertile of the volume/highest tentile of MD 
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distribution) to 3 (good; highest tertile of the volume/lowest tertile of the MD distribution) 
leading to a maximum score between 2 (lowest tertile of the volume + highest tertile of the 
MD distribution (1+1): worst hippocampal quality) and 6 (highest tertile of the volume + 
lowest tentile of the MD distribution (3+3):best hippocampal quality). A good hippocampal 
quality was defined as a score of > 4, while poor quality was defined as a score of 2 or 3. 
Statistical analysis 
Statistical analyses were performed with SPSS 16.0 for Windows (SPSS Inc., Chicago, IL, 
USA). Baseline characteristics were summarized as means (with standard deviations; SD) 
or proportions, for skewed variability parameters the median and the inter-quartile range 
were calculated. 
The relation between the cingular DTI (MD/ FA) parameters of the six ROIs and the RAVLT 
indices as well as with the compound scores for overall verbal memory performance, 
psychomotor speed, visuospatial memory and MMSE, were analyzed by multiple linear 
regression analysis. Adjustments were made for potential confounders including age, sex, 
educational level, depressive symptoms, normalized hippocampal volume and WML volume 
and the presence of lacunar infarcts. 
To assess whether the quality of the hippocampus modified the relation between cingular 
DTI parameters and performance in verbal memory, psychomotor speed, visuospatial 
memory and MMSE, we performed the previously described linear regression analyses 
stratified in two groups of hippocampal quality (good vs. poor); adjustments were made 
for the same confounders as mentioned above. Regression coefficients are presented as 
standardized ß-values. Bonferroni corrections were applied. 
Table 1 Baseline characteristics 
Participants n=499 
Demographics 
Age 65 6 (8 8) 
Male 282(56 5) 
Participants with only primary education (n, %)) 49 (9 8) 
CES-D 110(9 4) 
MMSE 28 1 (1 6) 
Participants with depressive symptoms (n, %) * 168 (33 8) 
Neuroimaging characteristics 
Normalized hippocampal volume (mL) 6.8 (0.9) 
Normalized cingular volume (mL) 4 9 (0.4) 
Left normalized cingular volume (mL) 2.5 (0.2) 
Right normalized cingular volume (mL) 2.4 (0.2) 
WML volume (mL) 7.1(3.4,18.1) 
Presence of lacunar infarcts (n, %) 171 (34) 
Numbers represent means (SD), percentages or medians (inter-quartile range) 
CES-D Centre of Epidemiological Studies on Depression Scale, WML: White Matter Lesions 
* Defined as CES-D scores >16 and/or the current use of anti-depressive medication 
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Results 
The total study population consisted of 503 participants. Three participants were excluded 
because of visible motion induced signal loss in the DTI data and one because of an 
automatic segmentation problem that could not be solved manually. Table 1 shows the 
baseline characteristics of 499 participants. The mean age of the population was 65.6 years 
(SD 8.8) and 56.5% were male. In table 2 the test scores of the cognitive test battery are 
shown. The mean MMSE score was 28.1 (SD 1.6). 
Table 2 Cognitive test scores 
Mini Mental State Examination (range 0-30) 28 1 (1.6) 
RAVLT(no of words recalled) 
Immediate recall trial 1 5.1(17) 
Immediate recall trial 2 7 3(2.2) 
Immediate recall trial 3 8 7 (2.5) 
Total trial 1-3 21.1(5 8) 
Delayed recall 6 0 (3 1) 
Delayed recognition 27 0 (3.2) 
Stroop test (time in sec ) 
trial 1 (words) 25 8 (6.3) 
trial 2 (colours) 33 2 (7.7) 
trial 3 (concept-shifting) 63 8 (22 1) 
Paper and Pencil memory scanning task (time in sec.) 
1 character 45 0(13.4) 
2 characters 62 3(19 7) 
3 characters 77 4 (26 5) 
Symbol digit substitution task (no. in 60 sec.) 27 1 (9 7) 
Rey Complex Figure Test (range 0-36) 
Copy trial 33 5(3 4) 
Immediate recall trial 18 2 (6 8) 
Delayed recall trial 18 1 (6 6) 
Numbers represent means (SD) RAVLT Rey Auditory Verbal Learning Test 
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Table 3 Mean MD and FA of the ROIs in the left and right cingulum and hippocampus 
Mean diffusivity Fractional anisotropy 
ROI A: anterior cingulum 
Left 8 48 (0 91) 0.40 (0.10) 
Right 8 38 (0.73) 0 38 (0.07) 
ROI Β: anterior cingulum 
Left 8.45(1.06) 0 40(0.11) 
Right 8.34 (0.89) 0.41 (0 09) 
ROI C: mid cingulum 
Left 7.90 (0.69) 0 51 (010) 
Right 7.97 (0.69) 0.50 (0.09) 
ROI D: superior-posterior cingulum 
Left 7 94 (0.57) 0 53 (0 07) 
Right 7 88 (0 53) 0 50 (0 07) 
ROI E: inferior-posterior cingulum 
Left 7.86 (0 48) 0.45 (0.07) 
Right 8 09 (0 58) 0.39 (0 07) 
ROI F: parahippocampal cingulum 
Left 8 73 (0.78) 0.25 (0.06) 
Right 8 93 (0 87) 0.26 (0.07) 
Hippocampus 
Left 12.00(1.11) 0.17(0.02) 
Right 12 01(113) 0 17(0 02) 
Numbers represent means (SD). MD Mean Diffusivity, expressed as 10-4 mm2/s FA .Fractional Anisotropy 
Table 3 shows the mean MD and FA values of the six bilateral ROIs and the hippocampus. In 
none of the participants was more than 5% of the ROIs in the cingulum affected by WML. 
The relations between the MD and FA of the six ROIs in left and right cingulum and the 
different cognitive tasks are shown in tables 4 and 5. 
Table 4 Relation between the MD values of the six ROls in the left and right cingulum and verbal memory performance and cognitive 
performance 
Overall memory performance1 
Immediate memory 
Delayed recall 
Delayed recognition 
Psychomotor speed1 
Visuospatial memory1 
MMSE 
MD ROI A 
Left 
-02 
-05 
.01 
-.08 
-.05 
05 
-.01 
Right 
02 
.01 
03 
-05 
-.05 
.03 
.03 
to anterioi 
MD ROI Β 
Left 
-.05 
-.07 
-02 
-.02 
-07 
-.05 
-05 
• < -
Right 
-.01 
- 0 1 
-.01 
-.08 
-05 
01 
.03 
mid cingul 
MD ROI C 
Left 
-.13* 
-.13* 
-.12* 
-.20*t 
- 1 1 * * 
-04 
-.12** 
urn 
Right 
-04 
-.03 
-05 
- 1 0 * * 
-.09** 
-06 
-.05 
-> to posterior 
MD ROI D 
Left 
-.10** 
-.13* 
-.07 
-.18*t 
-.13** 
-.06 
-05 
Right 
-03 
-.03 
-02 
-.07 
-.08** 
-.01 
01 
MD ROI E 
Left 
- 1 2 * * 
-.10** 
- 1 3 * * 
-.14** 
-05 
-03 
-.08 
Right 
-.10** 
-.10** 
-.08 
-.09** 
-.09 
.01 
-.05 
parahippocampal 
MD ROI F 
Left 
-05 
-03 
-06 
-08 
.03 
.01 
-.05 
Right 
-05 
-06 
-.03 
-.07 
-04 
-05 
-09** 
Numbers represent regression coefficients (standardized betas), adjusted for age, sex, educational level, depressive symptoms, hippocampal volume, WML volume and the presence 
of lacunar infarcts *p< 01, **p<.05; After Bonferonni correction· tp< 01; *p< 05; 'Compound scores 
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Significant relations were found between the MD values m the left mid cmgulum (ROI C) 
and in the posterior part of the left cmgulum (ROI D and E) and overall verbal memory 
performance (ß= -13, p= 006, ß= -10, p= 029 and ß= -12, p= 004), immediate recall (ß= 
-13, p= 008, ß= -13, p= 008 and ß= -10, p= 015) and delayed recognition (ß= - 20, p< 0005, 
ß= -18, p< 0005 and ß= -14, p= 002), independent of confounders Furthermore MD m 
the left mid (ROI C) and posterior cmgulum (ROI E) also showed a significant relation with 
delayed recall (ß= -12, p= 01 and ß= -13, p= 002) 
Table 5 shows almost the same distribution for the relation between the FA values of the six 
ROIs and (subprocesses of) verbal memory However these relations were less strong than 
for the MD values 
When stratified on good and poor hippocampal quality, the relations between the MD of 
the left mid (ROI C) and posterior cmgulum (ROI D and E) and verbal memory performance 
were most outspoken m participants with a good hippocampal quality (intact structural 
integrity) (n=338)(table 6) In participants with a poor hippocampal quality (n=161) almost 
no significant relations were found between the MD values of the six angular ROIs and 
verbal memory, numbers are not shown 
Table 5 Relation between the FA values of the six ROIs in the left and right cingulum and verbal memory performance and cognitive 
performance 
Overall memory performance' 
Immediate memory 
Delayed recall 
Delayed recognition 
Psychomotor speed1 
Visuospatial memory1 
MMSE 
FA ROI A 
Left 
.03 
05 
01 
.04 
-.01 
-.02 
-04 
Right 
-.01 
- 0 1 
- 0 1 
.03 
.05 
-.07 
-04 
to anterior <-
FA ROI Β 
Left 
05 
06 
04 
.06 
07 
03 
01 
Right 
-.01 
-02 
-.01 
.05 
.01 
-.09** 
-04 
mid cingulum 
FA ROI C 
Left 
1 1 * 
13*Φ 
.08 
.15·* 
.07 
.01 
05 
Right 
01 
01 
01 
.09*· 
.07 
-.04 
06 
-> to posterior 
FA ROI D 
Left 
.11* 
15** 
07 
.09· · 
.09·· 
.04 
.03 
Right 
12** 
12* 
1 1 * * 
.13** 
.12** 
05 
06 
FA ROI E 
Left 
09** 
.08** 
.08 
.08 
.03 
- 0 1 
04 
Right 
10** 
10** 
08** 
08 
.03 
01 
.06 
parahippocampal 
FA ROI F 
Left 
-03 
-03 
-03 
-.01 
-.04 
-.03 
-05 
Right 
- 0 1 
-05 
03 
-04 
.02 
-04 
03 
Numbers represent regression coefficients (standardized betas), adjusted for age, sex, educational level, depressive symptoms, hippocampal volume, WML volume and the presence 
of lacunar infarcts *p<01, **p<05 After Bonferonni correction· tp< 01, tp< 05 'Compound scores 
Table 6 Relation between the MD values of the six ROIs m the left and right cmgulum and verbal memory performance and cognitive 
performance in participants with a good hippocampal quality (n= 338) 
Good hippocampal quality 
Overall memory performance1 
Immediate memory 
Delayed recall 
Delayed recognition 
Pasychomotor speed1 
Visuospatial memory1 
MMSE 
MD ROI A 
Left 
-03 
-04 
- 0 1 
-09 
-06 
06 
-03 
Right 
06 
06 
06 
01 
-07 
04 
07 
to anterior <-
MD ROI Β 
Left 
-02 
-03 
- 0 1 
05 
-02 
07 
01 
Right 
- 0 1 
- 0 1 
- 0 1 
01 
-03 
06 
06 
mid ein igulum 
MD ROI C 
Left 
- 1 3 · * 
- 1 2 · · 
- 1 3 · * 
- 2 1 * t 
-06 
02 
- 1 1 
Right 
-03 
-02 
-04 
-05 
-03 
-06 
01 
-> to posterior 
MD ROI D 
Left 
-10 
- 1 1 * * 
-07 
-05 
-07 
03 
01 
Right 
-03 
02 
-03 
-04 
-07 
-05 
01 
MD ROI E 
Left 
-16*Φ 
- 1 4 * 
-16*Φ 
16** 
-08 
-05 
-09 
Right 
08 
-10 
-05 
-07 
- 1 1 * · 
- 0 1 
-04 
parahippocampal 
MD ROI F 
Left 
03 
01 
-06 
-05 
03 
-03 
-07 
Right 
05 
-05 
-03 
- 0 1 
-05 
-02 
-04 
Numbers represent regression coefficients (standardized betas), adjusted for age, sex, educational level, depressive symptoms, hippocampal volume, WML volume and the presence 
of lacunar infarcts *p< 01, **p< 05 After Bonferonni correction +p< 01, Φρ< 05 'Compound scores 
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Discussion 
Our results show that the microstructural integrity of the mid and posterior cingulum, as 
assessed by DTI, is related to verbal memory performance, especially to delayed recall and 
delayed recognition, independent of hippocampal volume and coexisting SVD Furthermore 
we found that this relation was most outspoken in participants with intact hippocampal 
structural integrity compared to those with a poor integrity 
To the best of our knowledge this is the first study investigating the relation between the 
microstructural integrity of the cingulum and verbal memory function in a large group 
of non-demented, independently living elderly with cerebral SVD Our data show that 
the microstructural integrity of the cingulum beyond the detection limit of conventional 
MRI is related to episodic memory formation On conventional MRI only less than 5% of 
the ROIs in the cingulum of our study population, showed the presence of visible WML, 
strengthening our assumption that we indeed investigated the earliest structural changes 
in the cingulum bundle integrity This finding is in line with the results of previous studies m 
patients with mild cognitive impairment (MCI) or dementia showing that loss of structural 
integrity of the cingulum is associated to impaired verbal memory performance910162152 
Furthermore we found this relation in people with an intact hippocampal volume and with 
the highest hippocampal microstructural integrity There is still much debate whether, 
in general, WM pathology is related to, or independent of, GM pathology There are two 
mam hypotheses, one suggesting that microstructural WM changes occur as a result of 
Wallenan degeneration", meaning that WM pathology is preceded by GM pathology In 
contrast, the retrogenesis theory proposes that loss of WM integrity is the result of myelin 
breakdown that occurs in the reverse order to myelogenesis 5''55 Our results suggest that 
loss of microstructural integrity of the white matter starts m the cingulum m respect to 
verbal memory, before micro- and marcostructural changes m the hippocampus occur, and 
possibly provide some evidence for the last mentioned hypothesis 
We found almost no significant relation between verbal memory performance and cingulum 
integrity m participants with a poor hippocampal quality A possible explanation might be 
that by the time both the microstructural integrity as well as the volume of the hippocampus 
is impaired, these changes in the hippocampus are more prominently related to verbal 
memory than the microstructural changes m the cingulum, even m our sample of participants 
with a relatively good hippocampal quality A recent study56 showed that microstructural 
integrity of the hippocampus is strongly related to verbal memory performance m older 
people, also m participants with an intact appearing hippocampus 
We found that the microstructural integrity of the mid and, especially, the posterior part of 
the cingulum is related to impaired verbal memory, probably suggesting that loss of structural 
integrity starts in these parts, and maybe further spreading to the parahippocampal parts 
with progression of verbal memory impairment and ultimately dementia Our results further 
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indicate that the structural integrity of the anterior cmgulum is not related to episodic 
memory Only a few other studies have assessed ROIs at different locations in the cmgulum 
in MCI and AD patients i925"05257 Most of them found that loss of microstructural integrity 
of the cmgulum begins near medial temporal structures, which is in line with our findings 
One study also reported FA reduction m the mid cmgulum in AD patients58 and one study 
reported FA reduction m the anterior cmgulum m MCI and AD patients " However these 
studies were underpowered and their study populations differ m disease severity compared 
to our study, therefore future studies are needed to describe the possible spread over time 
of the pathological process throughout the cmgulum A follow-up of the RUN DMC study is 
already being executed, to further investigate this 
Our findings show that cmgulum integrity is specifically related to verbal episodic memory 
We only found weak or no relations between cmgulum integrity and psychomotor speed, 
visuospatial memory and MMSE Although a recent study did find associations between 
(posterior) cmgulum integrity and attention/executive functioning and visuospatial 
memory,16 this discrepancy may be due to the limited additional adjustments performed 
m the latter study Furthermore their study population differed from ours Of their 220 
participants, 149 had MCI, while our study population had a mean MMSE of 28 1 As a result 
it is likely that more damage to the structural integrity of the cmgulum and MTL structures 
like the hippocampus has occurred m that study population The reason for not finding a 
relation between DTI parameters and visuospatial memory in our study, may be due to the 
fact that memory performance based on the Rey's Complex Figure Test may in part relay 
on motor learning, and as such, cannot be regarded as a pure measure of spatial memory 
as part of episodic memory, which as a result may be less dependent of the hippocampal 
memory circuit While it has been suggested that the medial temporal lobe also mediates 
executive functioning,59 the prefrontal lobes are predominantly involved m executive 
functioning,60 in agreement with our present lack of correlation between cmgulum integrity 
and executive function 
The MD, which reflects the magnitude of the diffusion of water, within the ROIs in the 
cmgulum was found to be more strongly related to verbal memory performance than the 
FA, a measure reflecting the dominant directionality of the diffusion of water This finding 
is in line with a recent study showing that MD is more sensitive than FA m detecting 
differences between AD and control participants 61 This might be due to the different 
underlying pathophysiology that both parameters (MD and FA) reflect Hypothetically it has 
been suggested that WM degeneration starts with demyelmation of axons, resulting m an 
increase of water diffusion in all directions (increased MD) Presumably, at this early stage 
the dominant diffusion direction remains unchanged as will the FA 21 We would expect that 
progression of white matter degeneration of the cmgulum bundle leads to disruption of 
axons, resulting in changes m MD as well as FA With respect to lateralization effects, our 
study showed that the strongest relation to verbal memory was found m the angular ROIs 
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C, D and E in the left hemisphere, as would be expected for a verbal task. 
Still, a few methodological considerations need to be addressed. Although our data are 
derived from the largest DTI study on the cingulum thus far, our study design is cross-
sectional, which prevents us from drawing conclusions with respect to causality. Follow-
up of this cohort has already been planned in 2011 to further investigate microstructural 
changes in cingulum integrity in relation with macrostructural changes in the cingulum 
and medial temporal lobe structures and in the development of cognitive decline and 
dementia.27 Furthermore, we used an atlas to identify the cingulum bundle, and manually 
placed the ROIs in order to avoid GM and WM of other tracts to blur our DTI measures. 
Although the placement of the atlas was visually checked and the placement of the ROIs 
was performed by an experienced neurologist, blinded to clinical data, this method can be 
somewhat subjective and make interpretation between studies difficult. 
A major strength of our study is the fact that it is a large, single-centre study with a response 
rate of over 70%. All MRI data were acquired on a single scanner in a similar way, and the 
hippocampus and WML were assessed volumetrically in a reliable, sensitive and objective 
way by two trained experts, who were blinded to all clinical data. Furthermore, extensive 
adjustments were made for possible confounders, such as educational level, depressive 
symptoms (a well known confounder in cognitive performance in elderly with SVD),51 
hippocampal volume, WML volume and lacunar infarcts. Moreover, cognitive function was 
assessed by only two investigators using a standardized cognitive battery. 
In conclusion, this study demonstrates that microstructural integrity of the mid and 
posterior cingulum is related to episodic memory function, notably verbal memory, in 
elderly with SVD, and this is especially true for participants with an intact hippocampal 
structural integrity. Consequently, our findings show that DTI is a sensitive diagnostic tool 
to detect early microstructural changes in the cingulum before macrostructural changes 
in the cingulum and hippocampus can be detected on conventional MRI. Future studies 
should prospectively investigate the predictive value of DTI parameters of the cingulum in 
relation to cognitive decline and incident dementia, even before macrostructural changes 
of both the cingulum and medial temporal lobe can be detected. If the predictive value is 
proven, DTI of the cingulum could possibly be a surrogate marker for future development of 
cognitive decline and dementia and could be a starting point for therapeutic trials aiming to 
prevent disease progression. 
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Chapter 10 
Loss of white matter integrity is associated with 
cognitive performance: A Tract-Based-Spatial-
Statistics study 
Submitted as: 
van Norden AGW, Tuladhar AM, de Laat KF, Morris DG, Zwiers MP, van Dijk EJ, de Leeuw F-E. 
Loss of white matter integrity is associated with cognitive disturbances in elderly with small 
vessel disease. 
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Abstract 
Cerebral small vessel disease (SVD), including white matter lesions (WML) and lacunar 
infarcts bleeds (MB), is common in elderly people and related to cognitive impairment and 
dementia. Possibly cognitive impairment is caused by disruption of white matter tracts 
that connect regions involved in cognitive functions. Pathological and imaging studies have 
shown abnormalities in the white matter that appear normal on conventional MRI. The 
loss of microstructural integrity in the normal appearing white matter (NAWM) may play 
a role in the cause of cognitive disturbances. As conventional MRI is not sensitive for the 
microstructural integrity of both the WML and the NAWM, we used tract-based spatial 
statistics (TBSS) to assess the relation between the white matter integrity and cognitive 
function. 
The RUN DMC study is a prospective cohort study among 503 independently living, non-
demented elderly with cerebral SVD aged between 50 and 85 years. All subjects underwent 
MRI and DTI scanning and an extensive neuropsychological assessment. 
Loss of white matter integrity, as indicated by a lower fractional anisotropy and higher 
mean diffusivity was related to cognitive performance. This relation was found in numerous 
regions mostly in the NAWM. The microstructural integrity in the genu and splenium 
showed the highest significant relation with general cognitive function, in the cingulum 
bundle with verbal memory performance and in the frontal white matter with psychomotor 
speed. Associations between DTI parameters and most cognitive domains remained present 
after adjustment for SVD visible on conventional MRI. In conclusion, our study showed that 
cognitive disturbances in elderly with cerebral SVD are attributable to loss of microstructural 
integrity of multiple white matter fibers connecting different cortical and subcortical 
regions. DTI could be of added value to conventional MRI parameters in investigating the 
pathophysiology of cognitive impairment in cerebral SVD. 
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Introduction 
Cerebral small vessel disease (SVD) includes white matter lesions (WML ) and lacunar infarcts 
and is very common in the elderly population. Both hospital - and population based studies 
have shown that SVD is related to cognitive impairment, and in some may ultimately lead to 
dementia.12 This is supposedly due to the disruption of the white matter tracts. Despite the 
high prevalence of WML and lacunar infarcts in the population over 60 years of age (90% 
and 20% respectively),34 relatively few develop evident cognitive decline or dementia.2 
Other factors apart from SVD related lesions on conventional MRI may determine the 
transition from intact cognitive performance to cognitive decline in some, while leaving the 
cognition unaffected in most. One of these factors could be the structural integrity of normal 
appearing white matter (NAWM) surrounding WML. It is important to realize that only a 
small proportion of the of the white matter (usually less than a few percent of its volume) 
is visibly affected by SVD on FLAIR MR images, even in individuals with severe SVD. As 
conventional MRI is not sensitive to loss of microstructural integrity in the NAWM, possible 
changes in this largest part of the white matter cannot be assessed. Pathological studies 
have demonstrated that abnormalities in this part of the white matter may, nevertheless, 
be present.5 
Diffusion tensor imaging (DTI) is a non-invasive MRI technique that provides valuable 
information on the microstructural organization of the white matter. By measuring the 
local water diffusion profiles, several common DTI-derived indices can be measured: the 
fractional anisotropy (FA), which represents a normalized ratio of diffusion directionality, 
the mean diffusivity (MD), which reflects the overall magnitude of water diffusion, axial 
diffusivity, which reflects the diffusivity parallel to the white matter tracts and radial 
diffusivity, which is the diffusivity perpendicular to these tracts.6 Loss of microstructural 
integrity is typically reflected by a reduction in FA and/or an increase in MD,7 which can 
result from different combinations of changes in axial and radial diffusivity. Investigating 
these four DTI measures conjointly provides more information about the possible changes 
of white matter microstructure than FA and MD alone. Studies showed that DTI can be used 
to assess the SVD-induced changes in the white matter and that areas with WML could have 
quite different characteristics on DTI.8 
A few studies in patients with cerebral SVD demonstrated a relation between DTI parameters 
and cognitive function, especially executive function.913 All of these studies had small sample 
sizes (n < 47), and did not or only limited adjust for possible confounders. A large population 
based cohort demonstrated a relation between microstructural integrity in both the WML 
and the NAWM and cognitive function." Most of these studies used either a region-of-
interest (ROI) approach or voxel-based morphometry (VBM)-style analysis. Both methods 
are prone to methodological constraints hindering analysis and interpretation of DTI data. 
Tract-based spatial statistics (TBSS) is a relatively new method that mitigates the limitations 
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of VBM analyses 15 Using TBSS, the analysis is restricted to those white matter voxels that 
constitute the skeleton (core) of the brains connectional architecture This skeleton can 
be matched more accurately (compared to whole-brain normalization) across subjects, 
enabling robust voxelwise analysis of the microstructural integrity of the white matter across 
subjects We hypothesized that cognitive disturbances in elderly with cerebral SVD would 
not only be related to loss of microstructural integrity of the white matter within the WML, 
but also of the NAWM We conducted TBSS to investigate the location of microstructural 
white matter loss related to cognitive disturbances In addition, we examined whether the 
associations in the white matter were primarily explained by SVD 
Methods 
Study population 
The Radboud University Nijmegen Diffusion tensor and Magnetic resonance imaging Cohort 
(RUN DMC) study prospectively investigates the risk factors and clinical consequences of 
brain changes among 503, 50-85 years old non-demented elderly with cerebral SVD The 
selection procedure of the participants and the study rationale and protocol were described 
previously in detail16 
In short, on the basis of established research criteria SVD was defined as the presence of 
lacunar infarcts and/or WML on neuroimagmg 17 Symptoms of SVD include acute symptoms, 
such as TIAs or lacunar syndromes, or subacute manifestations, such as cognitive, motor 
(gait) disturbances and/or depressive symptoms18 Accordingly, in 2006, consecutive 
patients referred to the Department of Neurology between October 2002 and November 
2006, were selected for participation Inclusion criteria were (a) age between 50 and 85 
years, (b) cerebral SVD on neuroimagmg (WML and/or lacunar infarcts) The main exclusion 
criteria were dementia, (psychiatric) disease interfering with cognitive testing or follow-up, 
WML or SVD mimics and MRI contraindications or known claustrophobia 
From 1,004 invited individuals by letter, 727 were eligible after contact by phone of whom 
525 agreed to participate In 22 individuals exclusion criteria were found during their visit 
to our research center, yielding a response of 71 3% (503/705) For the present study, 
63 subjects were additionally excluded because of territorial infarcts (n=55), inadequate 
quality of the MRI image (n=4) and four subjects because of incomplete data on cognitive 
test scores All participants signed an informed consent form The Medical Review Ethics 
Committee region Arnhem-Nijmegen approved the study 
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Measurement of cognitive function 
Cognitive function was assessed by a standardized neuropsychological test battery and has 
been described m detail elsewhere 16 Performance across tests was made comparable by 
transforming raw test results in z-scores We calculated compound scores for seven cognitive 
domains Global cognitive function was evaluated by the Mini Mental State Examination 
(MMSE) and the Cognitive Index The Cognitive Index is a compound score that was 
calculated as the mean of the z-scores of the 1-letter subtask of the Paper-Pencil Memory 
Scanning Task, the mean of the reading subtask of the Stroop test, the mean of the Symbol-
Digit Substitution Task and the mean of the added score on the three learning trials of the 
RAVLT and the delayed recall of this last test1 Verbal memory is a compound score of the 
mean of two z-scores from the Rey Auditory Verbal Learning Test, one for the added scores 
of the three learning trials of this test, and one for the delayed recall of this test Visuospatial 
memory is a compound score of the mean of the z-scores of the immediate recall trial and 
the delayed recall trial of the Rey's Complex Figure Test Psychomotor speed was calculated 
as the mean of the z-scores of the 1-letter subtask of the Paper-Pencil Memory Scanning 
Task, the reading subtask of the Stroop test and the Symbol-Digit Substitution Task 1 Fluency 
was calculated from the mean of the z-scores of both verbal fluency tasks Concept shifting 
was calculated as the z-score of the third subtask of the Stroop Attention is a compound 
score of the z-score of the total time of the Verbal Series Attention Test1 
Magnetic resonance imaging scanning protocol 
MRI scans of all participants were acquired on a single 1 5-T MRI The protocol included, 
among other sequences, the following whole brain scans 3D T l magnetization-prepared 
rapid gradient echo (MPRAGE) sequence (TR/TE/TI 2250/3 68/850ms, flip angleiss, voxel 
size 1 0x1 0x1 0mm), a fluid-attenuated inversion recovery (FLAIR) sequence (TR/TE/TI 
9000/84/2200ms, voxel size 1 0x1 2x5 0mm, mterslice gap 1 mm) and a DTI sequences (TR/ 
TE 10100/93ms, voxel size 2 5x2 5x2 5mm, 4 unweighted scans, 30 diffusion weighted scans 
with b-value 900s/mm2)16 
Conventional magnetic resonance imaging analysis 
WML were manually segmented on FLAIR images, and the number of lacunar infarcts 
was rated according to a standardized protocol16 All imaging analyses were performed by 
two trained raters blinded to clinical information In a random sample of 10%, interrater 
variability for total WML volume yielded an mtra-class correlation coefficient of 0 99, intra 
and mterrater reliability for the lacunar infarcts yielded a weighted kappa of 0 80 and 0 88 
We computed gray (GM) and white matter (WM) tissue and cerebrospinal fluid (CSF) 
probability maps using Statistical Parametric Mapping 5 unified segmentation routines on 
the T l MPRAGE images (SPM5, Wellcome Department of Cognitive Neurology, University 
College London, UK)19 Total GM, WM and CSF volumes were calculated by summing all 
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voxel volumes that had a p>.5 for belonging to that tissue class. Total brain volume (TBV) 
was taken as the sum of total GM and WM. Intracranial volume (ICV) was a summation of all 
tissue classes, i.e. total GM, total WM and CSF volume. To normalize for head size, TBV was 
expressed as percentage of total ICV. 
Diffusion tensor imaging analysis 
Diffusion data were first preprocessed to detect and correct head and cardiac motion 
artifacts, using an in-house developed iteratively re-weighted-least-squares algorithm 
named 'PATCH' (www.ru.nl/neuroimaEing/diffusion).20 Corrections of Eddy current and 
motion artifacts from affine misalignment are performed simultaneously by minimization of 
the residual diffusion tensor errors.21 Next, FA, MD, axial and radial diffusivity images were 
calculated using a DTIFit within the Functional MRI of the Brain diffusion toolbox, which 
were then fed into the TBSS pipeline.15 The thinning procedure was conducted on the mean 
FA image to create a common skeleton, which represents the core-structure of the white 
matter tract. Subsequently this skeleton was tresholded at FA-value 0.3 to include the major 
white matter tracts and to account for the inter-subject variability. All normalized FA data 
were then projected onto this skeleton. These skeleton projection factors were then applied 
to the mean, axial and radial diffusivity images. During the normalization procedures, 
the images were not modulated with the Jacobian of the spatial transformations (i.e. not 
corrected for the brain volume). These data were then fed into the voxel-wise cross-subject 
statistics. 
In addition, we obtained the mean FA, MD, axial and radial diffusivity for three parts of the 
corpus callosum by performing regions-of-interest analyses. We created the masks for genu, 
body and splenium of the corpus callosum by applying the white matter atlas (John Hopkins 
University white matter labels, provided by Functional MRI of the Brain Software Library 
(FSL)) on the mean FA skeleton. The masks were visually inspected and miscellaneous voxels 
that belonged to other regions, such as the cingulum bundle, were excluded. 
Other measurements 
Age, sex and level of education22, depressive symptoms and normalized TBV were 
considered possible confounders. Depressive symptoms were assessed using the Center of 
Epidemiologic Studies on Depression Scale (CES-D).23 Functional independence was assessed 
using the Barthel Index (range 0-20).24 For assessment of vascular risk factors, structured 
questionnaires were used together with measurements of blood pressure taken on separate 
occasions. The risk factors included presence of hypertension (mean blood pressure 
>140/90 mmHg and/or use of anti-hypertensive medications),25 diabetes (treatment with 
antidiabetic medications), hypercholesterolemia (treatment with lipid-lowermg drugs) and 
smoking status. 
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Statistical analysis 
Baseline characteristics were presented as mean ± standard deviation (SD) and for the 
skewed parameters the median and interquartile range were calculated. 
For the TBSS analyses, we assessed voxel-wise correlations between the skeletal DTI 
parameters (FA and MD) and cognitive performance on the several cognitive domains, 
while adjusting for age, sex, education, depressive symptoms and normalized TBV. To test 
whether these associations were attributable to SVD (i.e. WML and lacunar infarcts), we 
adjusted for SVD in a second model. For the voxel-wise statistical analyses, we applied 
permutation-based statistical interference tool for non-parametric approach as a part of 
the Functional MRI of the Brain Software Library, with number of permutation tests set to 
5000.15-26 Significant clusters were identified using the threshold -free cluster enhancement 
with a p-value < .05, corrected for multiple comparisons.27 In addition, we performed the 
same analysis with a threshold at ρ < .01. 
For the region-of- interest analyses, we computed regression coefficients of the mean FA, 
MD, axial and radial diffusivity of the three regions-of-interest in the corpus callosum (genu, 
body and splenium) with cognitive performance, while adjusting for age, sex, education, 
depressive symptoms and normalized TBV. Regression coefficients were presented as 
standardized ß-values. Bonferroni corrections were applied. 
Table 1 Baseline characteristics of the study population 
Characteristics η =440 
Demographics 
Age 
Male* 
Only primary education* 
MMSE 
CES-D scale 
Barthel Index 
Hypertension* 
Diabetes* 
Hypercholesterolemia* 
Smokers, current* 
Smokers, former* 
limaging 
TBV, ml 
ICV, ml 
WML volume, mit 
White matter volume, ml 
Lacunar infarcts* 
65 2 (8.9) 
239 (54 3) 
41 (9 3) 
28 2(1.6) 
11 1 (9.4) 
19.7(0 7) 
316(71.8) 
60(13 6) 
193 (43.9) 
66(15.0) 
240(54.5) 
1098 6 (119 0) 
1674 7 (157.4) 
6.5 (3 2; 17 9) 
466 8 (66.9) 
135 (30 7) 
Data represent Ν of subjects*(%), mean (SD), or mediant (interquartile range) 
MMSE Mini Mental State Exammahon, CES-D Center of Epidemiologic Studies on Depression, 
TBV total brain volume, ICV intracranial volume; WML white matter lesions 
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Results 
Demographic and neuroimaging characteristics are shown in Table 1. Mean age of the 
population (n=440) was 65.2 years (SD 8.9) and 54.3% were male. Mean WM volume was 
466.8ml (SD 66.9), the largest part of the WM consisted of NAWM, with a median percentage 
of 98.5 (IQR 96.0-99.2). 
Figure 1 shows the relation between the voxel-wise analysis of the FA and the cognitive 
domains tested (p<.05, corrected for multiple comparisons). FA in almost all regions was 
positively related to the cognitive index and verbal memory performance and negatively 
associated with psychomotor speed and concept shifting. 
Cognitive index 
A ^ η ν 
β * ; Λ ^ 
Verbal memory 
• ^ 
A r\ •ärJ 
Β χ~ Λ ο 
Visuospatial memory 
Λ ^  g ^ 
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Β H g 
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Β Ut & 
ft 
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».-,., 
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1 p<.001 
p<.05 
Figure 1 Voxel-wise analysis of the fractional anisotropy positively associated with cognitive 
index, verbal memory and visuospatial memory performance and negatively associated 
with psychomotor speed, concept shifting and attention. Adjusted for age, sex, education, 
depressive symptoms and normalized TBV (A) and additional adjustment for white matter 
lesions and lacunar infarcts (B). Thresholded at ρ < 0.05 and corrected for multiple 
comparisons. The statistical maps are superimposed onto the spatially normalized (Montreal 
Neurological Institute stereotactic space) and averaged (n=440) fractional anisotropy map 
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Figure 2 Voxel-wise analysis of the fractional anisotropy positively associated with cognitive 
index and verbal memory and negatively associated with psychomotor speed and concept 
shifting. Adjusted for age, sex, education, depressive symptoms and normalized TBV (A) and 
additional adjustment for white matter lesions and lacunar Infarcts (B). Thresholded at ρ < 
0.01 and corrected for multiple comparisons. The statistical maps are superimposed onto 
the spatially normalized (Montreal Neurological Institute stereotactic space) and averaged 
(n=440) fractional anisotropy map 
By contrast, fewer and less significant relations were found with visuospatial memory 
performance and attention. We found a similar distribution for the inverse association with 
MD and the cognitive domains, although for visuospatial memory no relations were found. 
With regard to MMSE and fluency, no significant associations were found with FA and MD. 
Additional adjustment for WML and lacunar infarcts (Figure IB) weakened the relations 
found between the FA and cognitive Index, verbal memory and concept shifting, however 
the associations remained present (p<.05). For psychomotor speed, the relation with FA 
of the body of the corpus callosum remained present after adjustment. With regard to 
visuospatial memory and attention, no associations were found after additional adjustment 
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for WML and lacunar infarcts We found no associations between MD and visuospatial 
memory, psychomotor speed, concept shifting and attention after additional adjustment for 
WML and lacunar infarcts 
Figure 2 shows the relation between the voxel-wise analysis of the FA and the cognitive 
domains thresholded at p< 01 (corrected for multiple comparisons) A high significant 
association was identified in almost all voxels of the skeleton in the relation between FA and 
cognitive index, psychomotor speed and concept shifting In verbal memory, these voxels 
with the highest significant association (p < 01) in the relation with FA were located in 
the corpus callosum along its complete course and the cmgulum bundle, the same was 
found for MD Additional adjustment for WML and lacunar infarcts (Figure 2B) showed 
the strongest significance for FA m relation to cognitive index, verbal memory and concept 
shifting remained located in the corpus callosum (p < 01) The voxels with the strongest 
significance (p < 001) in the relation between MD and psychomotor speed were located in 
the frontal lobe For the cognitive index they were located m the frontal lobe and the corpus 
callosum (data not shown) With a threshold at p< 01 we did not find significant relations for 
FA and MD and MMSE, visuospatial memory, fluency and attention 
We found that microstructural integrity of the genu and splemum of the corpus callosum 
related to cognitive index The microstructural integrity of the genu and body was 
associated with verbal memory, whereas the microstructural integrity of the splemum was 
related to visuospatial memory The DTI parameters m the genu and splemum are related 
to the executive domains, psychomotor speed and concept shifting We found no relations 
between microstructural integrity m the corpus callosum and attention, MMSE and fluency 
The associations with FA and MD and cognitive performance were mainly driven by changes 
in radial diffusivity, and not by changes m axial diffusivity 
Table 2 Association between the microstructural integrity of the corpus callosum and cognitive performance 
Cognitive Domains 
Microstructural integrity 
of the corpus callosum Cognitive index 
.14* 
-19* 
- 1 0 
-.22* 
.10 
-.11 
-.04 
-.17* 
.12* 
-.09 
-04 
- 1 7 * 
Verbal 
memory 
13 
-.19* 
-.11 
-.20* 
13* 
-.15* 
-.05 
-.19* 
.09 
-.09 
-.04 
-12 
Visuospatial 
memory 
.11 
-07 
-05 
-14 
07 
-01 
-09 
- 1 1 
.14* 
-.06 
- 0 8 
-.19* 
Psychomotor 
speed 
.16* 
-16* 
-04 
- 2 2 * 
07 
-.06 
- 0 1 
- 1 4 * 
14* 
-09 
-02 
- 2 1 * 
Concept 
shifting 
.14* 
- 1 3 * 
- 0 1 
-19* 
11 
-.07 
-.05 
-.16* 
.14* 
-.10 
-01 
-19* 
Attention 
09 
-.07 
- 0 1 
-.12 
08 
-09 
-02 
- 1 4 * 
.09 
-.08 
-01 
-.13* 
Genu 
fractional amsotropy 
mean diffusivity 
axial diffusivity 
radial diffusivity 
Body 
fractional amsotropy 
mean diffusivity 
axial diffusivity 
radial diffusivity 
Splenium 
fractional amsotropy 
mean diffusivity 
axial diffusivity 
radial diffusivity 
Standardized β values adjusted for age, sex, education, depressive symptoms and normalized TBV 
'Significant after Bonferroni correction p< 05 
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Discussion 
In this study we examined the relation between the microstructural integrity of the white 
matter and cognitive performance in subjects with cerebral SVD, using whole-bram TBSS 
analysis in an unbiased manner We demonstrated that a lower FA and a higher MD 
in multiple regions of the white matter skeleton were associated with a lower cognitive 
performance The corpus callosum showed the highest significant relation with cognitive 
function, especially m the genu and splemum The microstructural integrity in the cmgulum 
bundle showed the highest significant relation with verbal memory performance and in the 
frontal white matter with psychomotor speed 
Several issues should be addressed m this study First, a limitation is the cross-sectional nature 
of our study, which limits causal inferences The RUN DMC study has a longitudinal design 
and follow-up being executed to evaluate the effect of progression of SVD on (changes in) 
cognitive performance 16 Second, m moderate and severe stages of SVD, WML are diffusely 
distributed throughout the white matter, probably resulting in diffuse loss of microstructural 
integrity However, WML or microstructural loss in one region might be associated with those 
m other regions This prevents us from drawing conclusions about the importance of the 
microstructural integrity at a specific location in relation to cognitive disturbances Finally, 
WML and lacunar infarcts are widely accepted signs of SVD However, lacunar infarcts may 
also result from non-SVD related mechanisms, for example due to an embolism from the 
heart or proximal arteries2B We therefore cannot rule out that some lacunar infarcts have 
been misclassified as symptoms of SVD However, as the majority of lacunar infarcts is SVD 
related28 and all lacunar infarcts m our study were accompanied by some degree of WML, 
favoring an underlying SVD mechanism,29 we think that misclassification would be rather 
small and did not greatly influence our results 
Major strengths of the study included the large sample size, the single center design, the 
use of a single scanner and the high response rate Furthermore, we manually segmented 
the WML, the extensive assessment of cognitive function was performed by only two 
investigators and all analyses were extensively adjusted for potential confounders We 
intentionally did not adjust for vascular risk factors, such as hypertension or diabetes, as 
they were considered a part of the causal chain between SVD and cognitive performance 
The structural abnormality of the white matter tracts is a nondiscermble finding m 
neurodegenerative diseases, such as Alzheimers' disease and mild cognitive impairment30 33 
Also, age-related structural changes m the NAWM have been observed in a population based 
cohort, which were explained by the presence of white matter atrophy and WML34 and m a 
longitudinal study on 84 healthy adults, age-related DTI changes throughout the brain were 
demonstrated m a two-year follow-up assessed by TBSS 35 However, these studies did not 
investigate the relation with cognitive performance and so far, these studies have not yet 
been conducted m subjects with SVD related cognitive impairment using TBSS 
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In patients with SVD, clinical manifestations of cognitive impairment are usually of a 
characteristic and fairly homogeneous 'subcortical' pattern and include psychomotor 
slowing due to impaired executive function, deficits of attention, planning and set-shifting 
and forgetfulness 18 In our study, the white matters' structural integrity was associated with 
a lower performance on cognitive index, verbal memory, psychomotor speed and concept 
shifting We found no relations between microstructural integrity of the white matter and 
fluency and MMSE This might be explained by the fact that the MMSE is a too crude measure 
not designed for subcortical damage related function loss and hence not sensitive to detect 
subtle cognitive changes that correlate with macro- and microstructural SVD changes 
A strong significant relation between microstructural integrity and verbal memory 
performance was located m the cmgulum bundle This bundle, which connects the medial 
temporal lobe and the posterior cingulate cortex, is an important structure m verbal memory 
performance 36 DTI studies m patients with cognitive decline and dementia have shown loss 
of microstructural integrity of the cmgulum 37 Here, we demonstrated that this relation also 
occurs in SVD related early cognitive decline With regard to psychomotor speed, we found 
that a strong significant relation with microstructural integrity located in the frontal lobe 
The pre-frontal-subcortical circuits are known to be involved in executive function, which 
affects the psychomotor speed 18 The corpus callosum has been related to global cognitive 
status and, based on the topographical organization, the genu has been related to frontal-
lobe-mediated executive function and attention,38 whereas the splemum is associated with 
visuospatial construction 39 We demonstrated that global cognitive function (cognitive 
index) was associated with the microstructural of all three parts of the corpus callosum 
Verbal memory was associated with the anterior parts of the corpus callosum, whereas 
visuospatial memory was related to the splemum, corresponding with its connection with 
the parietal, temporal and occipital regions ',0 
The majority of the relations between microstructural integrity and cognitive performance 
were located m the NAWM, as this is 98 5% of the total white matter This suggests that the 
microstructural integrity of the NAWM has an important role in the cognitive disturbances 
in our subjects with SVD The presence of WML and lacunar infarcts weakened the relation 
between the microstructural integrity and cognitive performance This, together with the 
knowledge that the severity of damage in the NAWM is positively associated with the WML 
load,41 suggests that the damage to this NAWM might partially be SVD related Several 
explanations could therefore be proposed by which SVD may be related to the associations 
between microstructural integrity of the NAWM and cognitive performance First, it may be 
that these associations were, at least m part, explained by the coexisting WML, and not so 
much by the loss of integrity of the NAWM Second, the structural changes of the NAWM 
could be caused by direct additional damage to the NAWM m some, by the same risk factors 
that are involved m the development of SVD, such as hypertension "" This hypothesis is 
supported by the finding of increased blood-brain barrier permeability m the NAWM in 
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subjects with SVD '"' Finally, the observerd association between the microstructural integrity 
of the NAWM and cognitive performance could reflect indirect damage to the NAWM by 
distant effects of functionally the most severe WML by means of anterograde (Wallanan) or 
retrograde degeneration " ^ T h e pattern of a low FA, high MD , and a high radial diffusività 
and to a lesser extent axial diffusivity was related to impaired cognitive performance This 
pattern of change may provide some additional information on the underlying mechanisms 
of loss of white matter integrity in our study, as this pattern is believed to be mainly a result 
of myelin breakdown47 and axonal damage and atrophy7 resulting in an increase m extra-
axonal fluid and lower membrane density7 Both the direct effect of SVD and the chronic 
Wallenan degeneration can mirror this DTI pattern However, the exact (combination of) 
histopathological processes leading to changes in the diffusion tensor in humans and the 
interaction between these measures is still not fully understood 
Using TBSS we were able to assess the microstructural integrity of the whole-brain white 
matter in an unbiased manner Regions-of-mterest (ROI) analysis has the disadvantage of 
revealing only changes in the preselected regions that might not necessarily correspond 
to areas that are affected m cognitive impairment In addition, ROI analysis is an observer 
dependent analysis m which partial volume effect can confound the results by including 
different tissue types (GM and CSF), with a modest reliability and reproducibility 
Furthermore, TBSS analysis allowed us to identify regions with the strongest association with 
specific cognitive domains, that overcomes some limitations of voxel-based morphometry 
style analaysis, which is prone to residual misalignment and in which the results are 
affected by the amount of spatial smoothing 15 In addition, compared to ROI analyses , 
TBSS is sufficiently sensitive for detection of longitudinal regional microstructural integrity 
changes 35 This latter issue might be of importance during follow-up examination, which 
should identify whether changes m white matter integrity over time predict future cognitive 
decline and dementia 
In conclusion, our study showed that cognitive disturbances m elderly with cerebral SVD are 
attributable to loss of microstructural integrity of multiple white matter fibers connecting 
different cortical and subcortical regions Especially damage to the callosal fibers of the genu 
and the splemum, projecting to the prefrontal areas and parietal, temporal and occipital 
regions showed the highest significant relations with cognitive function The microstructural 
integrity in the cmgulum bundle showed to play an important role m verbal memory 
performance and m the frontal white matter with psychomotor speed DTI, by using 
TBSS, reveals functionally relevant damage to the white matter integrity which is related 
to cognitive disturbances, not detected by conventional MRI DTI could therefore serve as 
an additional tool to conventional MRI m order to investigate the cognitive consequences 
of cerebral SVD Future studies should prospectively investigate the predictive value of 
microstructural damage assessed by DTI for incident cognitive decline or dementia 
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Abstract 
Objective Diffusion tensor imaging (DTI), which measures the integrity of the white matter 
in both the white matter lesions (WML) and normal appearing white matter (NAWM), is an 
innovative imaging technique, that is suggested to be of added value m the explanation of 
cognitive dysfunction in cerebral small vessel disease (SVD) We investigated the value of DTI 
of NAWM and WML on top of conventional MRI parameters in the assessment of cognitive 
function in subjects with SVD 
Methods 499 individuals with SVD, 50-85 years, without dementia, underwent MRI scanning 
Grey (GM), white matter (WM), and WML volume, number of microbleeds, lacunar and 
territorial infracts, and mean diffusivity (MD) and fractional anisotropy (FA) in NAWM, WML 
and total WM were related to cognitive performance m multivariate regression analyses, 
after adjustment for age and sex 
Results All MRI parameters together accounted for 3-6% of the variance in cognitive 
function on top of 10-23% already explained by age and sex When considered separately, 
GM and WM volume, and MD of the NAWM had the strongest association with cognitive 
performance However, mean MD of the NAWM did not substantially contribute to the 
assessment of cognitive function, to that already explained by conventional MRI parameters 
Conclusion DTI of NAWM and WML has limited additional value to conventional MRI 
parameters in explaining variance in cognitive function among individuals with SVD 
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Introduction 
Conventional MRI plays an essential role in the diagnosis of cerebral small vessel disease 
(SVD), including white matter lesions (WML), lacunar infarcts and microbleeds Both 
hospital- and population based studies have shown that severe cerebral SVD is an important 
cause of cognitive impairment and may ultimately lead to dementia 13 Despite the high 
prevalence of SVD in the population over 60 years of age/6 only few individuals with SVD 
ultimately develop cognitive decline 
Apparently the SVD/WML m these patients differs from those without cognitive decline 
WML on conventional MRI merely reflect increased water content, and conventional MRI 
does not differentiate between mildly or more severely damaged areas while the latter 
results in (more outspoken) disruption of white matter tracts 7 Another potential factor that 
may contribute to the differential cognitive decline may be the integrity of the white matter 
surrounding the SVD SVD on conventional MRI usually affects only a few percent of the total 
white matter (WM),8 leaving the remainder of the normal appearing white matter (NAWM) 
unassessed 
Diffusion tensor imaging (DTI) has proven beneficial in assessing the microstructural integrity 
of both the WML and the NAWM 910 However, the relative importance of each of these MRI 
and DTI parameters m explaining the variance of cognitive performance in patients with 
SVD, and with that the value of DTI in clinical practice, is not clear It is unknown which 
(combination of) MRI parameter(s) explains most of the variance in cognitive function and 
to what extent the microstructural integrity of the WML and NAWM contributes to cognitive 
disturbances, on top of the abnormalities already seen on conventional MRI 
We therefore investigated which (combination of) MRI parameter(s) accounted for the 
largest portion of variance m cognitive function Furthermore, we determined the additional 
variance m cognitive function explained by the microstructural integrity of the WML and the 
NAWM to that explained by SVD, and other brain lesions, including territorial infracts and 
grey and white matter volume, visible on conventional MRI 
Methods 
Study population 
The Radboud University Nijmegen Diffusion tensor and Magnetic resonance imaging Cohort 
(RUN DMC) study prospectively investigates the risk factors and clinical consequences of 
brain changes among 503, 50-85 years old non-demented elderly with cerebral SVD The 
selection procedure of the participants and the study rationale and protocol were described 
m detail previously " 
In short, on the basis of established research criteria SVD was defined as the presence of 
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lacunar infarcts and/or WML on neuroimagmg 12 Accordingly, m 2006, consecutive patients 
referred to the Department of Neurology between October 2002 and November 2006, 
were selected for participation Inclusion criteria were (a) age between 50 and 85 years, (b) 
cerebral SVD on neuroimagmg (WML and/or lacunar infarcts) The mam exclusion criteria 
were dementia, (psychiatric) disease interfering with cognitive testing or follow-up, WML or 
SVD mimics and MRI contraindications or known claustrophobia 
From 1,004 invited individuals by letter, 727 were eligible after contact by phone of whom 
525 agreed to participate In 22 individuals exclusion criteria were found during their visit 
to our research center, yielding a response of 71 3% (503/705) All participants signed 
informed consent The local Medical Review Ethics Committee approved the study For the 
present study four subjects were excluded because of MRI artifacts 
MRI scanning protocol 
Standardized Tl- and T2-weighted and gradient echo T2*-weighted sequences on a single 
1 5 Tesla scanner, were acquired as earlier described u The scanning protocol included 
whole brain 3D T l magnetization-prepared rapid gradient-echo (MPRAGE) sequence, FLAIR 
pulse sequences, transversal T2* weighted gradient echo sequence and a DTI sequence 
Conventional MRI analysis 
WML were manually segmented, and the number of lacunar infarcts, territorial infarcts 
(diameter >15mm in known arterial territories) and microbleeds rated according to a 
standardized protocol Grey (GM) and white matter (WM) and cerebrospinal fluid (CSF) 
probability maps were obtained by automated segmentation using Statistical Parametric 
Mapping 5 unified segmentation routines on the T l MPRAGE images (SPM5, Wellcome 
Department of Cognitive Neurology, University College London, UK)13 Total GM, WM and 
CSF volumes were calculated by summing all voxel volumes that had a p>0 5 for belonging 
to the tissue class Total brain volume (TBV) was taken as the sum of total GM and WM 
Intracranial volume (ICV) was a summation of all tissue classes, ι e total GM, total WM 
and CSF volume To normalize for head size, TBV was expressed as percentage of total ICV 
Mutual information coregistration (SPM5) was used to align WML maps to the T l image and 
to yield a NAWM map (the complement of WML in WM) 
Measurement of DTI parameters 
The diffusion weighted images of each subject were realigned on the unweighted image 
using mutual information based co-registration routines from SPM5 Then, the diffusion 
tensor and its eigenvalues were computed using an SPM5 add-on (http //sourceforge net/ 
projects/spmtools) Unphysical spurious negative eigenvalues of the diffusion tensor were 
set to zero, after which the tensor derivatives the MD and FA were calculated 14 The mean 
unweighted image was used to compute the co-registration parameters to the anatomical 
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reference T l image (SPM5 mutual information co-registration), which were then applied 
to all diffusion weighted images and dérivâtes All images were visually checked for motion 
artifacts and co registration errors The mean MD and FA were then calculated m the WML, 
NAWM and total WM 
Measurement of cognitive function 
Cognitive function was assessed by a standardized neuropsychological test battery that has 
proven to be sensitive and suitable for this purpose m other, large epidemiological studies 
and has been described m detail elsewhere " In short, we calculated compound scores 
for seven cognitive domains; 1) Global cognitive function was evaluated by the la) Mini 
Mental State Examination (MMSE) and lb) the Cognitive Index The Cognitive Index is a 
compound score that was calculated as the mean of the z-scores of the 1-letter subtask of 
the Paper-Pencil Memory Scanning Task, the mean of the reading subtask of the Stroop test, 
the mean of the Symbol-Digit Substitution Task and the mean of the added score on the 
three learning trials of the RAVLT and the delayed recall of this last test1 2) Verbal memory 
is a compound score of the mean of two z-scores from the Rey auditory verbal learning test; 
one for the added scores of the three learning trials of this test, and one for the delayed 
recall of this test. 3) Visuospatial memory is a compound score of the mean of the z-scores 
of the immediate recall trial and the delayed recall trial of the Rey complex figure test 4) 
Psychomotor speed was calculated as the mean of the z-scores of the 1-letter subtask of the 
Paper-Pencil Memory Scanning Task, the reading subtask of the Stroop test and the Symbol-
Digit Substitution Task 1 5) Fluency was calculated from the mean of the z-scores of both 
verbal fluency tasks 6) Concept shifting was calculated as the z-score of the third subtask of 
the Stroop. 7) Attention is a compound score of the z-score of the total time of the verbal 
series attention test1 
Other measurements 
Level of education was assessed (classified using 7 categories; 1 being less than primary 
school and 7 reflecting an academic degree)15 Cardiovascular risk factors were assessed by 
structured questionnaires and an experienced research nurse measured blood pressure (3 
times in the supine position after 5 minutes of rest) Cardiovascular risk factors were defined, 
hypertension, as mean blood pressure > 140/90 mmHg and/or use of antihypertensive 
medications,16 diabetes as treatment with antidiabetic medications, hypercholesterolemia 
as treatment with lipid lowering medications and smoking as current, former or never 
smoker 
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Statistical analysis 
The baseline characteristics are presented as mean ± standard deviation (SD) and for the 
positively skewed WML volume distribution, the median and interquartile range were 
calculated WML volume distribution was normalized by log-transformation 
First, we used Pearson's correlations to assess the associations between age and MRI 
parameters, and their mutual correlations 
Second, to establish which MRI parameter (conventional MRI or DTI parameter) explained 
most of the variance in the different cognitive domains, we performed a multiple linear 
regression analysis (with age, sex and education included m every model), for each MRI 
parameter separately Territorial infarcts and brain atrophy were taken into account, because 
these abnormalities often co-exist with SVD-related MRI abnormalities and are related to 
cognition as well8 
Third, we assessed which combination of MRI parameters (MD and FA of both WML and 
NAWM, and all conventional MRI parameters which showed significant correlations when 
analyzed separately in step two accounted for the largest variance in cognitive performance 
For each cognitive domain, a multiple regression analysis was performed with the 
introduction of age, sex and education prior to the MRI parameters These MRI parameters 
were added in an automated (forward) stepwise fashion to optimize the model ht 
Finally, we assessed the increase of variance explained in cognitive performance by DTI on 
top of conventional MRI parameters m order to assess added value of DTI over conventional 
MRI We used a multiple linear regression model in which age, sex and level of education 
were introduced first, followed by all conventional MRI parameters (those that showed 
significant correlations when analyzed separately m step two), and subsequently the DTI 
parameters (MD of NAWM or WML or total WM) were added 
Collmeanty diagnostic procedures (tolerance statistics) did not reveal collmeanty between 
any of the MRI parameters m relation to cognitive performance 
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Table 1 characteristics of the study population 
Characteristics n=499 
Demographic and clinical characteristics 
Age, yrs. 
Male, no. 
Subjects with hypertension, no 
Subjects with diabetes, no 
Subjects with hypercholesterolemia, no 
Current smokers, no. 
Former smokers, no 
MMSE 
Subjects who finished primary school, no. 
65.6(8.8) 
282 (56.5) 
367(73.5) 
73(14.6) 
234 (46.9) 
75 (15.0) 
275 (55.1) 
28 1 (1 6) 
450 (90.2) 
Neuroimaging characteristics 
Grey matter volume, ml 
White matter volume, ml 
Intracranial volume, ml 
WML volume, mit 
NAWM volume, ml 
Subjects with microbleeds, no. 
Subjects with lacunar infarcts, no 
Subjects with territorial infarcts, no. 
Mean MD in NAWM * 10Λ-3 mm2/s 
Mean MD in WML * 10Λ-3 mm2/s 
Mean MD in total WM * 10Λ-3 mm2/s 
Mean FA in NAWM mm2/s 
Mean FA in WML mm2/s 
Mean FA in total WM mm2/s 
628 8 (67.0) 
464 4 (66.5) 
1676 3(156 3) 
7.1(3 4,18 1) 
450 3 (70.3) 
52(10 4) 
171 (34.3) 
58(116) 
0.89 (0 04) 
0 10 (0.67) 
0 89 (0 05) 
0.33 (0 02) 
0.34 (0.03) 
0 33 (0.02) 
Data represent numbers (%), mean (Standard deviation) or median t (interquartile range) 
WML white matter lesions, NAWM. normal appearing white matter, WM white matter, 
MD mean diffusivity, FA fractional amsotropy 
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Results 
Demographics and neuroimaging characteristics of 499 subjects are shown in Table 1, four 
subjects were excluded because of MRI artifacts. Mean age was 65.6 years (SD 8.8) and 
56.5% were male. Mean WM volume was 464.4 ml (SD 66.5), the largest part of the WM 
consisted of NAWM, with a median percentage of 98.5 (IQR 96.0-99.2). 
Table 2 represents the correlations between the distinct MRI parameters. Almost all MRI 
parameters were significantly correlated to each other, apart from some correlations with 
territorial infarcts and microbleeds. Mean FA and MD in the NAWM and total WM were 
almost similar for both the NAWM and total WM. Mean FA and MD of the WML, NAWM 
and total WM strongly correlated with WML volume (correlation coefficients for FA between 
-0.42 and -0.54, p<.001; for MD between 0.62 and 0.66, p<.001) and age. 
In table 3 we determined the amount of variance in cognitive performance explained by 
each MRI parameter separately, after adjustment for age, sex and education. Most of the 
MRI parameters were significantly associated with all cognitive domains, except for FA and 
MD in the WML, WM volume and territorial infarcts in relation to some cognitive domains. 
Mean MD in the NAWM and in the total WM explained most variance of the MMSE, cognitive 
index, verbal memory performance and attention. Additional to age, sex and education, it 
explained another 1.5-2.4% of the performance in the different cognitive domains, resulting 
in explained variance between 23% and 38% for the different cognitive domains. WM volume 
explained most of the variance, in psychomotor speed, followed by mean MD in the NAWM 
and total WM. In all cognitive domains, DTI parameters accounted for only slightly more 
variance in cognitive performance than the conventional SVD parameters (WML volume, 
number of lacunar infarcts and number of MB). 
Table 2 Pearson correlation coefficients for age and MRI parameters 
Age 
Grey matter volume 
White matter volume 
WMLvolumet 
Microbleeds, no 
Lacunar infarcts, no 
Territorial infarcts, no. 
NAWM, mean MD 
WML, mean MD 
Total WM, mean MD 
NAWM, mean FA 
WML, mean FA 
Total WM, mean FA 
Age 
-0 42** 
-0.44** 
0 48** 
0 13* 
0 2 1 * * 
0 11* 
0 66** 
0.56** 
0.66** 
-0 29** 
-0 30** 
0.29** 
tlog transformed*correlation is sigm 
WML. white matter lesions, NAWM· 
Grey 
matter 
volume 
0.65** 
-0 15** 
0.05 
-0 13* 
-0 05 
-0.39** 
-0.16** 
-0.38** 
0 33** 
0 17** 
0.33** 
White 
matter 
volume 
-0.13* 
-0 04 
-0 12* 
-0 12* 
-0.41** 
-0 19** 
-0 40** 
0.24** 
0.13* 
0.24** 
WMLt 
volume 
0.30** 
0.44** 
0 11* 
0.62** 
0 62** 
0 66** 
-0 54** 
-0.42** 
-0.54** 
Micro-
bleeds, 
no. 
0.32** 
-0 03 
0.32** 
0 36** 
0.35** 
-0 32** 
-0 29** 
-0.33** 
ficant at 2-tailed p< 05, **p< 001 
normal-appearing white matter, MD. mean diffusivity, 
Lacunar 
infarcts, 
no. 
0 12* 
0 42** 
0 42** 
0.45** 
-0.37** 
-0.34** 
-0 37** 
FA. fractional 
Terr 
infarcts, 
no. 
0.18** 
0.17** 
0.17** 
-0 02 
0 01 
-0 02 
anisotropy 
NAWM, 
mean 
MD 
0.78** 
100** 
-0.69** 
-0.52·* 
-0.69** 
WML, 
mean 
MD 
0.16** 
-0.51** 
-0.54*· 
-0.70** 
total 
WM, 
mean 
MD 
-0 70*· 
0.02 
0.67·· 
NAWM, 
mean 
FA 
0 58** 
1.00** 
WML, 
mean 
FA 
0.54** 
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Table 3 Value of each MRI parameter separately in the assessment of cognition 
MMSE Cognitive index Verbal memory 
S t e
'
>
 MRi t o t a ' e > < p ' ' Stand. total expl, Stand. total expl. Stand 
MRI parameter
 v a r i a n C e beta variance beta variance beta 
Psychomotor speed 
total expl. Stand 
variance beta 
Attention 
total expl. Stand 
variance beta 
age, sex, education 21.7 
Conventional MRI parameters 
35 7 24.3 35.0 27.9 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
GM volume, ml 
WM volume, ml 
WML volume, mit 
Microbleeds 
Lacunar infarcts 
Territorial infarcts 
DTI parameters 
NAWM, mean MD 
WML, mean MD 
WM, mean MD 
NAWM, mean FA 
WML, mean FA 
WM, mean FA 
22.6 
218 
22 9 
22 1 
23.1 
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23.1 
22.8 
23 2 
22.7 
22.3 
22.7 
0 12* 
0 05 
-0.13* 
-0.07 
-0.12* 
-0.03 
-0 16* 
-0 13* 
-0.17* 
0.11* 
0.08 
0.11* 
36.6 
36.8 
36.4 
37 3 
36.8 
36.5 
37.6 
37.1 
37 8 
37.0 
36.3 
37 0 
0 12* 
0 13* 
-0 10* 
-0.13** 
-0 11* 
-0 09* 
-019** 
-0 14* 
-0.19** 
0 13* 
0.09* 
0 13* 
24.7 
24 6 
24.4 
25.3 
24 9 
24 4 
25.7 
24.9 
25.7 
25 2 
24 6 
25 2 
0.07 
0 07 
-0 04 
-0 10* 
-0 08* 
-0.04 
-0 15* 
-0 09 
-0.15* 
0.10* 
0.06 
0.10* 
36.2 
37.6 
35 9 
36.7 
36 4 
37 0 
37.2 
37 1 
37.4 
36 5 
35.3 
36.5 
0 14* 
0 20** 
-0.11* 
-0.13** 
-0.12* 
-0.14** 
-0 20** 
-0.18** 
-0.20** 
0.13** 
0.05 
0.13** 
28.6 
28.7 
28.4 
29.5 
28.6 
27 9 
30.3 
30 2 
30.3 
28.6 
29.0 
28 9 
0 11* 
0 11* 
-0.09* 
-0.16** 
-0.09* 
-0.02 
-0 13** 
-0.12* 
-0 14** 
0.12* 
0 11* 
0.13* 
Age, sex and education were introduced in the model prior to one MRI parameter. Total explained variance (%) 
tlog transformed, *p<.05, **p< 001, GM grey matter, WM white matter, WML= white matter lesions, NAWM normal appearing white matter, WM· white matter, MD. mean 
diffusivity, FA fractional amsotropy. 
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Table 4 The value of a combination of MRI parameters in the degree of variance explained 
for the various cognitive domains 
Cognitive domain 
and step in model 
MRI parameters 
[independent variables remaining in 
model) 
Total explained 
variance (%) Stand, beta p-value 
MMSE 
1 
2 
Cognitive index 
1 
2 
3 
4 
5 
Verbal memory 
1 
2 
Psychomotor speed 
1 
2 
3 
4 
5 
Attention 
1 
2 
3 
Age, sex and education 
NAWM, mean MD 
Age, sex and education 
NAWM, mean MD 
Microbleeds, no 
White matter volume 
Territorial infarcts, no 
Age, sex and education 
NAWM, mean MD 
Age, sex and education 
White matter volume 
White matter lesionst 
Territorial infarcts, no 
Microbleeds, no. 
Age, sex and education 
NAWM, mean MD 
Microbleeds, no. 
21.7 
23.1 
24 3 
25 7 
-015 
-0.15 
0 003 
35.7 
37.6 
38.5 
39.3 
39 8 
-0.12 
-0.11 
0 11 
-0.08 
0.006 
0.023 
0.025 
0.046 
0 003 
35.0 
37 6 
39 9 
40.6 
4 1 4 
0 19 
-0.13 
-0.09 
-0 10 
<0 001 
0 004 
0 012 
0 012 
27 9 
30 3 
30 9 
-0.13 
0.11 
0 001 
0 028 
Age, sex and education were introduced in the model prior to MRI parameters MRI parameters (those significant in 
Table 3 and MD in the WML and NAWM and mean FA in WML and NAWM) were then added in a stepwise fashion Total 
explained variance and standardized beta-value describe the values till that step as variables are progressively added 
to the model NAWM normal appearing white matter, WML white matter lesions MD mean diffusivity, FA fractional 
amsotropy, +log transformed 
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Table 5 Contribution of DTI on top of conventional MRI parameters in the explained variance 
of the various cognitive domains 
Step in 
model 
MMSE 
1 
2 
3a 
3b 
3c 
Cognitive 
1 
2 
3a 
3b 
MRI parameter 
Age, sex and education 
Conventional MRI parameters 
NAWM, mean MD 
WML, mean MD 
Total WM, mean MD 
index 
Age, sex and education 
Conventional MRI parameters 
NAWM, mean MD 
WML, mean MD 
Total explained 
variance (%) 
21.7 
23.1 
23.5 
23.3 
23 6 
35 7 
38 7 
39 4 
39.0 
39.5 
24 3 
25 3 
26.3 
25 5 
26 3 
35.0 
39.2 
39.7 
39.4 
39 7 
27 9 
30.6 
31.2 
31.0 
31.2 
Standardized 
beta-value p-value 
3c Total WM, mean MD 
Verbal Memory 
1 Age, sex and education 
2 
3a 
3b 
3c 
Conventional MRI parameters 
NAWM, mean MD 
WML, mean MD 
Total WM, mean MD 
Psychomotor speed 
1 Age, sex and education 
2 
3a 
3b 
3c 
Attention 
1 
2 
3a 
3b 
3c 
Conventional MRI parameters 
NAWM, mean MD 
WML, mean MD 
Total WM, mean MD 
Age, sex and education 
Conventional MRI parameters 
NAWM, mean MD 
WML, mean MD 
Total WM, mean MD 
•0.11 
•0.07 
0 12 
0.097 
0.214 
0 076 
-0 13 
-0.08 
-0 15 
0.020 
0.150 
0 015 
•0 13 
•0 04 
•0 13 
0 017 
0.262 
0 018 
-0 11 
•0.10 
-0 12 
0 046 
0.065 
0 039 
•0.10 
•0 07 
•0 10 
0.047 
0.103 
0.042 
Age, sex and educahon were introduced in the model prior to conventional MRI parameters Conventional MRI 
parameters (those related to cognitive function m Table 3) were then added and subsequently the mean MD of the 
NAWM (3a) the WML (3b) or the total WM (3c) Total explained variance and standardized beta-value describe the 
values till that step as variables are progressively added to the model. NAWM normal appearing white matter, WML 
white matter lesions; WM white matter, MD mean diffusivity, tlog transformed 
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We furthermore determined which combination of MRI parameters best explained the 
variance in cognitive performance, after controlling for age, sex and level of education, which 
accounted for 21.7%-35.7% already (table 4). The mean MD of the NAWM explained most 
of the variance of the MMSE (1.4%), cognitive index (1.9%), verbal memory performance 
(1.4%), attention (2.4%) and visuospatial memory (0.7%; data not shown). WM volume 
was the most important determinant of psychomotor speed (2.6%) and concept shifting 
(2.2%; data not shown). GM volume explained most of the variance in fluency (1%; data 
not shown). The total explained variance of all MRI parameters (both conventional and DTI) 
together, on top of age, sex and education ranged from 1-6%. 
TableS shows the results of the added value of the mean MDof the NAWM, WML and total 
WM over conventional MRI parameters in terms of explained variance of cognitive function. 
Conventional MRI parameters accounted for another 1.0% to 4.2% over age, sex and level 
of education in the variance of all cognitive domains. A significant increase in variance, on 
top of conventional MRI measures, was explained by MD in the NAWM and total WM for 
the cognitive index, verbal memory performance, psychomotor speed and attention, but no 
more than 1.0 percent. This was not found for MMSE, visuospatial memory performance, 
fluency and concept shifting (for latter three data not shown). The MD in the WML did not 
explain an increase in variance in any of the cognitive domains. 
We performed the same analyses for FA in the NAWM, WML and total WM and all cognitive 
domains and found a similar amount of variance in cognitive domains explained by the 
mean FA. 
Discussion 
In this large cohort of individuals with cerebral SVD, all MRI parameters together explained 
1-6% additional variance in performance of the different cognitive domains to the 22-36% 
variance already explained by age, sex and level of education. Both the mean MD and FA of 
the NAWM, WML, and total WM did not substantially contribute to the variance explained 
of cognitive function, to that already explained by conventional MRI parameters. Conversely, 
when each MRI parameter (conventional and DTI) was investigated separately, the MD of 
the (NA)WM had the strongest association with most cognitive domains. 
Strengths of our study included the large sample size, the single centre design, with a 
high response rate, the extensive assessment of cognitive function and all participants 
examined by only two investigators. In addition, we performed all MRI scans (conventional 
and DTI sequences) on a single scanner, and with quantitative assessment of WML, GM 
and WM volume. Another strength is the manual segmentation of the WML without prior 
knowledge of the clinical data and the assessment of microbleeds as another manifestation 
of SVD. A limitation is the cross-sectional analysis of this part of the study, which prevents us 
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from drawing conclusions about the predictive value of DTI parameters in cognitive decline 
However, the RUN DMC study has a longitudinal design and follow-up is currently being 
executed 17 Second, cognitive function also is influenced by several factors for which we 
intentionally did not account in this study such as medial temporal lobe atrophy, as wanted 
to investigate the effect of SVD on cognitive function Finally, we investigated a rather 
healthy study population with a relatively intact cognitive function (mean MMSE 28 1, SD 
1 6) and most of them had mild to moderate white matter damage on Consequently the 
integrity of the NAWM m most participants will probably be relatively intact, limiting the 
statistical power to detect an additional effect of DTI parameters m the NAWM to that of 
conventional MRI parameters 
There might be several reasons why only a small part of the variance in cognitive function 
was accounted for by conventional MRI parameters for SVD (4%) and by the microstructural 
integrity of the (NA)WM (an additional 1%) Non-differential misclassification m both 
determinant and outcome could have played a role in the little contribution found In 
addition, other imaging parameters, as medial temporal lobe atrophy, and the presence of 
depressive symptoms might be other important factors in the variance of cognitive function 
m individuals with SVD, as both have been related to SVD and cognitive performance as 
well1819 Furthermore, it might be that age influenced the degree of variance explained 
Selective survival may have led to this due to a decreased susceptibility to the effect of 
SVD among survivors Moreover there is probably a selective non-participation of survivors 
with a higher degree of SVD and more cognitive disturbances Another explanation for the 
relative small contribution of SVD in the variance of cognitive performance may be due 
so called "competing risks" Competing risks occur in an aging population where multiple 
risk factors for one single disease are present, thereby limiting each individual (relative) 
contribution to the disease 
Our findings furthermore showed that GM and WM volume play an important role m the 
explained variance of psychomotor speed, fluency and concept shifting These findings are 
consistent with previous studies m SVD patients that have shown a relation between cognitive 
function and markers of cerebral atrophy,20 such as atrophy of the corpus callosum,21 gray 
matter volume and hippocampal volume 22 
Other cross-sectional studies investigated the value of DTI compared to conventional MRI 
m relation to cognitive function and found inconsistent results While some small studies 
among individuals with WML, showed that DTI parameters correlated stronger with 
cognition than conventional MRI parameters,2324 a diffusion weighted imaging study on 147 
CADASIL patients found brain atrophy to have a stronger independent influence on cognitive 
function than the mean apparent diffusion coefficient of the whole white matter25 However, 
it is difficult to compare our results with the results from these studies because of different 
study populations, the much larger sample size of our study, different methods in lesion 
quantification and different outcome measures In addition we took more conventional 
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MRI parameters into account, including brain atrophy, territorial infarcts, lacunar infarcts 
and microbleeds, which may have lead to the lower additional value of DTI parameters 
compared to other studies 
DTI parameters in the total WM and NAWM are highly correlated and explained the same 
amount of variance m cognitive performance This is probably due to the fact that the 
NAWM constitutes the largest part of the WM (median percentage of 98 5%) Damage to the 
structural integrity of the NAWM accounted for very little variance m cognitive performance 
m addition to the SVD related lesions visible on conventional MRI This might be explained 
by the fact that the cognitive tests used are not sensitive enough to detect these subtle 
changes m microstructural integrity Another explanation might be the high correlation 
between WML volume and the mean FA and MD of the NAWM which we found (table 2), 
which suggests that WML volume is a marker for the microstructural integrity of the NAWM, 
this is m Ime with findings m other studies 26 
Our results show that DTI does not seem necessary m clinical practice m order to understand 
cognitive impairment in patients with SVD However, despite the small contribution of 
DTI parameters m the variance of cognitive performance at the cross sectional level, DTI 
parameters may be of additional value m longitudinal studies and clinical trials m which 
there is interest m a surrogate marker for progression of cognitive disturbances and m the 
evaluation of potential therapeutic effects This is of great interest as the rate of cognitive 
decline is slow, neuropsychology is time consuming, expensive and of limited value in 
repeated testing due to learning effects, these limitations require very large samples and/ 
or long duration studies 27 A few longitudinal studies showed that DTI is sensitive to change 
over a short period of time and correlated with change m cognitive test scores, while this 
is not the case for conventional MRI markers 2 3 2 β 2 9 However, more longitudinal studies are 
needed to replicate these results with serial DTI analysis to establish the predictive value of 
DTI parameters m cognitive decline additional to conventional MRI parameters 
In conclusion, in clinical practice, DTI of the white matter (NAWM, WML or total WM) 
does not seem to be of added value to the conventional MRI parameters, in explaining 
the variance of cognitive impairment m subjects with SVD Future longitudinal studies are 
needed to demonstrate the sensitivity of both conventional MRI and DTI markers to changes 
in lesion load over time and their association with cognitive performance and to determine 
whether DTI measures of the (NA)WM or (a combination of) conventional MRI markers, 
such as WML volume, and atrophy could be a surrogate m therapeutic trials in SVD 
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On magnetic resonance imaging (MRI), cerebral small vessel disease (SVD) is characterized 
by white matter lesions (WML), lacunar infarcts and microbleeds (MB) Cerebral SVD is 
common m the elderly population, increases with age and is associated with vascular risk 
factors and is an important cause of cognitive decline and dementia However, individuals 
with a virtually identical SVD burden on conventional, routine T l and T2 images present 
with a wide variance m cognitive performance ranging from no complaints at all to overt 
dementia, independent of other factors as Alzheimer's disease pathology Other factors 
apart from SVD related lesions on conventional MRI may determine whether identical 
appearing SVD on routine imaging leads to cognitive decline m one person, while leaving 
others unaffected One of these factors could be the microstructural integrity of the white 
matter and the WML, as assessed with DTI 
In this thesis we describe the associations between different SVD related brain changes and 
cognitive performance with the use of a conventional MRI approach and a diffusion tensor 
imaging (DTI) approach 
In part I of the thesis we describe the rationale and design of the RUN DMC study, 
a prospective cohort study on the risk factors and cognitive, motor (gait) and mood 
consequences of functional and structural brain changes among 503 independently living, 
non-demented elderly, aged between 50 and 85 years, with cerebral SVD (chapter 3) 
A conventional MRI approach 
In part II we describe the associations between conventional MRI SVD parameters and 
cognitive performance WML were manually segmented and volumes were calculated and 
the number of lacunar infarcts and MB were rated All subjects had some degree of WML and 
lacunar infarcts were present m 31% Presence, number and location of MB were rated m 
the lobar (frontal, parietal, temporal, occipital), deep (basal ganglia and thalamus, the white 
matter of the corpus callosum, internal, external and extreme capsule), and mfratentonal 
(brainstem and cerebellum) regions Ten percent of the subjects had one or more MB 
Cognitive performance was assessed with an extensive neuropsychological test battery 
covering global cognitive function, verbal and visuospatial memory performance, executive 
function (e g psychomotor speed, verbal fluency and concept shifting) and attention The 
mean of the Mini Mental State Examination (MMSE) of our study population was 28 1 (SD 
1 6) In addition, subjective cognitive complaints were assessed with a semi-structured 
interview, 91% of the participants reported complaints in some degree 
MB have been related to cognitive impairment m elderly individuals, however this relation 
has predominantly been investigated m memory clinic patients, usually without taking 
location into account and without adjustment of coexisting SVD (ι e quantitative WML 
Summary and Discussion | 225 
volume and number of lacunar infarcts) We found that the presence, number and location 
of MB correlated with cognitive performance, independent of other manifestations of SVD 
(chapter 4) Furthermore MB were related to subjective cognitive, memory and executive 
complaints and were associated with progression of these failures over the past 5 years, 
especially m individuals with good objective cognitive function (chapter 5) Especially MB 
located in the frontal and temporal lobe were related to subjective cognitive complaints 
and cognitive performance In addition, lower hippocampal volumes have been related to 
subjective cognitive complaints however without taking into account the degree of SVD 
We described that lower hippocampal volume is related to subjective cognitive complaints 
independent of SVD and that this relation was strongest m those without objective cognitive 
impairment (chapter 6) 
A diffusion tensor imaging approach 
In part III we report on the associations between the microstructural integrity of the 
white matter and cognitive performance, assessed by DTI In chapter 7 we investigated 
the relation between the mean diffusivity (MD) and fractional anisotropy (FA) within the 
WML and the normal appearing white matter (NAWM) and cognitive performance We 
demonstrated that these DTI parameters m both the WML and NAWM correlate with 
cognitive performance, independent of SVD visible on conventional MRI These relations 
were most pronounced for subjects with severe WML As the hippocampus and cingulum 
bundle are important structures in verbal memory performance, we investigated the 
relation between hippocampal and angular microstructural integrity and verbal memory 
performance In chapter 8 we report on the relation we found between the microstructural 
integrity of the hippocampus and verbal memory performance, independent of SVD, these 
relations were most outspoken for subjects with a normal hippocampal volume In chapter 
9 we used a region of interest analysis to assess the microstructural integrity m six regions 
along the cingulum bundle The microstructural integrity of the mid and posterior cingulum 
was associated with verbal memory performance independent of hippocampal volume and 
integrity and SVD 
In chapter 10 we use Tract-Based Spatial Statistics (TBSS), a method restricted to the 
white matter voxels that constitute the skeleton of the brain's connectional architecture, 
and demonstrated that the tracts associated with cognitive performance are scattered 
throughout the white matter In addition, we showed that the strongest spatially localizing 
associations were found m the corpus callosum, predominantly the genu and splemum, 
the cingulum bundle for verbal memory performance and the frontal white matter for 
psychomotor speed The microstructural integrity of the corpus callosum is important in 
cognitive performance in all cognitive domains 
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Conventional MRI compared to diffusion tensor imaging 
In part IV of this thesis we investigated the additional variance in cognitive performance 
explained by DTI measures to that of SVD related lesions visible on conventional MRI. Our 
results described in part III of the thesis suggested that microstructural damage in the 
WML but also in the NAWM plays an important role in cognitive impairment. In chapter 
11 we describe that the structural integrity of the WML, NAWM and total WM accounted 
for very little additional explained variance (1%) in cognitive performance on top of co-
existing conventional MRI markers of SVD, e.g. WML and lacunar infarcts. Of note, the total 
explained variance of all cerebral MRI markers, apart from age, sex and education (which 
explained 36% of the variance in global cognitive performance), was about 4.2%, in which 
the MD in the (NA)WM played an important role. 
In conclusion, SVD related brain changes are associated with cognitive performance, 
although the cross-sectional relation is rather weak and microstructural integrity of the 
WM accounted for very little additional explained variance. However, considering the whole 
range of SVD features may better predict the clinical consequences. 
Conclusion 
The studies described in this thesis identified MRI markers that can serve as the basis 
for future research and help us to gain more insight in the pathophysiological processes 
underlying cognitive disturbances in cerebral SVD. 
Longitudinal examination is needed to assess whether these imaging markers indeed indicate 
early disease. The true impact of identifying those at risk will depend on the availability and 
effectiveness of preventive treatment for the disease. 
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Chapter 13 
General discussion and future perspectives 
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The overall objective of this thesis was to gain more insight in the role of brain changes due 
to cerebral small vessel disease (SVD) in cognitive impairment with the use of conventional 
MRI and diffusion tensor imaging (DTI). The studies described in this thesis are based on 
data from the RUN DMC study, a prospective cohort study on the risk factors and cognitive, 
motor (gait) and mood consequences of functional and structural brain changes among 503 
independently living, non-demented elderly with cerebral SVD, aged between 50 and 85 
years. In this chapter methodological considerations will be addressed, mam findings and 
potential clinical implications will be discussed, and finally suggestions for future research 
will be made. 
Methodological considerations 
Selection of the study population 
Studies described in thisthesis aimed at investigatingthe role of SVD in cognitive performance. 
As the onset of cerebral SVD is often insidious, clinically heterogeneous and typically with 
mild symptoms, patients with SVD are difficult to diagnose on the basis of clinical symptoms 
alone, making it rather inefficient to include them in studies only on clinical grounds as many 
individuals without SVD may have similar symptoms. Consequently, fairly large numbers of 
patients would then be needed in order to be able to include the number required. It has 
therefore been suggested that the selection of subjects with cerebral SVD should be based 
on the more consistent, generalizable features namely neuroimaging.1 We invited subjects 
to participate in the RUN DMC study based on SVD on neuroimaging. The selected age range 
of 50-85 years was chosen because prevalence of both determinant (SVD) and the outcome 
(cognitive performance) is high in this age range. The most important exclusion criteria were 
baseline dementia and psychiatric disease interfering with cognitive testing. 
Internal validity 
Validity is the most important issue when a study is judged on its methodological merits. 
Validity of results involves restricting systematic error or bias. Three general types of bias 
can be identified: selection bias, information bias and confounding. 
Selection bias results from a different association between the determinant (MRI and DTI 
parameters for SVD) and the outcome (cognitive performance) between participants and 
non-participants, who were potentially eligible for the study. The RUN DMC study had a high 
response rate of 71.3%. Non-participants compared to participants were older (response 
rate in subjects between 50 and 60 years was 82% compared to 56.5% in subjects aged 
between 70 and 85 years) and had more severe WML than participants, as assessed by the 
Age Related White Matter Changes scale.2 Since age and SVD predict cognitive performance 
and decline, older people with severe SVD and severe cognitive disturbances may have 
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refused to participate more often than those without or less cognitive disturbances We 
obviously could not collect data on cognitive function in these non-responders, however it is 
likely that we missed those with the highest degrees of SVD and highest degrees of cognitive 
disturbances This would have resulted m a less precise estimation of the strength of the 
relation between the most severe SVD and the most severe cognitive dysfunction 
Information bias results from measurement error of the determinant (different SVD 
parameters) that depends on the outcome (cognitive performance) or when assessment of 
the outcome is influenced by (the severity of) the determinant In our study the assessment 
of the determinants (WML, lacunar infarcts, microbleeds (MB) and DTI parameters) was 
performed independently and blinded for clinical information In addition, assessment of 
outcome (subjective cognitive complaints and objective cognitive function) was performed 
in the days before MRI scanning and therefore independent from the knowledge of the 
determinant, minimizing any observer bias Therefore it is very unlikely that misclassification 
would have been differential and hence would only have resulted m a random error Some 
measurement error may have occurred in the rating of the MB, as novel MRI techniques have 
improved the detection of MB detecting more MB in more patients 3This may have resulted 
in an underestimation of the actual number of MB in our population However, a recent 
study did not find stronger relations (or more variance explained) between cognition and 
MB detected with novel MRI techniques ' In addition, it is not clear whether this improved 
detection is linearly present across the whole range of MB, or if this predominantly plays 
a role in those with multiple MB, which probably would have resulted in a differential 
measurement error 
Confounding results from confusion of the determinant under study with that of an 
extraneous factor A confounder is associated with both the determinant and the outcome 
and is not an intermediate factor in the causal chain leading to the outcome variable under 
study In our studies we dealt with confounding by adjusting for potential confounders in 
multivariate regression models Adjusting for an intermediate factor would result m an 
underestimation of the effect of that factor 
The most important confounder in the relation between SVD and cognitive function is age, 
and potentially, gender, level of education, the presence of depressive symptoms and other 
neuroimagmg characteristics, such as territorial infarcts, brain- and hippocampal volume 
Because of the large number of subjects included in our study, we were able to control for 
these confounders We intentionally did not adjust for cardiovascular risk factors such as 
hypertension as they were considered to cause SVD and in that way they are an earlier part 
of the causal chain between SVD and cognitive performance 
The question is whether or not to adjust for SVD markers, visible on conventional MRI, 
when investigating the association between the microstructural integrity of both the WML 
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and NAWM and cognitive performance When we stratified these analysis on severity of 
WML, we found that especially in those with severe WML, damage to the microstructural 
integrity m the NAWM is related to impairment m cognitive function This suggests effect 
modification between the DTI parameters in the NAWM and WML volume in relation with 
cognitive function The question remains whether WML volume is also a confounder in this 
relation, a factor in the causal relationship or both It could be, that m almost none of the 
individuals with very mild WML the integrity of the NAWM is affected, and therefore the 
microstructural integrity of the NAWM in these individuals is not associated with cognitive 
performance In individuals with the highest severity of WML, the observed association 
between the microstructural integrity of the NAWM and cognitive performance could 
reflect, 1) direct additional damage to NAWM in some by the same risk factors that are 
involved m the development of severe WML, and 2) indirect damage to the NAWM by 
distant effects of functionally the most severe WML Both are biologically more plausible 
effects than WML inducing a spurious association between NAWM integrity and cognitive 
performance Therefore adjustment for WML volume m these analyses would probably 
result m over-adjustment 
Precision 
Precision reflects the amount of random error (non-differential misclassification) m a given 
measurement and thereby affects the reproducibility of that measurement We tried to 
increase overall precision m the RUN DMC study by having a large sample size (n=503) In the 
assessment of the determinant (different SVD parameters), all imaging data were collected 
with a single scanner, without adjustment m hardware or software during the study period, 
and most of the determinants were assessed quantitatively WML and hippocampal volumes 
were manually segmented and lacunar and territorial infarcts and MB were rated visually 
by two trained raters Both raters independently assessed 10 percent of all manual and 
visual assessments with high inter- and mtra-rater agreements Brain tissue segmentation 
and the analysis of the DTI data were fully automated, to prevent systematic error (such as 
co-registration errors) these data were visually checked 
Furthermore, the precision in measurement of the outcome (cognitive performance) 
was greatly enhanced by performing multiple neuropsychological tests, chosen because 
of their robustness m detecting age-related impairment and sensitivity to subcortical 
dysfunction 5 7 Tests were assessed m the same order, on the same time of the day, by the 
same two investigators Compound scores were constructed for eight cognitive domains 
taking the mean of several tests that were individually standardized to z-scores The tests 
within one compound score assess the same cognitive domain and act therefore as multiple 
measurement of the same variable, thereby reducing the mtra-mdividual variability and 
giving a better estimate of the true value per domain 
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External validity 
External validity involves the extent to which the results of the study can be generalized 
beyond the study population We included a large group of consecutive patients aged 
between 50 and 85 years with SVD who were referred to the Department of Neurology and 
who underwent neuroimagmg We initially selected patients based on the neuroimagmg 
characteristics of SVD and subsequently asked for acute or subacute clinical symptoms 
of SVD in order to fulfill established criteria for SVD 1 We think that our results can be 
generalized to patients with SVD in general hospitals and to community-dwelling population 
for several reasons First, although our participants were seen in an university hospital our 
results can be generalized to the general SVD population, as most of them were seen as a 
first opinion In addition, SVD is a common disorder m the elderly with a prevalence over 
90% in the general population over 60 years of age 8 We included, independently living, 
non-demented subjects with a mean Mini Mental State Examination of 28 1 (SD 1 6), which 
corresponds with the estimates m the general population,5910 a cogmtively rather healthy 
population, all with some degree of SVD on neuroimagmg Furthermore, the prevalence 
of vascular risk factors for SVD was very similar compared to community-dwelling cohorts 
with SVD We therefore think that our study has a reasonably high external validity for the 
general population aged between 50 and 85 years of age with SVD on neuroimagmg likely 
to be related to arterio(lo)sclerosis and vascular risk factors We do not think our results can 
be extended to individuals with other causes of SVD or to individuals with SVD at a much 
younger age 
Causal inference 
A precisely measured association between a factor and an outcome that is free of bias, 
does not imply that the observed association is a causal one There has been much 
debate on the criteria for causal inference, which has elaborated m a widely recognized 
set of inductively oriented causal criteria useful as a basis for inferring causality11 One of 
the most important criteria for establishing a causal relation is temporality Temporality 
refers to the necessity that the cause precedes the effect m time Our studies were based 
on cross-sectional data, limiting our abilities to establish a temporal relationship, leaving 
the probability that the proposed determinant is m fact the cause (inverse causality) 
This would be the case if cognitive decline induces lifestyle changes, which result m the 
development of SVD In addition, it could be possible that change in cognitive function is 
caused by another factor that also caused SVD, m that way SVD is an epiphenomenon and 
not a cause of cognitive impairment However based on prior data and our results, the 
last two hypotheses are much less likely than that SVD causes cognitive impairment The 
RUN DMC study has a longitudinal design, the 5 year follow-up of the study population 
has already started to evaluate the parenchymal changes over time, changes in cognitive 
performance, development of cognitive decline and incident dementia This prospective 
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nature with repeated measurements of both the determinant and the outcome will reduce 
the possibility of inverse relations 
General discussion of the main findings 
A conventional MRI approach (part II) 
We found that microbleeds (MB), which are another manifestation of SVD on conventional 
M RI, were related to cognitive performance and subjective cognitive complaints, independent 
of co-existing quantitatively assessed WML volume and lacunar infarcts and that location 
played a role m the association Our findings suggest that MB have a direct effect on cognitive 
performance rather than simply reflecting the presence of other markers of SVD First, this 
might be explained by the presence of MB representing subjects with the highest severity of 
SVD, as all our subjects some degree of WML, 31% of these subjects had lacunar infarcts and 
almost all subjects with MB (92%) also had lacunar infarcts Second, a dose-effect relation 
is suggested as m both studies there was a stronger relation between the number of MB, 
than the mere presence of MB with cognitive performance A third explanation might be 
the location of MB We demonstrated a relation between frontal and temporal located MB 
and subjective cognitive complaints and objective cognitive performance These are both 
important locations involved m executive function and memory performance Although the 
temporal lobe is not a predilection site for WML, we found a relation with temporal located 
MB and cognitive performance 12 In addition, a recent study found lobar MB significantly 
more often in the temporal lobe 13 Fourth, the underlying mechanisms of the association 
between MB and cognitive function are unknown Histopathologic studies have shown that 
the MB indicate widespread damage of arterioles by hypertension or by amyloid deposition, 
but also of damage to the white matter due to surrounding gliosis and frank necrosis or 
infarction, resulting m microstructural damage1415 Taken together, MB may represent 
additional disruption of white matter tracts important for cognitive function on top of the 
damage caused by WML and lacunar infarcts However, the imaging techniques used in 
these studies could not identify this microstructural damage in relation to the presence of 
MB 
Furthermore, we investigated the relation between the location of MB and cognitive 
performance It is suggested that the distribution of MB may reflect the underlying etiology 
of MB It might be that this location of MB also differentiates in the different underlying 
pathologies of concomitant WML and lacunar infarcts and in that way partly influence 
their relation with cognition, lobar MB are presumably attributable to cerebral amyloid 
angiopathy (CAA), whereas MB m the deep/mfratentorial regions are considered to 
represent hypertension related arteriosclerotic angiopathy1617 Together with the fact that 
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the temporal lobe is known to be more affected by CAA, the relation observed between the 
frontal and temporal located MB and lower cognitive performance is in agreement with the 
notion that CAA may be the underlying pathology This finding could be of importance as 
CAA is highly frequent among persons with Alzheimer's disease 18 Follow-up study may help 
to elucidate the potential relation between MB, CAA and the risk of Alzheimer's disease 
A diffusion tensor imaging approach (part III) 
The microstructural integrity of the normal appearing white matter (NAWM) and WML was 
related to cognitive performance on several cognitive domains In our study population 
WML volume highly correlated with DTI parameters m the NAWM, which ism line with other 
studies in which larger WML volumes correlated with a higher mean diffusivity (MD) and 
lower fractional amsotropy (FA) m the NAWM 19 WML on conventional MRI merely reflect 
increased water content, and conventional MRI does not differentiate between mildly and 
more severely damaged areas, while the latter results m (more outspoken) disruption of 
white matter tracts DTI reveals changes in the white matter that are imperceptible with 
conventional MRI These changes may precede lesions visible on conventional MRI and 
m that way DTI may be a sensitive tool to assess early white matter damage However, 
we found the strongest relations between microstructural integrity of the NAWM and 
cognitive performance m those with the highest degree of WML The used cognitive tests 
may not be sensitive enough to detect differences m cognitive performance associated 
with loss of microstructural integrity m those with mild WML On the other hand it might 
be that those with mild WML the integrity of the NAWM is affected and that changes m 
the NAWM m fact reflect late damage due to the presence of severe WML Severe WML 
may lead to axonal loss m areas (ι e NAWM) connected by axons that travel through 
these WML by anterograde (Wallanan) or retrograde neural degeneration, resulting in 
disconnection and cognitive dysfunction In addition it could be that SVD on conventional 
MRI and microstructural changes of the NAWM assessed by DTI share similar risk factors 
for SVD, such as hypertension 20 Furthermore, it may be that the relation between the 
microstructural integrity of the NAWM and cognitive performance is, at least in part, 
explained by the coexisting WML, and not so much by the loss of microstructural integrity 
of the NAWM Although the relation found for the NAWM was relatively weak, the observed 
relations between the microstructural integrity of the corpus callosum, cmgulum bundle and 
hippocampus with cognitive performance, all regions usually without WML on conventional 
MRI, do show the importance of loss of microstructural integrity in this part of the white 
matter m relation to cognitive disturbances m SVD 
In conclusion, all our findings suggest that SVD is a widespread disease throughout the 
whole brain, exceeding WML, lacunar infarct and MB visible on conventional MRI with 
loss of microstructural integrity m the NAWM These findings together with those from 
functional and pathological studies suggest a disruption of cortical-cortical and cortical-
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subcortical connections, and a subsequent 'disconnection-syndrome' accounting for the 
cognitive disturbances in SVD patients Although DTI does not add a lot to conventional MRI 
in explaining the variance of cognitive impairment in individuals with SVD, DTI is a promising 
tool in gaming more insight in the pathophysiological processes underlying cognitive 
disturbances in cerebral SVD assessing cerebral connectivity in vivo 
Cognitive function 
In patients with SVD, cognitive impairment is usually of a characteristic 'subcortical' 
pattern and include psychomotor slowing due to impaired executive function, deficits of 
attention, planning and set-shifting 21 In our studies an extensive neuropsychological test 
battery was used to assess objective cognitive function This encompasses items from other 
large scale epidemiological studies that cover virtually all cognitive domains and were 
chosen because of their robustness m detecting age-related impairment and sensitivity to 
subcortical dysfunction 57 We constructed compound scores which consisted of the mean 
of several tests that were individually standardized to z-scores 5 As measures of global 
cognitive function we used a combination of all tests56 as well as the widely used Mini 
Mental State Examination (MMSE)22 For both memory compound scores, verbal memory 
and visuospatial memory, we used the free recall capabilities, which are affected by cortical 
as well as subcortical dysfunction 23 We intentionally used only the most basic elements of 
the test parameters for the compound score of psychomotor function, as this enabled us 
to strictly assess the psychomotor speed that was intended to be measured The Stroop 
test consists of three subtasks of which we used the simplest, the reading task, in most 
analyses 24 The interference task, the more complex subtasks of the Stroop test, was used 
for the domain concept shifting, as it measures psychomotor speed, but also sensorimotor 
processes as stimulus encoding and response selection u 
There was no relation between the MMSE, a widely used bedside test, and the number of MB, 
whereas there was only a weak association with microstructural integrity measures of the 
white matter This might be because the MMSE is not sensitive to 'subcortical' (dys)function 
and merely reflects 'cortical' (dys)function In addition, in our rather healthy population 
(mean MMSE of 28 1 (SD 1 6, 24-30), the MMSE score might be a too robust measure to 
detect subtle cognitive changes, or the variance in the outcome measure (MMSE) might be 
too small, to detect correlations with MB of loss of microstructural integrity 
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Explained variance by cerebral small vessel disease 
We found an association between SVD markers on conventional MRI (ι e MB) and cognitive 
function, as well as a relation between loss of microstructural integrity, assessed by DTI, 
and cognitive function Although, only a small part of the variance in cognitive function 
was accounted for by SVD There may be several explanations for this First, in the elderly, 
neurodegenerative disease and cerebrovascular disease are both common and both entities 
often coexist Evidence is accumulating that the joint occurrence of these diseases is based 
not merely on chance, they share many identical vascular risk factors25 and brains of persons 
diagnosed with late-onset dementia often show a mixture of ischemic and typical Alzheimer's 
disease pathology at autopsy26 Although, we tried to adjust for neurodegenerative disease 
by normalized total brain or hippocampal volume, neurodegenerative disease could play a 
role in the relation with cognitive function m our study population In addition, lobar MB are 
associated with CAA,1617 and we found a relation between lobar MB and cognitive function 
Part of this relation with cognitive function could be explained by underlying CAA 
Second, age (sex and educational level) were considered to be confounding factors in all 
our analyses It might be that the strengths of the associations is influenced by age, as 
the presence and severity of SVD increases with age, and 90% of the general population 
over the age of 60 years has some degree of SVD8, m that way SVD may to some extent be 
regarded to as 'normal aging' Higher age is related to longer exposure to risk factors and 
their possible interactions Competing risks occur in an aging population where multiple 
risk factors for one single disease are present, thereby limiting each individual (relative) 
contribution to the disease In addition there could be a distortion of the effect of SVD 
on cognitive performance due to several reasons First, selective survival may play a role 
SVD is associated both with cognitive performance and mortality It may therefore be that 
only those who are not or differently vulnerable to the effect of SVD survive, and that the 
effect of SVD on cognition is different in these survivors Another potential source of bias 
is selection of participants, especially m the oldest category, in which response rate was 
lowest, as discussed earlier Non-responders were older and had more severe SVD and may 
have had more severe cognitive disturbances Finally, due to end-stage of disease effect, 
in patients with SVD, low blood pressure might be a risk for poor cerebral perfusion and 
in that way lead to cognitive impairment By adjusting for age in our analyses the role of 
SVD in relation to cognitive impairment could have been underestimated, due to decreased 
susceptibility to the effects of SVD and selective non-participation of survivors with severe 
SVD and severe cognitive impairment Third, it might be that the neuropsychological tests 
used are not sensitive enough to detect subtle changes m cognitive function that relate to 
SVD related lesions assessed with conventional MRI and DTI Greater variance m cognitive 
function during follow-up examination could result in a more outspoken relation between 
cognitive (dys)function and MRI and DTI parameters 
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Finally, another explanation could be the concept of brain and cognitive reserve, which 
postulates that the brain must undergo a certain amount of pathological change before the 
attendant clinical symptoms emerge The idea of the cognitive reserve theory posits that 
individuals with higher reserve are more able to cope with brain pathology, through some 
form of compensatory strategy, ι e by functioning on a previously higher cognitive level27 
Consequently, they may experience a longer subclinical cognitive deterioration, despite the 
presence of SVD Another explanation could be the presence of compensatory networks 
that may compensate for SVD based disruption of pre-existing networks This may obscure 
the relation between SVD burden and cognitive performance In younger individuals the 
presence of cognitive reserve could have underestimated the effect of SVD on cognitive 
performance, m older age adaptive and compensating mechanisms may fail and increase 
the susceptibility for disease 
Clinical relevance 
People with severe WML and silent lacunar brain infarcts on MRI have an increased risk of 
dementia, depression, stroke and death 28 32 By the time people are diagnosed with cognitive 
impairment and dementia, they already have irreversible brain damage Therefore the focus 
m brain research is gradually shifting to early detection of pathologic changes and possible 
prevention Studies like ours can identify early markers of disease which may help us to 
modify the risk of development or prevent progression of disease 
Our results suggest that subjective cognitive complaints reported by subjects with SVD 
should not be ignored as they are related to cerebral MB and hippocampal volume, even 
m those without objective cognitive impairment, and these complaints have shown to be 
related to the development of dementia years later33 ^ 
In addition to the identification of WML and lacunar infarcts on conventional T l and 12 
imaging, we showed that additional T2* imaging could be of interest in gaming more insight 
in the role of SVD m cognitive impairment as our results suggest that MB have a direct effect 
on cognitive performance rather than simply reflecting the presence of other markers of 
SVD Even more, because cerebral MB have been identified as potential imaging biomarkers 
of arteriosclerotic microangiopathy or CAA, and therefore might reflect different etiologies 
of both MB and WML 
In the clinical setting, additional DTI sequences seem not necessary, as it does not seem to 
be of added value to conventional MRI parameters, m explaining the variance of cognitive 
impairment in subjects with SVD However, we showed that loss of microstructural white 
matter integrity of the NAWM and WML, and also of the corpus callosum, cmgulum bundle 
and hippocampus has an impact on the cognitive performance m SVD This indicates that 
DTI promising tool m gaming more insight in the pathophysiological processes underlying 
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cognitive disturbances in cerebral SVD In addition DTI may provide surrogate markers to 
monitor treatment effects, as DTI parameters have shown to change over a short period of 
time, compared to conventional SVD parameters and were related to change in cognitive 
performance 35 
Identification of individuals at risk for cognitive decline and dementia becomes more and 
more important The imaging markers described m this thesis will not directly identify those 
at risk for disease However, the studies described m this thesis identified MRI markers 
that can serve as the basis for future research and help us to gam more insight in the 
pathophysiological processes underlying cognitive disturbances in cerebral SVD and m 
that way might open a way for intervention Longitudinal examination is needed to assess 
whether these imaging markers indeed indicate early disease Until now no randomized trial 
has specifically addressed the treatment of people with SVD to prevent dementia m late life 
The true impact of identifying those at risk will depend on the availability and effectiveness 
of preventive treatment for the disease 
Recommendations for future research 
Study design - prospective 
Dementia poses a major burden on individuals, caregivers and society Within our aging 
society research on possible modifiable risk factors for the development of dementia 
is therefore very important Cardiovascular risk factors may be one of these modifiable 
risk factors In this thesis we report on the mediating role of SVD m the relation between 
cardiovascular risk factors and cognitive function and showed that, next to WML and lacunar 
infarcts, MB and white matters' microstructural integrity are potential relevant biomarkers 
in the relation with cognitive function 
However, our findings need to be replicated m other cross-sectional studies, as the observed 
associations between MB and microstructural integrity of the white matter with cognitive 
function have been shown by others, although not or only sporadically in SVD populations 
Findings from our cross-sectional studies can be verified by relating progression changes 
to cognitive decline and the development of dementia in the follow-up of the RUN DMC 
participants If, using serial neuroimagmg assessment, change SVD severity can be related 
to change in cognitive performance and incident dementia it would greatly enhance the 
evidence for a causal relation The longitudinal part the RUN DMC study could also clarify 
whether subjects who report progression of subjective cognitive complaints are a high risk 
group for the development of cognitive dysfunction and dementia and more importantly 
whether this coincides with an increase of MB (and/or other manifestations of SVD) and 
decrease in hippocampal volume Of note, longitudinal studies on DTI in aging are rare, 
however a few longitudinal studies showed that change in DTI parameters could be detected 
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over a short period of time, and DTI parameters correlated with change in cognitive 
performance.35·36 In contrast there were no correlations with change in WML volume and 
cognition. Therefore it will be of great interest to analyze serial DTI scans for developing 
SVD pathology. In addition, it might be of special interest to investigate whether change in 
the microstructural integrity of the NAWM predicts/ is related to cognitive decline and the 
development of incident dementia in those with the highest degree of WML severity 
Furthermore, follow-up of the RUN DMC participants over time for the occurrence of 
new MB, cognitive decline and incident dementia may help to elucidate the potential link 
between lobar MB, the supposed underlying pathology CAA and the risk of Alzheimer's 
disease. 
Advances in MRI data analysis 
Visualization of white matter tracts and performing tract-based spatial statistics are 
promising methods investigating the neural pathways disrupted m cognitive disturbances. 
DTI tractography can also help to explore structural connectivity between brain regions, 
increasing our understanding of how SVD pathology in one region may affect the structural 
integrity within the other, connected, region and results in cognitive impairment.3738 With 
these techniques it might be able to gain evidence for the reserve theory and visualize 
compensatory networks. 
Study design - intervention 
Hypertension is recognized as one of the major risk factors for SVD, but evidence for the 
benefit of antihypertensive therapy on WML progression is still scarce.39 Ultimately, future 
studies should unravel whether adequate treatment of vascular risk factors in subjects 
with SVD may reduce the course of brain lesions, and subsequently reduce the number of 
patients who develop cognitive decline and dementia. Of note, a Cochrane review showed 
that blood pressure lowering in late life does not prevent the development of cognitive 
decline and dementia."0 However, one of the possible explanations for this unequivocal role 
of (treatment of) hypertension could be that the deleterious effects of vascular risk factors 
in general and hypertension specific already occurs decades before either cardiovascular or 
cognitive symptoms occur. By the time the risk factors result into disease, the damage is not 
remediable anymore. 
Future studies should try to include people early in mid-life (30-40 years), as this might be 
an effective strategy to detect people at risk for SVD and possibly cognitive decline relatively 
early in life, thus opening a way for prevention or reduction of severity. A major drawback of 
this option is that it will take a long time before the outcome under study occurs. 
A major question to be answered is whether and which proportion of subjects with SVD 
will eventually progress to dementia. As the rate of cognitive decline is slow, requiring large 
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samples and/or long lasting studies, neuropsychological testing is time consuming and 
learning effects reduce sensitivity, our study and other studies suggest that MRI markers 
of SVD could serve as surrogate markers for cognitive disturbances in future studies 
and therapeutic trials However, future studies are needed to evaluate which imaging 
parameter, WML volume, number of lacunar infarcts, increase in number of MB, change 
in DTI markers, or a combination thereof will be the best predictor of cognitive decline and 
incident dementia Probably it will not be one imaging marker alone, but a combination of 
this neuroimagmg with genetic risk factors and biochemical biomarkers 
In conclusion, SVD related brain changes, assessed by conventional MRI and DTI, are 
associated with cognitive performance, although the cross-sectional relation is rather weak 
and microstructural integrity of the NAWM accounted for very little additional explained 
variance, within this cohort of cognitive healthy elderly individuals However, considering 
the whole range of SVD features they may better predict the clinical consequences The 
studies described in this thesis identified MRI markers that can serve as the basis for future 
research and help us to gam more insight in the pathophysiological processes underlying 
cognitive disturbances in cerebral SVD 
Longitudinal examination is needed to assess whetherthese imaging markers indeed indicate 
early disease The true impact of identifying those at risk will depend on the availability and 
effectiveness of preventive treatment for the disease 
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Cognitief functioneren bij oudere mensen met cerebrale 
microangiopathie: een MRI-studie 
Beschadiging van kleine bloedvaten in de hersenen, ook wel cerebrale microangiopathie 
genoemd, wordt m het Engels 'cerebral small vessel disease (SVD)' genoemd Op een 
MRI (magnetic resonance imaging) scan van de hersenen wordt SVD gekenmerkt door 
wittestofafwijkingen, lacunaire herseninfarcten en microbloedingen SVD is geassocieerd 
met vasculaire risicofactoren, zoals hypertensie, en komt veel voor bij ouderen Meer dan 
90 procent van de ouderen heeft enige mate van SVD op de MRI-scan en de prevalentie 
neemt toe met het voortschrijden van de leeftijd Door die beschadigingen van de kleine 
bloedvaten kunnen stoornissen in de doorbloeding van de hersenen ontstaan, met als 
gevolg het beschadigen van wittestofbanen waardoor verbindingen tussen belangrijke 
hersengebieden verbroken worden. Als gevolg van onderbrekingen kunnen cognitieve 
stoornissen, cognitieve achteruitgang en dementie ontstaan Echter, mensen met 
dezelfde mate van SVD op conventionele MRI-beelden, (Tl en 12 gewogen), presteren 
zeer verschillend op cognitieve taken, variërend van normaal cognitief functioneren tot 
dementie Naast afwijkingen op een conventionele MRI die passen bij SVD, zijn er mogelijk 
andere factoren, naast de reeds bekende aan Alzheimer gerelateerde factoren, die bepalen 
waarom mensen met identieke afwijkingen op conventionele MRI beelden een grote 
variatie in cognitief functioneren vertonen. Uit pathologisch onderzoek komt naar voren 
dat alhoewel wittestofafwijkingen er op een conventionele MRI hetzelfde uitzien, deze toch 
behoorlijk kunnen verschillen m mate van beschadiging (microstructurele integriteit) van de 
wittestof. Het zou kunnen zijn dat de microstructurele integriteit van de wittestofafwijkingen 
juist bepaalt welke personen stoornissen krijgen m het cognitief functioneren Daarnaast 
zou de microstructurele integriteit van de wittestof die er normaal uitziet op conventionele 
MRI kunnen bijdragen aan de aanwezigheid van cognitieve stoornissen. De microstructurele 
integriteit van de wittestof kan gemeten worden met een nieuwe MRI-techmek genaamd 
'diffusion tensor imaging' (DTI). 
In dit proefschrift beschrijven we de associaties tussen veranderingen m de hersenen 
gerelateerd aan SVD en cognitief functioneren, m beeld gebracht met conventionele MRI-
en DTI-scans. 
In deel I van het proefschrift beschrijven we de gedachte achter en de opzet van de RUN 
DMC (Radboud University Nijmegen Diffusion tensor and Magnetic resonance imaging 
Cohort) studie; een prospectieve cohortstudie die de risicofactoren voor functionele en 
structurele veranderingen van de hersenen onderzoekt en de gevolgen daarvan op cognitie, 
lopen en stemming. Dit is onderzocht bij 503 onafhankelijk levende, met dementerende 
ouderen, tussen de 50 en 85 jaar, met tekenen van SVD op de MRI-scan van de hersenen 
Tijdens het eerste cross-sectionele onderzoek in 2006, waar dit proefschrift op is gebaseerd, 
had niemand dementie of parkmsonisme (hoofdstuk 3) 
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De relatie tussen 'small vessel disease' en cognitief functioneren: een 
conventionele MRI benadering 
In deel II van dit proefschrift beschrijven we de associaties tussen parameters van SVD 
zoals te zien op conventionele MRI-beelden en cognitief functioneren Wittestofafwijkmgen 
werden handmatig gesegmenteerd en de volumes werden berekend, daarnaast werd het 
aantal lacunaire infarcten en microbloedmgen geteld Alle deelnemers aan het onderzoek 
hadden enige mate van wittestofafwijkmgen en 31 procent van de deelnemers had lacunaire 
infarcten De aanwezigheid, het aantal en de locatie van de microbloedmgen werden geteld 
per kwab (frontaal, panetaal, temporaal en occipitaal), m diepe (basale kernen, thalamus 
en de wittestof van het corpus callosum en de capsula interna, externa en extrema), en 
mfratentoriele (hersenstam en cerebellum) regio's Tien procent van de deelnemers had 
een of meer microbloedmgen Het cognitief functioneren werd getest met behulp van een 
uitgebreid neuropsychologisch testprotocol, waarbij het globaal cognitief functioneren, 
het verbale en visuospatiele geheugen, het executief functioneren, met onder andere 
de psychomotore snelheid, en de aandacht werd getest De gemiddelde MMSE (Mini 
Mental State Examination) van onze studie populatie was 28 1 (SD 1 6) Daarnaast werden 
subjectieve geheugenklachten vastgelegd met behulp van een semigestructureerd interview, 
91 procent van de deelnemers meldden enige mate van subjectieve geheugenklachten 
Microbloedmgen werden m eerder onderzoek reeds gerelateerd aan cognitief 
falen bij ouderen, echter deze relatie werd met name onderzocht bij patiënten die 
geheugenpoliklmieken bezochten, waarbij met werd gekeken naar de locatie van de 
microbloedmgen en zonder correctie voor de aanwezigheid van andere kenmerken van SVD, 
zoals kwantitatieve volumes van de wittestofafwijkmgen en het aantal lacunaire infarcten 
WIJ stelden vast dat de aanwezigheid, het aantal en de locatie van microbloedmgen zijn 
gerelateerd aan cognitief functioneren, onafhankelijk van andere manifestaties van SVD 
(hoofdstuk 4) Tevens zijn microbloedmgen gerelateerd aan subjectieve cognitieve klachten 
en zijn ZIJ gerelateerd aan toename van deze klachten over de afgelopen vijf jaar Deze 
relatie was het meest duidelijk bij mensen met een goed objectief cognitief functioneren 
(hoofdstuk 5) Met name microbloedmgen m de frontale en temporale kwabben zijn 
gerelateerd aan subjectieve cognitieve klachten en cognitief functioneren 
Een kleiner hippocampusvolume werd reeds gerelateerd aan subjectieve cognitieve 
klachten, echter zonder dat werd bekeken m hoeverre SVD hieraan mogelijk bijdraagt WIJ 
stelden vast dat een kleiner hippocampusvolume is gerelateerd aan subjectieve cognitieve 
klachten, onafhankelijk van de aanwezigheid van SVD Deze relatie was het sterkst bij de 
deelnemers zonder objectief cognitief falen (hoofdstuk 6) 
250 (Chapter 14 
De relatie tussen 'small vessel disease' en cognitief functioneren: 
een DTI benadering 
In deel III van het proefschrift beschrijven we de relaties tussen de microstructurele integriteit 
van de wittestof en het cognitief functioneren, gemeten met DTI In hoofdstuk 7 hebben we 
de relatie onderzocht tussen de gemiddelde diffusiviteit (MD) en de fractionele anisotropie 
(FA) in de wittestofafwijkmgen en de normaal ogende wittestof en cognitief functioneren Uit 
de resultaten blijkt dat deze DTI-parameters m zowel de wittestofafwijkmgen als de normaal 
ogende wittestof correleerden met cognitief functioneren, onafhankelijk van beschadiging 
van de kleine bloedvaten zichtbaar op conventionele MRI Deze relaties waren het meest 
sterk m de groep mensen met de meest ernstige beschadigingen van de kleine bloedvaten 
Aangezien de hippocampus en het cmgulum belangrijke hersenstructuren zijn voor verbaal 
geheugen, hebben we deze structuren specifiek bekeken In hoofdstuk 8 beschrijven we de 
relatie tussen de microstructurele integriteit van de hippocampus en het verbaal geheugen, 
onafhankelijk van parameters voor SVD op conventionele MRI Deze relaties waren het 
meest sterk bij personen met een normaal hippocampusvolume In hoofdstuk 9 hebben 
we een 'region of mterest'-analyse gebruikt om de microstructurele integriteit te bepalen m 
zes regio's van het cmgulum De microstructurele integriteit van de mid- en het posterieure 
cmgulum was geassocieerd met verbaal geheugen onafhankelijk van het hippocampus 
volume en de hippocampus integriteit en onafhankelijk van SVD 
In hoofdstuk 10 hebben we gebruik gemaakt van 'Tract-Based Spatial Statistics' Dit 
is een methode die zich beperkt tot de wittestof-voxels die het skelet vormen van de 
verbmdmgsarchitectuur van de hersenen Uit onze analyses blijkt dat de banen die 
geassocieerd zijn met cognitief functioneren verspreid zijn door de gehele wittestof van 
de hersenen De sterkste relaties voor verbaal geheugen werden gevonden m het corpus 
callosum, met name de genu en het splemum, en het cmgulum en voor psychomotore 
snelheid m de frontale wittestof De microstructurele integriteit van het corpus callosum is 
belangrijk voor het functioneren op alle cognitieve domeinen 
Conventionele MRI in vergelijking met DTI 
In deel IV van het proefschrift beschrijven we of het maken van een DTI-scan naast een 
conventionele MRI-scan nuttig is om als clmicus beter m te kunnen schatten m hoeverre 
cognitieve stoornissen gerelateerd zijn aan eventuele beschadigingen m de hersenen De 
resultaten beschreven m deel III van dit proefschrift suggereren dat de microstructurele 
schade m de wittestofafwijkmgen, maar ook m de normaal ogende wittestof een rol speelt m 
het cognitief falen In hoofdstuk 11 beschrijven we dat de microstructurele integriteit van de 
wittestofafwijkmgen, de normaal ogende wittestof en de totale wittestof verantwoordelijk 
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zijn voor maar een zeer klem deel van de variantie m cognitief functioneren bovenop dat wat 
verklaard werd door de conventionele MRI-markers voor SVD, zoals wittestofafwijkingen, 
lacunaire infarcten en microbloedingen Daarnaast wilden we weten of een DTI-scan 
wetenschappelijk van aanvullende waarde kan zijn m bijvoorbeeld trials bij mensen met 
SVD Om dit te onderzoeken hebben we bekeken of de gemiddelde diffusiviteit van de 
totale wittestof een betere voorspeller is voor cognitief functioneren dan de afwijkingen 
op conventionele MRI-scans Leeftijd, geslacht en opleiding verklaarden tot 36 procent 
van het cognitief functioneren De gemiddelde diffusiviteit van de totale wittestof bij een 
aantal cognitieve taken verklaarde meer dan elk van de conventionele MRI-parameters 
apart, echter dit was maar maximaal 1 procent Bovendien werd slechts 4,2 procent van 
de variantie m cognitief functioneren verklaard door de conventionele MRI parameters 
(wittestofafwijkingen, lacunaire infarcten, microbloedingen, grijze- en wittestof volume) 
Concluderend kunnen we zeggen dat veranderingen van de hersenen gerelateerd aan SVD 
zijn geassocieerd met cognitief functioneren Echter de cross-sectionele relatie is vrij zwak 
en de microstructurele integriteit van de wittestof is verantwoordelijk voor maar een klem 
deel van de variantie m cognitief functioneren DTI-parameters lijken geen toegevoegde 
waarde te hebben bovenop conventionele MRI-parameters m relatie tot cognitie m de 
klinische praktijk Desalniettemin, de microstructurele integriteit van de totale wittestof is 
verantwoordelijk voor een kleine variante m cognitie Mogelijk zijn veranderingen m DTI 
parameters eerder en beter detecteerbaar dan veranderingen m conventionele MRI-maten 
DTI zou derhalve een goede marker voor verandering m tijd kunnen zijn en zou kunnen 
fungeren als een surrogaat uitkomstmaat m therapeutische trials bij mensen met SVD 
Conclusie 
In de studies beschreven m dit proefschrift hebben we MRI-markers gevonden die kunnen 
fungeren als basis voor toekomstig onderzoek en die ons kunnen helpen om meer inzicht 
te krijgen m de onderliggende pathofysiologische processen die achteruitgang m cognitie 
veroorzaken bij mensen met SVD 
Longitudinaal onderzoek is nodig om vast te stellen of deze markers op beeldvorming 
inderdaad tekenen zijn van een vroeg of laat stadium van de ziekte Het daadwerkelijke 
belang van het identificeren van mensen met een risico op het ontwikkelen van cognitief 
falen als gevolg van SVD wordt bepaald door de beschikbaarheid en effectiviteit van een 
preventieve behandeling 
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Dankwoord 
Allereerst wil ik de meer dan 500 deelnemers aan de RUN DMC studie heel hartelijk danken 
ZIJ hebben, door hun vrijwillige deelname aan een uitgebreid onderzoek op de polikliniek en 
m het MRI centrum, de studies beschreven m dit proefschrift mogelijk gemaakt en hebben 
ons m de jaren daarna gesteund met bemoedigende kaartjes 
Mijn bijzonder grote dank gaat uit naar mijn copromotoren Dr FE de Leeuw en Dr EJ van Dijk 
Frank-Erik, zonder jou geen proefschrift, met alleen vanwege je creatieve geest, kritische blik, 
en razendsnelle correcties, maar ook vanwege je persoonlijke begeleiding en interesse De 
afgelopen 8 jaar heb ik met enorm veel plezier met je samengewerkt, de wereld rondgereisd 
en heb je me geïntroduceerd m de vasculaire neurologie Al snel na mijn start m Nijmegen 
vroeg je me deel te nemen aan een mooi, nieuw, groot project, de RUN DMC studie 
Inmiddels vele publicaties, van meerdere promovendi, m hoog impact tijdschriften verder, 
ben ik erg trots op wat we bereikt hebben Ik bewonder je gedrevenheid, enthousiasme, 
ongekende toewijding, maar bovenal waardeer ik je als mens Dank voor alle mogelijkheden 
die je mij geboden hebt, ik kijk uit naar een nog lange samenwerking 
Ewoud, je was verbaasd dat je werd gevraagd als copromotor, en dat na al het werk dat je 
hebt gestoken in de laatste manuscripten, de zeer waardevolle discussies, en de aanvullingen 
en suggesties voor de introductie en discussie van dit proefschrift Je bent de perfecte 
tegenhanger van Frank-Erik Jullie vormen een geweldig team om mee samen te werken m 
zowel de wetenschap als de patiëntenzorg Veel dank voor alles1 
Prof dr BR Bloem, Bas, mijn promoter, en natuurlijk met alleen ceremonieel Dank voor je 
bijdrage aan de opzet van het onderzoek, je interesse m de vordering van het onderzoek en 
het proefschrift en je suggesties aan het eind van dit promotie traject Daarnaast waardeer 
ik het zeer dat je mij drie jaar geleden hebt gevraagd als lid van de hoofdredactieraad van 
het Tijdschrift voor Neurologie en Neurochirurgie Ook daar werk ik met veel plezier met je 
samen 
Prof dr GWAM Padberg, hartelijk dank voor de tijd en ruimte die ik tijdens mijn opleiding 
heb gekregen voor dit onderzoek U geeft met veel bevlogenheid en betrokkenheid leiding 
aan een mooie, professionele, inspirerende en ambitieuze afdeling Dank voor uw interesse 
en steun gedurende dit promotie traject 
Karlijn de Laat, mijn co-promovenda Lieve Karlijn, iedere deelnemer aan 'ons' onderzoek 
hebben we samen getest en gescand gedurende vele avond- en weekenduren Elk manuscript 
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hebben we samen geschreven Dit heeft geresulteerd m een erg gezellige en waardevolle 
samenwerking, waarbij we elkaar goed aanvullen, en bovenal een hele fijne vriendschap 
Erg speciaal is dat we nu ook samen 'ons' onderzoek en proefschrift verdedigen, dank voor 
het wachten 
Het Donders Centrum Prof dr D Norns, thank you for the opportunity to perform all MRI 
scans at the Donders Institute and your contributions to the manuscripts Dr MP Zwiers, 
Marcel, dank voor je bijdrage aan de bewerking en analyses van alle MRI scans, het oplossen 
van allerlei technische problemen en je waardevolle bijdrage aan de manuscripten En Paul 
Gaalman, je had er weinig vertrouwen in, meer dan 500 mensen scannen, dat zou toch nooit 
lukken, maar het is ons gelukt, mede dankzij jouw hulp en ondersteuning, dank1 
Alle mede-auteurs van de manuscripten wil ik hartelijk danken voor hun bijdrage In het 
bijzonder Prof dr RPC Kessels, Roy, dank voor je waardevolle suggesties en opmerkingen 
en het fijne overleg Het was zeer leerzaam de resultaten te bekijken vanuit een 
neuropsychologische invalshoek 
Enkele studenten wil ik bedanken voor hun bijdrage aan het onderzoek, de analyses, het 
segmenteren van al de wittestofafwijkmgen en hippocampi en het samen schrijven van de 
manuscripten lima Pick, Heleen van den Berg, Lucas van Oudheusden, Ellen van der Holst 
en Inge van Uden, veel dank voor jullie inzet 
De andere RUN DMC-ers Rob, dank voor de gezellige tijd en de leuke samenwerking, veel 
succes met jouw boekje, dat moet er wel komen, he1 Anil, leuk om samen het TBSS stuk te 
hebben geschreven, jouw technische 'Donders' blik is voor ons allemaal zeer waardevol, 
veel succes1 Inge en Ellen, van fanatieke studenten, naar neurologen m opleiding en nu onze 
opvolgers in het RUN DMC onderzoek, geweldig dat jullie het doen en heerlijk om te zien dat 
het met dezelfde ups en downs verloopt, heel veel succes met de follow-up en veel plezier1 
De secretaresses van de 5e verdieping, in het bijzonder Sylvia Spaan, wil ik bedanken voor 
de administratieve ondersteuning en het beantwoorden van de vele telefoontjes van onze 
deelnemers Manelle van Elst-de Bruijn, dank voor je hulp op de polikliniek tijdens de dagen 
dat we de patiënten zagen 
De collega's van de Neurologie, dank voor een gezellige onderzoeks- en opleidmgstijd, de 
prettige samenwerking en de goede werksfeer Manelle en Danielle, wat was het gezellig, al 
die kilometers samen tussen Utrecht en Nijmegen op en neer Ilse, dank voor alle gezelligheid 
ook buiten het werk, succes en tot m Groenlo1 Fand, dank voor je vriendschap en steun, ik 
heb veel geleerd van onze relativerende gesprekjes, veel geluk1 Lieve Lucille, ik mis je nog 
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iedere dag als overbuurvrouw en collega, maar gelukkig met als vriendin, dank voor je steun 
tijdens het onderzoek, voor het delen van hef en leed aan de overkant van de straat en voor 
een bijzonder fijne vriendschap 
Lieve familie en vrienden, dank voor al jullie gezellige telefoontjes, lieve mailtjes en 
ondersteunende kaartjes Meiden, dank voor alle gezelligheid1 Peter, dank voor je 
taalkundige bijdrage, ik zal het woord 'vonden' nooit meer gebruiken1 
Lieve paranimfen, Rafli Verstraete-van de Laar en Ester Frusch-Maassen, wat fijn dat jullie 
naast mij willen staan de 30ste 
Rafli, mijn Utrecht-vriendinnetje, en nu ook promotie onderzoek in Nijmegen Knap van je 
dat je dit besluit hebt genomen Het is soms een beetje te gezellig zo samen in Nijmegen Je 
vriendschap is bijzonder waardevol voor mij Wat heerlijk dat we nog steeds met zijn allen 
op skivakantie gaan, nu met al onze kinderen erbij 
Ester, mijn Sittard-vriendmnetje, een van de weinige 'met'-dokter vriendinnetjes, maar altijd 
bijzonder geïnteresseerd en betrokken, ook tijdens de afronding van dit promotie traject Je 
gezelligheid en vriendschap zijn voor mij onmisbaar Ik hoop dat ook wij weer snel samen 
met onze gezinnen op vakantie gaan 
Lieve schoonfamilie, heerlijk dat we het zo gezellig samen hebben Dank voor jullie liefde, 
steun en interesse Tjeu, heel veel dank voor je hulp bij het logo van onze studie, de lay-out 
van het boekje en het ontwerp van de kaft 
Lieve Sanne en Michiel, mijn lieve 'kleine' zusje, ik ben trots op wie je bent, wat je doet en 
hoe je dat doet, soms zelfs een beetje jaloers Geniet en heel veel geluk met Michiel 
Papa en Mama, jullie zijn de liefste Zonder jullie onvoorwaardelijke vertrouwen, steun en 
liefde was ik met gekomen waar ik nu ben Heel erg veel dank hiervoor Papa, nog altijd 
bezorgd om zijn meisjes, maar zo betrokken, geïnteresseerd en gelukkig om ons steeds weer 
te zien Mama, je staat altijd voor ons klaar, ongelooflijk wat voor bergen je kunt verzetten, 
mets is te gek Dank voor het prachtige schilderij voor de kaft, ik ben er trots op1 En met te 
vergeten jullie liefde en zorgzaamheid voor ons kleine mannetje, het is heerlijk te zien hoe 
jullie van hem gemeten' 
En dan, mijn twee allerliefste mannen, Roel en Justus, jullie zijn mijn alles, wat is het 
leven geweldig samen met jullie Roel, samen zijn met jou maakt al het andere heerlijk 
onbelangrijk Justus, je bent de mooiste en de liefste 
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Stellingen 
behorend bij het proefschrift 
'Cognitive function in elderly individuals with cerebral small vessel disease An MRI study ' 
Anouk G W van Norden, 30 november 2011 
1 'Cerebral small vessel disease' kan variabele stoornissen veroorzaken binnen het volledige spectrum 
aan cognitieve functies (dit proefschrift) 
2 Subjectieve geheugenklachten hebben een radiologisch detecteerbaar pathologisch-anatomisch 
substraat (dit proefschrift) 
3 Longitudinaal onderzoek naar de relatie tussen microbloedingen en cognitieve stoornissen is nodig om 
een onderling oorzakelijk verband te onderscheiden van een gemeenschappelijke oorzakelijke factor 
(dit proefschrift) 
4 'Cerebral small vessel disease' is een uitgebreide ziekte waarbij ook de microstructurele integriteit van 
de normaal ogende wittestof betrokken is bij het cognitief functioneren (dit proefschrift) 
5 Imaging van de microstructurele integriteit van de wittestof heeft voor de klinische praktijk van 
patiënten met cognitieve stoornissen geen toegevoegde waarde bovenop conventionele MRI (dit 
proefschrift) 
6 De microstructurele integriteit van de wittestof geeft meer inzicht in de onderliggende 
pathofysiologische processen van cognitieve achteruitgang (dit proefschrift) 
7 De verklaarde vanantie in cognitief functioneren door 'cerebral small vessel disease' wordt deels 
bepaald door de homogeniteit van een studiepopulatie (dit proefschrift) 
8 Dementie op oudere leeftijd wordt veroorzaakt door meerdere elkaar versterkende factoren 
9 De uitdaging in de moderne geneeskunst is om medische ontwikkelingen tijdig plaats te laten maken 
voor een natuurlijk ziektebeloop 
10 Het liberale rookbeleid van de huidige minister van Volksgezondheid geeft de vrijheid om gevangene 
te blijven van je eigen verslaving en anderen daar onvrijwillig in te betrekken 
11 Het competentiegericht opleiden vergt een grote investering van zowel opleider als AIOS, maar brengt 
completer opgeleide medisch specialisten voort 
12 Het bijhouden van een opleidingsportfolio is uitsluitend een middel maar met een doel op zich 
13 Werkende moeders worden nogal eens als ontaard bestempeld terwijl ze zich niet anders gedragen 
dan werkende vaders 
14 Een kraamhoofd (cerebrale sinus trombose tijdens het kraambed) is voor zowel neuroloog als 
gynaecoloog een bloedstollende ziekte 
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